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Transparency and measurement of quality of health care have received considerable 
attention worldwide in recent years. However, the assessment of quality of care is very 
complex. Quality indicators have been developed in an attempt to differentiate between 
high and low-quality of healthcare processes [1]. These indicators create the basis for quality 
improvement and transparency in the health care system [2]. Three different types of quality 
indicators, which are closely related to each other, are defined by Donabedian and generally 
adapted and used in medical care [3]: structure, process, and outcome indicators. Structure 
indicators reflect the setting in which the care is provided (e.g., case volume, access to specific 
technologies, etc.). Process indicators reflect the total care system (e.g., multidisciplinary 
team management, surgical approach, etc.). Finally, outcome indicators reflect direct clinical 
outcomes and are most commonly used by healthcare professionals to assess the quality of 
surgical care. Ideally, an optimal indicator of quality should support to measure, compare, 
monitor, and -most importantly- improve the quality of delivered care. Assessing quality is 
an indispensable step to ensure patient safety and maintain high quality of care, particularly 
for the field of surgery. 
Since the introduction of minimally invasive surgery (MIS) in the past decades, some new 
and evolving technologies have been introduced without proper evidence regarding their 
benefits and safety (e.g. robotic surgery, LESS (laparoscopic endoscopic single-site surgery)). 
This can potentially lead to patient safety issues in daily clinical practice [4]. This observation 
was also emphasized by the report of the Dutch Health Care Inspectorate published in 2007, 
in which concerns were expressed regarding patient safety during MIS [5]. This report stated 
that specific quality measures are needed to develop a formal quality system for laparoscopic 
procedures to enhance patient safety. 
Initially, the field of gynaecology remained reticent regarding the introduction of advanced 
laparoscopic procedures. However since the introduction of laparoscopic hysterectomy (LH) 
in 1989 [6] its implementation has significantly increased worldwide [7]. LH is nowadays 
even the most frequently performed advanced laparoscopic procedure in the field of 
gynaecology. As a result, it is particularly relevant to determine for this procedure a proper 
method to assess quality. 
Three different surgical approaches of hysterectomy can be distinguished: laparoscopic 
hysterectomy (LH), abdominal hysterectomy (AH) and vaginal hysterectomy (VH) [8]. From an 
evidence-based perspective the VH remains the approach of first choice. When VH is technically 
not feasible, the laparoscopic approach may avoid a conventional AH [8]. However, since the 
introduction of MIS, a worldwide shift from VH towards LH is observed and the proportion of 
VH performed for benign gynaecologic conditions has decreased [9]. At the same time, the 
advantages of LH are getting more evident, and recently prospectively designed studies even 
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consider LH superior to VH (in the absence of prolapse) [10-12]. These results contribute to 
the current international debate regarding the position of the vaginal versus the laparoscopic 
approach. One of the biggest concerns is the growing lack of proficiency of gynaecologists 
to carry out a VH [9, 13]. To draw any conclusions about the position of VH versus LH, more 
insight is needed into the present (Dutch) distribution of hysterectomies per approach. Is the 
use of vaginal approach in hysterectomy indeed in decline? Are residents and gynaecologists 
less exposed to VH because of the implementation of the relatively newer technique of LH? 
And how is the implementation of these “newer” advanced laparoscopic procedures? 
It is well established that new technology and advanced laparoscopic procedures such as 
LH require a more challenging work environment compared to conventional surgery. This 
can potentially lead to patient safety issues [4]. Therefore, in order to guarantee the highest 
level of (surgical) care, there is an urge to appropriately measure the quality of surgical care 
and the proficiency of the surgeon performing these advanced procedures. 
In this context, since increased surgeon- and hospital volume seem to be directly related 
to improved outcomes [14-17], a mandatory case volume has been introduced for several 
high-risk low-volume procedures. This case volume has served as quality indicator for 
several years now and subsequently, a mandatory case volume as a proxy for quality has also 
entered the field of gynaecological surgery. For gynaecological oncology, an annual volume 
of 20 procedures is considered [18]. Also for the advanced gynaecological laparoscopic 
procedures (level 3 & 4 procedures according to the European Society for Gynaecological 
Endoscopy (ESGE)) [19] the Dutch Working Group Gynaecologic Endoscopy (WGE) opened 
the debate to define a minimum number of procedures per hospital/surgeon. Especially 
the number of LHs performed is still under debate, since there is no conclusive data on the 
association between a minimum case volume of 20 and improved surgical outcomes in the 
field of advanced laparoscopic gynaecologic surgery. This makes this “optimal” volume of 
20 procedures only speculative [14, 20]. 
Insight is needed in the number of performed procedures and the number of practising 
gynaecologists in the Netherlands as this will help to assess the (logistical) consequences 
of a required case volume. Furthermore, case-volume alone is not sufficient to accurately 
measure quality of surgical care, and measuring individual surgeon’s skills seem to be 
more relevant [21]. During the surgical training program of residency, (basic) laparoscopic 
skills are taught to future gynaecologists. However it is doubtful if residents are adequately 
trained to independently perform laparoscopic procedures directly after finishing residency. 
Furthermore, to monitor the individual surgical skills, an accurate quality assessment tool 
is required. 
Unfortunately, most of these outcome quality indicators have specific limitations; they 
are usually not based on evidence, are not easily available, are not suitable for quality 
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improvement, and/or are not corrected for case-mix characteristics [2, 22-24]. Case-mix 
variables are defined as specific (patient) characteristics that affect (surgical) outcome. Quality 
assessment without correction for case-mix characteristics, will result in an invalid comparison 
of outcomes among healthcare providers [25, 26]. To illustrate; referral hospitals perform more 
complex procedures and treat more challenging cases (e.g. morbid obese patient, more co-
morbidities, patients with prior surgery) which can potentially result in less optimal surgical 
outcomes. Therefore, case-mix correction is of highest importance and identification of relevant 
case-mix characteristics for LH is necessary when developing a reliable quality indicator.  
Monitor tools based on cumulative sum (CUSUM) charts have already been used many 
decades to detect deteriorations in industrial processes [27-29], and also in healthcare 
processes recent research has shown that risk-adjusted CUSUM graphs can be used to 
continuously monitor individual surgical outcomes and to detect consistently suboptimal 
performance [30]. These CUSUM charts have been shown to be ideally suited to detect 
small persistent changes over time, and modified Observed minus Expected (O-E) CUSUM 
charts provide an easy to understand representation of feedback [31-33]. Benchmarking and 
providing the clinician with feedback appear to have positive effects on the quality of care, 
and these are recognized as important areas for quality improvement [34-36]. Therefore, for 
the development of a new outcome quality indicator, (O-E) CUSUM charts will be ideal to 
use. Furthermore, an important characteristic of a good quality indicator is the possibility to 
improve the quality of the delivered care. Therefore, consistently suboptimal performances 
should be detected and ideally be reflected on. 
A next step in quality improvement is the identification of patient safety risk factors causing 
suboptimal performance (e.g., technological related problems, distractions of the surgical 
process). A recent study on this subject already showed a patient safety framework and 
prioritized various risk factors for MIS [37]. This framework should be evaluated into daily 
practice to find out which risk factors are important and clinically relevant in (gynaecological) 
surgery. Knowledge about and awareness of these patient safety risk factors are crucial to 
improve and enhance the surgical team, the environment and finally surgical quality.
The main objective of this thesis is to develop and test a unique dynamic quality assessment 
tool to correctly measure individual surgical performance of laparoscopic hysterectomy. 
To substantiate the development of this new quality instrument, the implementation of LH 
in the Netherlands and in residency program was assessed, relevant case-mix characteristics 
for LH were explored, several ways to monitor surgical quality were analyzed and attempts 
were made to make quality registries less comprehensive for clinicians. Subsequently, patient 
safety risk factors in LH were identified to enhance patient safety and finally to improve the 
surgical quality of LH. 
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Abstract
Study objective: To assess the implementation of advanced laparoscopic gynecologic 
surgical procedures, assess the number of gynecologists performing these procedures and 
highlight the distribution of surgical approaches to hysterectomy. 
Design: Observational multicenter study.
Design classification: Canadian Task Force classification II-2.
Setting: All hospitals in The Netherlands.
Sample: Minimally invasive surgical procedures in all 90 hospitals in the year 2012, and the 
number of gynecologists performing these procedures. Data were compared with national 
surveys conducted in 2002 and 2007.
Interventions: The number of advanced laparoscopic gynecologic procedures, the 
number of gynecologists performing these procedures, and the distribution of approaches 
to hysterectomy were collected through a Web-based questionnaire.
Measurements and main results: The response rate was 96% (86 of 90 hospitals). A total 
of 4979 advanced laparoscopic gynecologic procedures were performed in 2012 (mean per 
hospital, 58; median 50.5; SD, 44.4), which is a significant increase over 2007 (95% CI 30.3-
46.5; p < .001). The proportion of laparoscopic hysterectomy increased from 3% in 2002 to 
10% in 2007 and to 36% in 2012. The proportions of abdominal hysterectomy (68% in 2002, 
54% in 2007 and 39% in 2012) and vaginal hysterectomy (29% in 2002, 36% in 2007 and 25% 
in 2012) decreased significantly. However, approximately 37% of gynaecologists (n=76) and 
12% of hospitals (n=9), performed fewer than 20 advanced laparoscopic procedures (level 
3 and level 4) annually.
Conclusions: Implementation of advanced laparoscopic gynecologic procedures has 
accelerated tremendously in the last decade, owing mainly to the increased number of 
laparoscopic hysterectomies. A significant shift has occurred from abdominal and vaginal 
hysterectomies toward a laparoscopic approach. The vaginal hysterectomy should be 
brought back in focus, to prevent the deterioration of skills needed to perform this least 
invasive approach. Furthermore, the introduction of case volume as quality assessment 
is sure to have consequences for daily gynecologic surgical practice in The Netherlands. 
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Introduction
Transparency and improvement of quality and safety in healthcare have generated 
considerable worldwide attention in recent years. To get insight into doctors’ performance, 
a growing social demand has been observed from insurance companies and governmental 
associations, as well as from the patient’s perspective.
Given that laparoscopy is being increasingly applied to a broader palette of gynecologic 
surgical procedures and thus is indispensable to the current daily practice of the gynecologic 
surgeon, growing emphasis is being placed on the quality assessment of these minimal 
invasive techniques. 
In highly complex surgery, for example, patient safety issues and outcome measurements are 
directly connected to case volume and hospital volume. Furthermore, surgeon case volume 
has served as a quality measurement tool for several years now [1, 2]. The assumption that 
higher case volume is associated with better patient outcomes in a variety of complex surgical 
procedures is frequently supported in the literature [1, 3, 4]. In addition, the Dutch Health 
Care Inspectorate expressed concerns about low volume and highly complex procedures 
and urgently demanded case volume as quality assessment for these procedures [5]. 
As the laparoscopic approach gains popularity and gynecologic surgeons’ laparoscopic 
skills improve, there is an ongoing shift in surgical indications in the minimally invasive 
approach. Therefore, the demand for volume has also entered the field of advanced 
laparoscopic gynecologic surgery. In this context, a minimum annual volume of 20 procedures 
is mentioned; however, there remain no conclusive data on the association between 
higher case volume and improved surgical outcomes in the field of advanced laparoscopic 
gynecologic surgery, an thus the optimal case volume is only speculative [6]. Furthermore, 
there is ongoing debate regarding centralization and the maximum possible number of 
gynecologists performing these advanced laparoscopic procedures to maintain their surgical 
skills with an adequate case volume. 
To make valid decisions regarding this subject, reliable data are needed to provide insight into 
the current case volume and, not less importantly, the number of gynecologists performing 
these procedures. At the same time, there is growing international concern about an 
undesired shift in the approach of vaginal hysterectomy (VH) to laparoscopic hysterectomy 
(LH), because VH remains the first-choice method for benign indication [7, 8].  
Currently, conclusions regarding the national exposure of advanced laparoscopy and the 
distribution of approaches to hysterectomy in The Netherlands are based on data from 
2007 [9]. 
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On these grounds, the aim of the present study was to assess the current state of advanced 
laparoscopic gynecologic surgery, the number of gynecologists and hospitals performing 
these laparoscopic procedures, and the distribution of the surgical approaches to 
hysterectomy, to analyze the possible practical consequences of an increasing demand for 
high-volume surgeons.  
Materials and methods
In 2013, a Web-based questionnaire was sent to all hospitals in the Netherlands containing 
questions about the number of advanced laparoscopic procedures performed in 2012 and the 
number of gynecologists performing these procedures. The data were extracted from the local 
electronic database or from the theatre lists. In addition, the annual report of each hospital was 
obtained to double-check the provided data. The laparoscopic procedures were classified by 
the 4 levels of difficulty according to the internationally introduced classification [10]. Level 3 
and 4 are considered advanced laparoscopic procedures (level 3: hysterectomy, myomectomy, 
extensive adhesiolysis, and severe endometriosis; level 4: sacrocolpopexy, lymphadenectomy, 
and recto-vaginal endometriosis). The questionnaire also included questions about the number 
of procedures performed using robotic surgery. Furthermore, the numbers of abdominal 
hysterectomies (AHs) and VHs for benign indications and endometrial cancer were collected 
to detect a possible shift in approach. VHs involving pelvic organ prolapse were excluded. In 
addition, the number of abdominal sacrocolpopexy procedures was requested as well. 
To increase the response rate, 2 reminder e-mails were sent after 8 and 12 weeks, and follow-
up calls were made. The collected data were compared with previous data obtained from 
2002 and 2007 [9, 11]. 
The percentages of hospitals in which the different types of laparoscopic and robotic 
procedures are performed were determined. Subgroup analysis was performed with respect 
to teaching hospitals (both academic and nonacademic) and nonteaching hospitals. 
Furthermore, the mean numbers, median, minimum, maximum and standard deviation (SD) 
of procedures performed per hospital were determined, including only the hospitals in which 
procedures were performed. To compare the absolute total number of advanced procedures 
performed in 2007 and in 2012, a subcalculation was done including only the hospitals 
that provided data in both years. In addition, the number of gynecologists performing each 
procedure was collected, to calculate the mean number of annually performed advanced 
procedures per gynecologist and per hospital. The number of procedures were stratified by 
volume into 3 groups: low volume (< 20 procedures), medium volume (20 to 59 procedures) 
and high volume (≥ 60 procedures). The percentages of the different approaches to 
hysterectomy and sacrocolpopexy were determined. 
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Statistical analyses were performed using SPSS version 20.0 (IBM, Armonk, NY). The paired t 
test was used to assess the significance of differences in the total number of procedures for 
2007 and 2012 and to calculate the 95% confidence intervals (CIs) of this difference. The χ² 
test and Fisher’s exact test were used to calculate the differences in hysterectomy techniques 
between 2002, 2007 and 2012 and the differences between teaching and nonteaching 
hospitals. Here p values < .05 were considered statistically significant.
Results
Advanced laparoscopic procedures
Of the 90 hospitals in The Netherlands, 86 (96%) provided the requested data on the 
procedures performed in 2012 and the number of performing gynecologists. The distribution 
of the responding hospitals was 52% teaching (45 of 86) and 48% nonteaching (41 of 86), which 
reflects the national distribution in the Netherlands (50% teaching and 50% nonteaching).
The responding 86 hospitals performed a total of 4979 advanced laparoscopic procedures 
in 2012 (mean per hospital, 58; median 50.5; SD, 44.4). In 2007, 71 responding hospitals were 
included, performing a total number of 1657 advanced procedures (mean per hospital, 23; 
median, 15; SD, 29.7). All of these 71 hospitals provided data in both 2007 and 2012. A total of 
4380 advanced procedures were performed in these 71 hospitals in 2012 (mean per hospital, 
62; median, 53; SD 43,7), which is a significant increase over 2007 (95% CI, 30.3-46.5; p < .001). 
The mean numbers of procedures performed per hospital in 2007 and 2012 are compared in 
Table 1. Significant increases were observed in the number of LHs (95% CI 24.4-34.8; p < .001), 
myomectomies (95% CI 0.4-1.9; p = .003), and lymphadenectomies (95% CI 0.4-3.1; p = .01). 
Table 2 shows the percentage of hospitals where the different procedures were performed, 
along with the distribution among teaching and nonteaching hospitals. With the exception 
of the laparoscopic-assisted vaginal hysterectomy (LAVH), all advanced procedures were 
performed more frequently in teaching hospitals compared to nonteaching hospitals. 
A total of 643 sacrocolpopexies were performed in 2012, with the abdominal approach used 
in 251 (39%) and the laparoscopic approach used in 392 (61%), of which 166 (42%) were 
performed using robotic surgery.
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Number of performing gynecologists and hospitals
The number of advanced procedures performed per gynecologist and per hospital are 
presented in Table 3. The table shows that 37% of gynaecologists (n=76) and 12% of hospitals 
(n=9, including 3 teaching hospitals) perform fewer than 20 advanced procedures annually.
Surgical approaches to hysterectomy
The contribution of LH increased significantly from 3% in 2002 to 10% in 2007 to 36% in 2012, 
including 1.5% using the robotic approach. The proportion of AHs (68% in 2002, 54% in 2007, 
and 39% in 2012) and VHs (29% in 2002, 36% in 2007, and 25% in 2012) decreased significantly 
(Figure 1). The proportion percentage of VHs was significantly higher in nonteaching hospitals 
than in teaching hospitals (29% vs. 23%; (p < .001). Of the various laparoscopic approaches 
Table 2 Percentage of teaching and nonteaching hospitals in which procedures are performed
 Procedure
Hospitals
p value Total (n) Non-teaching (n) Teaching (n) 
Level 3
LH total 91% (78) 80% (33) 100% (45) 0.002
TLH 78% (67) 61% (25) 93% (42) < 0.001
LAVH 31% (27) 41% (17) 22% (10) 0.096
SLH 45% (39) 37% (15) 53% (24) 0.227
Myomectomy 40% (34) 32% (13) 47% (21) 0.116
Adhesiolysis 55% (47) 44% (18) 64% (29) 0.050
Endometriosis 51% (44) 39% (16) 62% (28) 0.074
Level 4
Sacrocolpopexy 24% (21) 5% (2) 42% (19) < 0.001
Lymphadenectomy 14% (12) 7% (3) 20% (9) 0.090
Rv endometriosis 21% (18) 5% (2) 36% (16) < 0.001
Total
Robotic 14% (12) 5% (2) 22 % (10) 0.020
Level 3 91% (78) 81% (33) 100% (45) 0.002
Level 4 38% (33) 10% (4) 64% (29) < 0.001
Percentages were calculated using only the responding hospitals (n=86). Rv = rectovaginal; LH = laparoscopic 
hysterectomy; TLH = total laparoscopic hysterectomy; LAVH = laparoscopic assisted vaginal hysterectomy; 
SLH = supracervical laparoscopic hysterectomy. Teaching hospital include academic and nonacademic 
teaching hospitals.
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Table 3 Amount of performed advanced procedures in 2012 per number of gynecologist and hos-
pital
Number of gynecologists          Number of hospitals
Volume of level 3 and 
4 procedures n (%)
Cumulative sum 
n (%) n (%)
Cumulative sum
 n (%)
Low
1-9 28 (14) 28 (14) 4 (5) 4 (5)
10-19 48 (23) 76 (37) 5 (7) 9 (12)
Medium
20-29 64 (31) 140 (68) 7 (9) 16 (21)
30-39 35 (17) 175 (85) 8 (10) 24 (31)
40-59 27 (13) 202 (98) 18 (23)  42 (54)
High
60-79 3( 2) 205 (100) 11 (14) 53 (68)
 80-99 - - 12 (15) 65 (83) 
100-149 - - 9 (12) 74 (95) 
>150 - - 4 (5) 78 (100) 
Figure 1 Trends in various types of hysterectomies.
Abdominal and vaginal approach decreased significantly, laparoscopic approach increased significantly 
(p<0.001).
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to hysterectomy, total laparoscopic hysterectomy (TLH) was the most commonly performed, 
accounting for 70% of these procedures, followed by 17% for supracervical laparoscopic 
hysterectomy (SLH), 9% for LAVH, and 4% for the robotic approach.
Discussion
A significant increase has been observed in the implementation of advanced laparoscopic 
gynecologic procedures in the Netherlands. This is related especially to the enormous 
increase in the number of LHs performed, but a comparable trend is visible even for the less 
commonly performed myomectomy and lymphadenectomy procedures, demonstrating 
that laparoscopic surgery is being adapted in other fields of gynecologic surgery as well 
(e.g., fertility, oncology). Furthermore, an ongoing shift toward the laparoscopic approach 
can be expected, owing to the adoption of new technologies, increased surgical experience, 
and broader indications (e.g., oncology, performance of more complex procedures, removal 
of larger uteri) [12]. Moreover, the embedment of LH in residency programs has increased, 
with LH currently performed in all teaching hospitals and in 81% of nonteaching hospitals. 
Nonetheless, LAVH is performed more often in nonteaching hospitals. This is remarkable, 
given that TLH seems superior to LAVH with respect to significantly lower blood loss [13]. 
In addition, the proportion of VH was higher in nonteaching hospitals, indicating a slower 
rate of adaptation of LH in nonteaching hospitals, presumably owing to the established 
predominance of VH technique in these hospitals. LAVH may be the first choice for 
gynecologists with less laparoscopic experience and more vaginal surgery experience. 
Our study demonstrates that a large proportion of gynecologists and 12% of the hospitals in 
The Netherlands perform fewer than 20 advanced procedures annually. Thus, acceptance of 
the aforementioned case volume of 20 procedures and implementation of the requirements 
of the Dutch Health Care Inspectorate is almost certain to have consequences for more than 
one-third of the gynecologists performing these procedures. 
The main strength of this study is its highly representative picture of our country; 96% of all 
hospitals provided the requested data. In addition, the study included all types of hospitals: 
academic, teaching, and nonteaching; therefore, our results are also generalizable outside 
The Netherlands. This is the first study to provide data on the numbers of gynecologists and 
hospitals performing these procedures, thereby making an important contribution to our 
case volume analysis.
Most previous studies did not exclude the number of VHs regarding prolapse indications; 
therefore, comparing these studies with our data underestimates the VH rate in The 
Netherlands. However, we asked the same numbers and indications in our previous 
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studies, and thus we can observe a clear trend [9, 11]. Furthermore, one possible reason 
for the decrease in the vaginal approach is the reduced incidence of uterine prolapse and 
the upcoming uterine-sparing surgery for prolapse indications [14]; by excluding prolapse 
surgery from our study, we can eliminate this cause.  
Preferably, additional data on clinical outcomes would even be more informative than the 
volume data alone. Unfortunately, we do not have access to these data and thus cannot 
draw any conclusions about clinical outcomes.
Although the significant decrease in the number of AHs is responsible for 58% of the 
tremendous increase of LHs (Figure 1), an undesirable decrease in the number of VHs was 
observed. This decrease is a matter of concern, given that VH is considered the approach of 
choice in hysterectomy [7, 15]. At the advent of LH a decade ago, an internationally stable or 
even increased percentage of the vaginal approach was observed [9, 16-20]. In this context, 
it might be necessary for training hospitals to bring the vaginal approach back in focus as 
the hysterectomy of first choice during residency, because the experience level of residents 
in VH seems relatively low [8, 21]. However, some argue that LH is superior to VH, and this 
issue is currently a matter of debate. Candiani and coworkers mentioned reductions in blood 
loss, operative pain and hospital stay in favor of the laparoscopic approach, but a reduced 
mean operating time as a clear advantage of the vaginal route [22, 23].
To enhance patient safety, case volume is considered of considerable value. A growing 
number of studies support the influence of surgeon and hospital volume on the clinical 
outcome of several high-risk procedures, such as esophageal cancer resection, colon cancer 
surgery, and abdominal aortic aneurysm repair [1, 3, 24]. Therefore, surgeons and hospital 
volume has become a mandatory aspect of maintaining certification for various surgical 
procedures [6]. Owing to the rapid increase in advanced laparoscopic surgical procedures 
within gynecology, the discussion on case volume has also entered our field. To supply all 
gynecologists who perform advanced laparoscopy with at least 20 advanced laparoscopic 
procedures, the total number needs to increase to at least 740 procedures yearly, an increase 
of 15%. Another solution, in this context, is centralization.
The question remains as to whether there is actually an optimal annual case volume for 
advanced laparoscopic procedures. Doll et al. [6] showed that composite morbidity for benign 
hysterectomy favored high-volume surgeons; however, there is a lack of prospective studies 
to confirm this statement, and no substantial evidence is available on recommendations 
about the optimal annual surgeon and hospital volumes in the field of gynecology. Other 
studies examining other fields of surgery noted that the optimal case volume is procedure-
specific, ranging from 25 to 750 procedures, and the years of surgical practice seem to be 
relevant as well [6]. Introducing surgeon volume for advanced laparoscopic procedures as 
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measurement tool for quality will have considerable consequences for the daily practice. 
In addition, arbitrarily chosen volume criteria seem to be weak and ignore the fact that 
lower volumes do not exclude high-quality surgery, and that high volumes do not rule out 
suboptimal care [25].
Conclusion
Accelerated implementation of advanced laparoscopic gynecologic surgery in The 
Netherlands, particular LH, has been achieved. A significant shift in approach from AH and 
VH toward the laparoscopic approach was observed. Because VH remains the procedure of 
first choice, we should bring this approach back in focus to avoid the deterioration of skills 
needed to perform the vaginal approach. 
Using case volume as a quality assessment tool has consequences for a reasonable number 
of gynecologists and should be introduced with more caution. To accurately measure quality, 
other aspects, such as case-mix, surgical skills, and experience, must be considered as well 
[26].
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Summary
Increase in laparoscopic hysterectomy: shift in indications and dilemmas
Hysterectomy is still one of the most frequently performed gynaecological procedures. The 
use of the laparoscopic approach has increased over recent years and a shift in indication 
has been observed. However, not every clinic or gynaecologist is able to provide laparoscopic 
hysterectomy for more challenging patients. Therefore, referral to an expert center is of the 
highest importance in order to offer the patient the least invasive approach to hysterectomy. 
The advantages of the laparoscopic approach have become more evident over recent 
years. The widespread introduction of minimally invasive surgery means that surgeons 
are encountering new challenges, such as the rapid introduction of new instruments, the 
absolute increased incidence of rare complications and the provision of post-operative 
counseling on recovery. Maintaining knowledge of these matters is essential in order to 
secure the quality of care.
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Dames en heren, 
Ondanks de introductie van meerdere medicamenteuze en hysteroscopische alternatieven, 
is de hysterectomie nog altijd één van de meest uitgevoerde grote ingrepen binnen 
de gynaecologische chirurgie. De laparoscopische uterusextirpatie, die in 1989 werd 
geïntroduceerd door Reich, werd begin jaren 90 voor het eerst uitgevoerd in Nederland. 
Sindsdien neemt de implementatie van deze nieuwe chirurgische techniek toe en breidt 
het indicatiegebied snel uit [1]. Aan de hand van 3 casussen illustreren wij de verschuiving 
van het indicatiegebied van de laparoscopische hysterectomie en een aantal dilemma’s die 
daarbij een rol kunnen spelen. 
Patiënte A, een 62-jarige vrouw, para 4, werd doorverwezen naar de polikliniek gynaecologie 
wegens postmenopauzaal bloedverlies. Patiënte had geen andere gynaecologische klachten. 
Wel had zij in de voorgeschiedenis morbide obesitas (BMI: 48 kg/m²), diabetes mellitus 
type 2 en COPD. In speculo zagen we een gave cervix; het vaginaal toucher was illusoir door 
de obesitas. Transvaginale echografie toonde een uterus van 90x60x55mm en een verdikt 
endometrium van 18mm. Op basis van “endometriumsampling” werd een endometrioïdtype 
adenocarcinoom van het endometrium vastgesteld. Aanvullend werd een röntgenfoto van 
de thorax gemaakt, die geen bijzonderheden liet zien. Gezien de niet-afwijkende grootte 
van de uterus verrichtten we een totale laparoscopische hysterectomie met bilaterale 
salpingo-oöphorectomie, die ongecompliceerd verliep. De huidige richtlijn beschrijft dat 
een laparoscopische benadering bij patiënten die een endometriumcarcinoom met een 
laag stadium en laag risico hebben, in ervaren handen even effectief is als de klassieke open 
procedure [2]. Het postoperatieve beloop was ongecompliceerd. Pathologisch onderzoek 
toonde een adenocarcinoom van het endometrium graad 1 met >50% doorgroei in het 
myometrium. De ovaria en cervix waren niet afwijkend. Gezien de leeftijd van patiënte (≥ 60 
jaar) werd zij behandeld met aanvullende brachytherapie van de vaginatop om zo het risico 
op een locoregionaal recidief te minimaliseren [3]. We controleerde patiënte poliklinisch; 2 
jaar na de operatie was zij klachten- en ziektevrij.  
Patiënte B, een 52-jarige vrouw, para 2 bezocht de polikliniek gynaecologie wegens een zeu-
rende pijn in de onderbuik. Patiënte had bemerkt dat haar buik in omvang was toegenomen. 
Ze had een regulaire cyclus, waarbij de eerste 2 dagen van de menstruatie gepaard gingen 
met hevig vaginaal bloedverlies. In speculo zagen wij een gave cervix. Bij vaginaal toucher was 
de uterus palpabel tot navelhoogte. Transvaginale echografie toonde 2 vergrote structuren 
in de onderbuik, die het meest pasten bij een leio- of adenomyoom. Omdat er onzekerheid 
was over de oorsprong van de structuren werd een MRI scan verricht (Figuur 1). Deze toonde 
een uterus myomatosus met een beeld dat paste bij 2 grote myomen: 1 myoom craniaal van 
het corpus uteri met een afmeting van 75x95x90mm en 1 myoom dorsaal van 90x100x90mm. 
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Bij aanvullend laboratorium onderzoek was de Hb-waarde 4.9mmol/l (referentiewaarde 
7.5-10.0mmol/L). Gezien de hemoglobineondermijnende menorragie en mechanische 
klachten bij een uterus myomatosus bespraken we de verschillende behandelopties met 
patiënte, zoals hysterectomie of embolisatie. Patiënte koos voor een hysterectomie. We 
behandelden haar eerst met ijzersuppletie en een gonadotropine-‘releasing’ hormoon 
(GnRH)-agonist gedurende 3 maanden. Voorbehandeling met GnRH-agonist resulteert in 
een pre- en postoperatieve stijging van de Hb-waarde en in volumereductie van de myomen 
of uterus. Hierdoor is een minimaal invasieve benadering kansrijker. Hiertegenover staan 
echter de hoge kosten van behandeling met een GnRH-agonist en het optreden van post-
menopauzale symptomen [4]. Na de voorbehandeling verrichtten we een totale laparosco-
pische hysterectomie, die ongecompliceerd verliep. We verwijderden de uterus door deze 
te fragmenteren (morcellatie); de uterus woog 930 gram. Het postoperatieve beloop was 
ongecompliceerd. Bij de controle 6 weken later was patiënte klachtenvrij.
Patiënte C, een 47-jarige vrouw, para 0, bezocht de polikliniek gynaecologie wegens hevig 
menstrueel bloedverlies en dysmenorroe. In het verleden had patiënte een hormoonhoudend 
spiraal en orale anticonceptie gebruikt, maar deze werkten onvoldoende en gaven 
bijwerkingen. Bij lichamelijk onderzoek vonden we geen bijzonderheden. Transvaginale 
echografie toonde een beeld dat paste bij een deels intramuraal, deels submuceus myoom 
van 34x25mm. Een vaginale hysterectomie zou de behandeling van eerste keus zijn, maar 
Figuur 1 MRI-scan van patiënt B, met een myoom van 75 x 95 x 90 mm dat craniaal ligt en een 
myoom van 90 x 100 x 90 mm dat dorsaal ligt van het corpus uteri.
(a) Sagittaal, (b) transversaal en (c) coronaal vlak.
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ente wilde een definitieve oplossing en na voorlichting 
 
FIGUUR 1  mRI-scan van patiënt b, met een myoom van 75 x 95 x 90 mm dat craniaal ligt en een myoom van 90 x 100 x 90 mm dat dorsaal ligt van he  corpus uteri. 
(a) Sagittaal, (b) transversaal en (c) coronaal vlak. 
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deze benadering was niet mogelijk omdat patiënte een te nauwe vagina had. Patiënte 
wilde een definitieve oplossing en na voorlichting over de verschillende behandelopties, 
zoals endometriumablatie, hysteroscopische myoomresectie of hysterectomie, koos zij 
voor een totale laparoscopische hysterectomie, waarbij de adnexa in situ zouden blijven. 
Deze ingreep verliep ongecompliceerd; we sloten de vaginatop laparoscopisch met een 
doorlopende hechting met weerhaakjes. Op de tweede dag na de operatie was patiënte 
klachtenvrij en ontsloegen we haar uit het ziekenhuis. Na 6 weken zagen wij patiënte voor 
controle terug op de polikliniek; zij had geen klachten. Bij lichamelijk onderzoek waren er 
geen bijzonderheden; in speculo was de hechting van de vaginatop nog zichtbaar. Ruim 
3 maanden later werd patiënte met spoed ingestuurd wegens acuut ontstane buikpijn na 
coïtus. In speculo zagen we een ruime hoeveelheid sereus vocht en een vaginatop dehiscentie 
van 2-3 cm met herniatie van de tuba. We verrichten daarom een laparoscopie. Omdat beide 
tubae niet vitaal waren verwijderden we deze; de ovaria waren niet-afwijkend. We sloten de 
vaginatop vaginaal gesloten en behandelden patiënte met intraveneuze antibiotica. We 
zagen patiënte hierna nog 2 keer op de polikliniek wegens zeurende buikpijn, waarvoor we 
geen oorzaak konden vinden. 3 maanden later was patiënte klachtenvrij en verwezen we 
haar terug naar de huisarts. 
Beschouwing
Indicatiegebied 
Aanvankelijk werd de laparoscopische hysterectomie geïntroduceerd als alternatief voor 
de abdominale benadering (wanneer de vaginale benadering niet mogelijk was) en werd 
deze alleen uitgevoerd bij de “ideale patiënt”. Zoals onze casussen illustreren worden de 
grenzen voor het uitvoeren van een laparoscopische hysterectomie echter steeds verder 
verlegd. Zo zijn tegenwoordig patiënten met een grote uterus, endometriumcarcinoom met 
een laag stadium en laag risico, of een hoge BMI eveneens geschikt voor de laparoscopische 
benadering. 
Grote uterus. De ontwikkeling van het laparoscopisch verwijderen van een grote uterus, zoals 
bij patiënte B, komt door de verbetering van de laparoscopische vaardigheden van de huidige 
gynaecoloog maar ook door de introductie van nieuwe technologieën en instrumenten, 
zoals bijvoorbeeld de morcellator. 
Endometriumcarcinoom. Bij patiënten met een endometrium carcinoom met een laag 
stadium en laag risico, zoals patiënte A, is de laparoscopische benadering inmiddels de 
eerstekeusbehandeling geworden. De opnameduur en complicatieratio zijn lager dan bij de 
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abdominale route en deze benadering is bewezen veilig [5]. Ook binnen de gynaecologische 
oncologie breidt de rol van minimaal invasieve chirurgie zich snel uit. 
Hoge BMI. Zelfs morbide obesitas, zoals bij patiënte A, is geen belemmering om een ingreep 
succesvol laparoscopisch uit te voeren. Wel is bij patiënten met een hogere BMI of grotere 
uterus het risico op een complicatie of het converteren naar een abdominale benadering 
groter [6]. Een recente meta-analyse laat echter zien dat de laparoscopische benadering bij 
obese patiënten met een BMI ≥35kg/m² gepaard gaat met significant minder complicaties 
en een kortere opname duur, vergeleken met patiënten die een abdominale hysterectomie 
ondergingen [7]. 
Zoals beschreven lijken er nog maar weinig contra-indicaties om de hysterectomie via 
de laparoscopische route te verrichten. Niet elke kliniek beschikt over de praktische 
mogelijkheden om de hysterectomie laparoscopisch uit te voeren bij deze complexere 
patiënten. Om toch de juiste zorg te kunnen verlenen dienen gynaecologen zich te realiseren 
dat ze een patiënte kunnen doorverwijzen naar een expertisecentrum. Op deze manier wordt 
de patiënte de mogelijkheid geboden van de minst invasieve benadering van hysterectomie. 
Voor patiënten met een benigne aandoening geldt de vaginale hysterectomie tot op heden 
nog altijd als gouden standaard en eerstekeuzebenadering, zoals ook beschreven wordt 
in een recente Cochrane-review [8, 9]. Wanneer deze chirurgisch technisch moeizaam 
uitvoerbaar lijkt, vanwege een te nauwe vagina, zoals bij patiënte C, of het ontbreken van 
descensus van de uterus, wordt gekozen voor een laparoscopische benadering voordat de 
conventionele abdominale hysterectomie wordt toegepast.  
Uit recent onderzoek in Nederland is gebleken dat het aantal abdominale hysterectomieën 
afneemt (van 54% in 2007 naar 39% in 2012) ten gunste van het aantal laparoscopische (van 
10% in 2007 naar 36% in 2012). Het aantal vaginale hysterectomieën lijkt echter ook af te 
nemen tijdens de implementatie van de laparoscopische hysterectomie (van 36% in 2007 
naar 25% in 2012) (Figuur 2) [1]. Of dit een zorgelijke ontwikkeling is, is momenteel onderdeel 
van discussie. De voordelen van de laparoscopische benadering vergeleken met de vaginale 
hysterectomie lijken steeds duidelijker te worden, zoals een kortere opname duur, minder 
bloedverlies en minder postoperatieve pijn [10]. Daarentegen is de operatie duur van de 
vaginale benadering nog altijd sterk in het voordeel vergeleken met de laparoscopische 
ingreep. De voorkeur en ervaring van de gynaecoloog spelen een belangrijke rol in de keus 
voor het type benadering [11], maar de indicatie en de voorkeur van patiënte dienen hierin 
leidend te zijn.
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Dilemma’s
Mede door de opkomst van de ‘power morcellator’ zijn de mogelijkheden van laparoscopie 
flink toegenomen en worden steeds grotere uteri en myomen met laparoscopie verwijderd. In 
tegenstelling tot de introductie van nieuwe medicijnen, worden nieuwe instrumenten relatief 
snel en vaak zonder eenduidig wetenschappelijk bewijs op de operatiekamer geïntroduceerd. 
Dit kan potentiële risico’s met zich meebrengen. 
Morcellatie. Zo is ook het gebruik van de morcellator in opspraak geraakt jaren na de 
intro ductie. Recent zijn casussen gepubliceerd waarbij onbedoeld uterussarcomen werden 
gemorcelleerd, wat de prognose negatief beïnvloedt. Er zijn echter geen eenduidige 
symptomen of diagnostische middelen die een uterussarcoom met 100% zekerheid 
kunnen aantonen of uitsluiten. Dit heeft ertoe geleid dat de Amerikaanse Food and Drug 
Administration (FDA) adviseert morcelleren te verlaten in bijna alle gevallen [12]. Als 
reactie hierop probeert men het morcelleren veiliger te maken. Eén van de ontwikkelingen 
is morcelleren in een zak. Op deze manier wordt weefseldisseminatie in de buikholte 
voorkomen. De langetermijnresultaten en mogelijke complicaties van deze methode zijn 
nog niet bekend en daarom moet ook deze techniek zorgvuldig worden geanalyseerd. 
Figuur 2 Trends in verschillende benaderingen van hysterectomie in Nederland in de periode 2002-
2012 [1].
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Recente studies tonen de grote voordelen van de laparoscopische benadering met 
morcellatie vergeleken met laparotomie met betrekking tot de morbiditeit, mortaliteit en 
kosteneffectiviteit. Het huidige standpunt van de Nederlandse beroepsvereniging over deze 
kwestie is dat alle voordelen en risico’s uitgebreid met de patiënte besproken moeten worden 
voordat wordt overgegaan tot morcelleren. 
Vaginatopdehiscentie. Naast de vele bekende voordelen van laparoscopische hysterecto-
mie is het van belang te realiseren dat een vaginatopdehiscentie vaker voorkomt bij 
deze benadering, zoals bij patiënte C het geval was. Deze complicatie manifesteert zich 
meestal laat (>6 weken na de ingreep) en kan –zelden– tot zelfs 6 maanden na de ingreep 
optreden [13, 14]. De incidentie ervan varieert internationaal tussen de 0.3 en 3.1%; een 
Nederlandse studie vond een incidentie van 3.3% [14]. De meest voorkomende klachten 
zijn onderbuikspijn, bloed- en vochtverlies. Vaak volstaat het om de vaginatop vaginaal 
of laparoscopisch te overhechten. Hoewel een relatie wordt vermoed tussen coïtus en het 
optreden van dehiscentie, is er geen reden om coïtus af te raden na 6 weken na de operatie. 
Coïtus zou volgens de huidige zienswijze alleen een dehiscentie uitlokken die vroeg of laat 
toch al zou optreden, omdat er al eerder sprake lijkt te zijn van een primair genezingdefect 
van de vaginatop [14]. Het type hechtmateriaal (met weerhaakjes, mono- of multifilament) 
en type hechttechniek (doorlopend, enkellaags, dubbellaags) zijn regelmatig bestudeerd 
als mogelijke predisponerende factor voor het optreden van een dehiscentie, maar hierover 
geeft de literatuur geen eenduidige conclusie. Vaginatop dehiscentie blijft een zeldzame 
complicatie, maar door de stijging van het aantal laparoscopische hysterectomieën is kennis 
van deze complicatie steeds belangrijker. De klachten van de patiënten worden soms niet 
of niet meer direct gerelateerd aan de ingreep, waardoor er een vertraging in het stellen van 
de juist diagnose kan ontstaan.
Herstel. Patiënten die laparoscopisch geopereerd worden, hebben postoperatief een aan-
zienlijk kortere opnameduur. De veronderstelling dat laparoscopisch geopereerde patiënten 
ook sneller herstellen in de thuissituatie klopt echter regelmatig niet. Zo heerst er soms 
onduidelijkheid over wanneer en met welke dokter contact moeten worden opgenomen in 
het postoperatieve traject. Ook tijdens de thuissituatie blijft de medisch specialist verant-
woordelijk voor de postoperatieve patiënte. Wanneer de patiënte zich bij de huisarts meldt 
met klachten, moet zij worden doorverwezen naar de medisch specialist, zodat de klachten 
in kaart kunnen worden gebracht in relatie tot de uitgevoerde ingreep.  
Recent wetenschappelijk onderzoek in Nederland laat zien dat postoperatief advies op 
maat, bijvoorbeeld met een webbased e-healthprogramma, het postoperatieve herstel 
significant verkort en leidt tot minder postoperatieve pijn, snellere werkhervatting en een 
hogere kwaliteit van leven [15]. Mede door de komst van dit soort patiëntgerichte interventies 
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zal de laparoscopische benadering nog meer tot haar recht kunnen komen. Tevens zal dit 
de maatschappelijke kosten aanzienlijk reduceren en de patiënt tevredenheid vergroten.
Dames en Heren, de laparoscopische hysterectomie is momenteel niet meer weg te denken 
uit het chirurgische palet van de gynaecoloog. Er is verschuiving van het indicatiegebied 
voor deze operatie; in expertisecentra zijn er nog maar weinig contra-indicaties. De juiste 
chirurgische benadering van hysterectomie dient altijd gekozen te worden in nauw overleg 
met patiënte. De mogelijkheid tot doorverwijzing speelt hierbij een belangrijke rol, zodat 
de patiënte de minst invasieve behandeling kan krijgen. 
Naast de vele voordelen van de minimaal invasieve chirurgie, worden gynaecologen maar 
ook andere specialisten geconfronteerd met nieuwe uitdagingen, zoals de snelle introductie 
van nieuwe instrumenten, de absolute toename van zeldzame (late) complicaties en de 
voorlichting bij het postoperatieve herstel. Het is zaak om hiervan kennis te hebben en te 
onderhouden, zodat de hoogste kwaliteit van zorg gewaarborgd blijft.
Leerpunten
  Door een verschuiving van het indicatiegebied wordt laparoscopische hysterectomie 
steeds vaker uitgevoerd.
  Patiënten met een hoge BMI, endometriumcarcinoom met een laag stadium en laag 
risico, of grote uterus komen tegenwoordig in aanmerking voor een laparoscopische 
hysterectomie.
  Vaginatopdehiscentie is een zeldzame, maar late complicatie, die vaker voorkomt bij 
patiënten die een laparoscopische hysterectomie ondergingen dan bij degenen die 
behandeld werden met een vaginale of abdominale hysterectomie.
  Voor patiënten met een benigne aandoening is vaginale hysterectomie de behandeling 
van eerste keus; hierna volgt de laparoscopische en daarna de abdominale hysterectomie.
  Als de gynaecoloog zelf niet beschikt over de praktische mogelijkheden voor de minst 
invasieve benadering van hysterectomie, kan hij of zij de patiënte doorverwijzen naar 
een expertisecentrum om zo de beste zorg te bieden.
  De veronderstelling dat laparoscopisch geopereerde patiënten sneller herstellen in 
de thuissituatie klopt regelmatig niet; goede, op maat gemaakte voorlichting kan het 
postoperatieve herstel wel aanzienlijk verkorten.
  Voordat wordt overgegaan tot het fragmenteren van de uterus (morcelleren) dienen alle 
voordelen en risico’s hiervan uitgebreid besproken te worden met de patiënte.
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Abstract
Objectives: To assess the current state of laparoscopic gynecologic surgery in the Dutch 
residency program, the level of competence among graduated residents, and whether 
they still perform these procedures. Furthermore, their current attitudes toward the 
implementation of minimally invasive surgery into residency training were assessed. 
Design: An online survey (Canadian Task Force Classification III) regarding the level of 
competence, performance, training, and interest for gynecologic laparoscopic procedures.
Participants/Setting: Gynecologists who finished residency training between 2008 and 
2013 in the Netherlands.
Results: Response rate was 73% (171/235). The scores for all basic and intermediate 
laparoscopic procedures performed immediately after residency showed the highest 
competence level (median 5, of scale 1-5). The competence level for advanced laparoscopic 
procedures was less at 3, indicating that the graduated residents are not able to perform 
these procedures without supervision. Overall, 56% of the gynecologists no longer perform 
any level 3 advanced procedures, and 86% do not perform level 4 advanced procedures. 
Gynecologists who still perform the inquired laparoscopic procedures scored a significantly 
higher competence level immediately after residency training for most of procedures 
compared with the gynecologists who do not perform these procedures.
Conclusion: Residents are sufficiently trained for basic and intermediate laparoscopic 
procedures during residency training. However, they are not sufficiently equipped to perform 
advanced laparoscopic procedures without supervision. We should consider training 
advanced procedures especially to a selected group of residents because most gynecologists 
do not perform these procedures after residency. The learning curve for advanced procedures 
continues to rise after finishing residency for those who keep on performing these procedures, 
therefore an additional fellowship is recommended for this group. 
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Introduction
In 2013, the Dutch gynecologic residency program implemented new guidelines, which also 
had surgical requirements [1]. Besides the quantity of performed procedures, the level of 
competence was introduced (Table 1). The requirements of laparoscopic procedures are 
mainly based on performing basic and intermediate (level 1 and 2) laparoscopic procedures 
without supervision, but performance of some advanced (level 3 and 4) procedures with 
supervision is also required (Table 1). Basic and intermediate laparoscopic procedures, 
according to the European Society for Gynaecological Endoscopy [2], are sufficiently taught 
during residency in the Netherlands [3]. However, advanced laparoscopic procedures are 
not formally embedded into this training program [3, 4].
The residency training program forms the basis for the gynecologist to obtain sufficient 
education and adequate proficiency in laparoscopic skills; however, many graduated 
residents do not think they are sufficiently prepared to perform all levels of laparoscopic 
procedures at the completion of their residency program [5-7]. Because laparoscopic 
approach is increasingly preferred to open surgery, there is a growing demand for an adequate 
and structured education program for all levels of laparoscopic procedures during residency. 
The latter is even more important because the Dutch Health Care Inspectorate showed 
concerns about patient safety regarding minimally invasive surgery (MIS) and stated a need 
for improved training in MIS [8]. Therefore, residency training programs are under pressure 
to incorporate both basic and advanced laparoscopic procedures. The question remains 
whether it is even necessary and required to train all residents in these more advanced 
procedures, as a large proportion of residents will potentially perform only basic laparoscopic 
procedures after residency in their daily practice. 
Table 1 Dutch requirement of laparoscopic procedures during gynecological residency
Procedure
Required
number
Level of
competence*
Diagnostic laparoscopy 50 At least 10 on level 4
Laparoscopic adhesiolysis 10 Not specified
Salpingotomy/salpingectomy/ectopic pregnancy 20 Not specified
Cystectomy (laparoscopic or abdominal) 25 At least 5 on level 4
Myomectomy (laparoscopic or abdominal) 5 Not specified
Hysterectomy (VH, AH or LH) 40 Not specified
* Level 1: has theoretical knowledge, level 2: is able to perform under strict supervision, level 3: is able to 
perform under limited supervision, level 4: is able to perform without supervision, level 5: is able to supervise 
and educate others.  
VH = vaginal hysterectomy, AH = abdominal hysterectomy, LH = laparoscopic hysterectomy.
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The aim of this study is to assess the implementation of laparoscopic gynecologic surgery 
in daily residency training program, the level of competence among graduated residents, 
whether they still perform laparoscopic procedures, and at which level they currently perform 
these procedures. Furthermore, this study determines their current attitudes towards the 
implementation of MIS into residency program, to identify barriers and find practical ways 
to optimize the implementation of MIS into the gynecologic residency curriculum.  
Materials and methods
A web-based survey (NetQ) was sent through e-mail to all gynecologists who finished 
residency within the previous 5 years (2008-2013) and were registered at the Dutch Society 
of Obstetricians and Gynecologists (NVOG). Names and e-mail addresses were obtained from 
the NVOG. To maximize the response rate, 3 reminder mails were sent. 
The survey consisted of questions covering demographic characteristics, level of competence 
immediately after finishing residency, current level of competence, and whether the 
respondent still performs these procedures. The same questions were asked regarding 
abdominal and vaginal hysterectomy to compare the different surgical approaches 
to hysterectomy. In addition, the survey included questions about the interest of the 
respondents in performing the procedures and training acquired during residency. The last 
item of the survey was a request for possible solutions to optimize laparoscopic training 
during residency and was answered as free text. A 5-point Likert scale was used to measure the 
state of agreement and the degree of their interest: 1 (strongly disagree) to 5 (strongly agree); 
1 (not interested) to 5 (very interested). Guidelines of the European Society for Gynaecological 
Endoscopy [2] were used to classify the requested laparoscopic procedures according to the 
4 levels of difficulty- first level (basic): diagnostic laparoscopy and laparoscopic sterilisation; 
second level (intermediate): salpingotomy/salpingectomy/ectopic pregnancy, salpingo-
oophorectomy, moderate adhesiolysis, and minimal endometriosis; third level (advanced): 
hysterectomy, myomectomy, extensive adhesiolysis, and severe endometriosis; and fourth 
level (advanced): sacrocolpopexy, lymphadenectomy, and recto-vaginal endometriosis. To 
indicate the level of competence, the Dutch residency curriculum uses 5 different competence 
levels to perform surgery, based on Miller’s pyramid of clinical competence (Figure 1) [9] - level 
1: has theoretical knowledge, level 2: is able to perform under strict supervision, level 3: is 
able to perform under limited supervision, level 4: is able to perform without supervision, 
and level 5: is able to supervise and educate others.  
If the respondents did not answer every item of the questionnaire, subcalculations with 
different denominators were made. Teaching hospitals represent university and nonuniversity 
teaching hospitals.
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Subanalysis of the basic characteristics was performed for sex. Furthermore, the distribution 
of the different subspecialties was calculated. In addition, a subcalculation including the 
gynecologists who are and those who are not performing the surveyed procedures currently 
was performed. This subcalculation is necessary to avoid skewed data, because some 
respondents (e.g., subspecialists maternal-fetal medicine) do not practice any advanced 
laparoscopic procedures. 
Data were analysed with SPSS version 20 (IBM SPSS Statistics, Chicago, IL). The t test and chi-
square test were used to calculate the demographic differences between sexes. The paired 
and unpaired t tests were used to assess the difference between the levels of competence. 
Both mean and median levels of competence were calculated, as both provide useful 
information. A p < 0.05 was considered statistically significant.
Results
Of 235 surveyed gynecologists, 171 responded (73%). Table 2 shows the general characteristics 
of these participants. In total, 51 (30%) respondents were men. Most respondents worked 
Figure 1 Competence levels used in the Dutch curriculum based on Miller’s pyramid.
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in a teaching hospital (n = 135, 78.9%), of which 51 (29.8%) worked in a university teaching 
hospital.
There was an equal distribution of the number of years after finishing residency between the 
respondents; 22% graduated less than one year ago, 24 % 1 to 2 years ago, 18% 2 to 3 years 
ago, 18% 3 to 4 years ago, and 18% finished their residency 4 to 5 years ago.
Level of competence
For the respondents who are still performing the procedures, the current level of competence 
is significantly higher for the majority of all procedures compared with their competence 
level immediately after residency (Table 3). Furthermore, comparing the competence level 
immediately after residency between performing and nonperforming gynecologists, a 
significantly higher competence level is observed for most of the procedures in favor of the 
respondents who still perform the procedures. Only basic laparoscopic procedures show 
similar competence levels for both groups (Table 3). 
For all groups, basic and intermediate laparoscopic procedures scored a median and mean 
competence level between 4 and 5 (Table 3), immediately after residency as well as currently. 
All advanced laparoscopic procedures (level 3 and 4 procedures) were scored a competence 
level less than 3 after residency, indicating that the graduated residents were not able to 
perform these procedures under limited supervision. Furthermore, 56% of the gynecologists 
Table 2 Baseline characteristics of respondents 
Variable 
Men 
(n=51) 
Women 
(n=120)
Total 
(n=171) P value
Mean age (range, median) 38.5 38.0 38.2 (33-49, 38) 0.276
Currently working % (n)
Non-teaching hospital 9.8 (5) 25.8 (31) 21.1 (36) 0.019
Teaching hospital* 90.2 (46) 74.2 (89) 78.9 (135) 0.019
Subspecialty % (n)
General gynecology 27.5 (14) 25.8 (31) 26.3 (45) 0.854
Reproductive gynecology/infertility 17.6 (9) 19.2 (23) 18.7 (32) 0.816
Maternal-fetal medicine 41.2 (21) 35 (42) 37 (63) 0.444
Oncology 11.8 (6) 16.7 (20) 15.2 (26) 0.414
Urogynecology 17.6 (9) 16.7 (20) 17 (29) 0.876
* Teaching hospitals represent university and non-university teaching hospitals.
47
Proficiency for advanced laParoscoPic Procedures in residency
4
Ta
bl
e 
3 
Pe
rc
en
ta
ge
 o
f r
es
po
nd
en
ts
 n
ot
 p
er
fo
rm
in
g 
th
e 
pr
oc
ed
ur
es
 cu
rr
en
tly
 a
nd
 co
m
pe
te
nc
e 
le
ve
l o
f t
he
 re
sp
on
de
nt
s,
 d
iv
id
ed
 b
et
w
ee
n 
re
sp
on
de
nt
s p
er
fo
rm
in
g 
an
d 
no
t p
er
fo
rm
in
g 
th
e 
pr
oc
ed
ur
es
 c
ur
re
nt
ly
Pe
rc
en
ta
ge
 o
f a
ll 
re
sp
on
de
nt
 w
ho
 n
ot
 
pe
rf
or
m
in
g 
cu
rr
en
tly
%
 (n
)
M
ed
ia
n 
le
ve
l o
f c
om
pe
te
nc
e 
a  
of
 re
sp
on
de
nt
s p
er
fo
rm
in
g 
th
e 
pr
oc
ed
ur
e 
cu
rr
en
tly
M
ed
ia
n 
le
ve
l o
f c
om
pe
te
nc
e 
a  o
f 
re
sp
on
de
nt
s n
ot
   p
er
fo
rm
in
g 
th
e 
pr
oc
ed
ur
e 
cu
rr
en
tly
Pr
oc
ed
ur
e
Im
m
ed
ia
te
ly
 
af
te
r r
es
id
en
cy
(m
ea
n,
 S
D)
No
w
(m
ea
n,
 S
D)
P 
va
lu
e
Im
m
ed
ia
te
ly
 a
ft
er
re
si
de
nc
y
(m
ea
n,
 S
D)
P 
va
lu
e 
c
Va
gi
na
l h
ys
te
re
ct
om
y
43
 (6
7)
4 
(4
.4
1,
 0
.6
4)
5 
(4
.7
1,
 0
.5
3)
<0
.0
1 
4 
(3
.9
5,
 0
.8
1)
<0
.0
1 
Ab
do
m
in
al
 h
ys
te
re
ct
om
y
23
 (3
5)
5 
(4
.5
4,
 0
.6
3)
5 
(4
.8
1,
 0
.4
4)
<0
.0
1 
4 
(4
.1
2,
 0
.7
7)
<0
.0
1 
Fi
rs
t l
ev
el
 la
pa
ro
sc
op
y 
(b
as
ic
) b
Di
ag
no
st
ic
 la
pa
ro
sc
op
y
17
 (2
6)
5 
(4
.8
5,
 0
.3
8)
5 
(4
.9
1,
 0
.2
8)
0.
05
5 
(4
.7
7,
 0
.5
1)
0.
42
La
pa
ro
sc
op
ic
 st
er
ili
sa
tio
n
30
 (4
5)
5 
(4
.8
3,
 0
.4
3)
5 
(4
.8
6,
 0
.5
2)
0.
22
5 
(4
.8
4,
 0
.4
3)
0.
94
Se
co
nd
 le
ve
l l
ap
ar
os
co
py
 (i
nt
er
m
ed
ia
te
)
Sa
lp
in
go
to
m
y/
sa
lp
in
ge
ct
om
y/
EP
16
 (2
5)
5 
(4
.6
0,
 0
.6
0)
5 
(4
.8
1,
 0
.4
5)
<0
.0
1
4 
(4
.1
3,
 0
.7
4)
<0
.0
1
Sa
lp
in
go
-o
op
ho
re
ct
om
y 
    
    
    
    
23
 (3
5)
5 
(4
.6
2,
 0
.5
7)
5 
(4
.8
2,
 0
.4
1)
<0
.0
1
4 
(4
.1
8,
 0
.7
6)
<0
.0
1
M
od
er
at
ed
 a
dh
es
io
ly
si
s
44
 (6
6)
5 
(4
.5
4,
 0
.6
6)
5 
(4
.7
9,
 0
.4
7)
<0
.0
1
4 
(4
.1
8,
 0
.9
5)
<0
.0
1
M
in
im
al
/m
ild
 e
nd
om
et
rio
si
s
42
 (6
4)
5 
(4
.4
9,
 0
.6
5)
5 
(4
.8
1,
 0
.4
5)
<0
.0
1
4 
(3
.8
5,
 1
.0
4)
<0
.0
1
Ta
bl
e 
3 
co
nt
in
ue
s o
n 
ne
xt
 p
ag
e
Chapter 4
48
Ta
bl
e 
3 
Co
nt
in
ue
d
Pe
rc
en
ta
ge
 o
f a
ll 
re
sp
on
de
nt
 w
ho
 n
ot
 
pe
rf
or
m
in
g 
cu
rr
en
tly
%
 (n
)
M
ed
ia
n 
le
ve
l o
f c
om
pe
te
nc
e 
a  
of
 re
sp
on
de
nt
s p
er
fo
rm
in
g 
th
e 
pr
oc
ed
ur
e 
cu
rr
en
tly
M
ed
ia
n 
le
ve
l o
f c
om
pe
te
nc
e 
a  o
f 
re
sp
on
de
nt
s n
ot
   p
er
fo
rm
in
g 
th
e 
pr
oc
ed
ur
e 
cu
rr
en
tly
Pr
oc
ed
ur
e
Im
m
ed
ia
te
ly
 
af
te
r r
es
id
en
cy
(m
ea
n,
 S
D)
No
w
(m
ea
n,
 S
D)
P 
va
lu
e
Im
m
ed
ia
te
ly
 a
ft
er
re
si
de
nc
y
(m
ea
n,
 S
D)
P 
va
lu
e 
c
Th
ird
 le
ve
l l
ap
ar
os
co
py
 (a
dv
an
ce
d)
La
pa
ro
sc
op
ic
 h
ys
te
re
ct
om
y
63
 (9
7)
3 
(2
.8
8,
 0
.9
9)
4 
(4
.0
6,
 1
.0
3)
<0
.0
1
2 
(2
.3
1,
 0
.8
3)
<0
.0
1
M
yo
m
ec
to
m
y
88
 (1
33
)
2 
(2
.2
8,
 0
.9
0)
3 
(3
.0
0,
 1
.2
8)
0.
02
2 
(2
.0
2,
 0
.8
2)
0.
21
Ex
te
ns
iv
e 
ad
he
si
ol
ys
is
 
77
 (1
15
)
2 
(2
.6
7,
 1
.1
4)
4 
(3
.7
8,
 0
.9
4)
<0
.0
1
2 
(2
.0
4,
 0
.7
9)
<0
.0
1
Se
ve
re
 e
nd
om
et
rio
si
s 
88
 (1
33
)
2 
(2
.3
9,
 1
.3
8)
3 
(3
.2
2,
 1
.3
5)
<0
.0
1
2 
(1
.9
0,
 0
.7
4)
0.
02
Fo
ur
th
 le
ve
l l
ap
ar
os
co
py
 (a
dv
an
ce
d)
Sa
cr
oc
ol
po
pe
xy
 
95
 (1
45
)
1 
(1
.8
6,
 1
.2
2)
2 
(2
.2
9,
 1
.5
)
0.
08
1 
(1
.3
9,
 0
.6
5)
0.
08
Ly
m
ph
ad
en
ec
to
m
y
94
 (1
44
)
2 
(2
.1
1,
 0
.9
3)
3 
(3
.3
3,
 1
.1
2)
0.
04
1 
(1
.2
8,
 0
.5
3)
<0
.0
1
Re
ct
o-
va
gi
na
l e
nd
om
et
rio
si
s
96
 (1
45
)
2 
(2
.0
0,
 1
.2
3)
1 
(2
.2
0,
 1
.6
4)
0.
66
1 
(1
.3
1,
 0
.5
5)
0.
01
a  L
ev
el
s o
f c
om
pe
te
nc
e:
 L
ev
el
 1
: h
as
 th
eo
re
tic
al
 k
no
w
le
dg
e,
 le
ve
l 2
: i
s a
bl
e 
to
 p
er
fo
rm
 u
nd
er
 st
ric
t s
up
er
vi
si
on
, l
ev
el
 3
: i
s a
bl
e 
to
 p
er
fo
rm
 u
nd
er
 li
m
ite
d 
su
pe
rv
is
io
n,
 le
ve
l 4
: i
s 
ab
le
 to
 p
er
fo
rm
 w
ith
ou
t s
up
er
vi
si
on
, l
ev
el
 5
: i
s a
bl
e 
to
 su
pe
rv
is
e 
an
d 
ed
uc
at
e 
ot
he
rs
.
b  C
la
ss
ifi
ca
tio
n 
of
 la
pa
ro
sc
op
ic
 p
ro
ce
du
re
s a
cc
or
di
ng
 to
 th
e 
ES
GE
 (E
ur
op
ea
n 
So
ci
et
y 
of
 G
yn
ae
co
lo
gi
ca
l E
nd
os
co
py
).
c  P
 va
lu
e 
of
 le
ve
l o
f c
om
pe
te
nc
e 
di
re
ct
ly
 a
fte
r r
es
id
en
cy
 b
et
w
ee
n 
re
sp
on
de
nt
s p
er
fo
rm
in
g 
th
e 
pr
oc
ed
ur
es
 a
nd
 re
sp
on
de
nt
s n
ot
 p
er
fo
rm
in
g 
th
e 
pr
oc
ed
ur
es
 c
ur
re
nt
ly
. 
EP
 =
 e
ct
op
ic
 p
re
gn
an
cy
.
49
Proficiency for advanced laParoscoPic Procedures in residency
4
no longer perform any level 3 procedure currently, and depending on the type of procedure, 
the response varied between 63 and 88% (Table 3). For level 4 procedures, the response was 
86%, and depending on the type of procedures, it varied between 94 and 96% (Table 3).
Hysterectomy
A subcalculation including all respondents showed that performance of the vaginal 
hysterectomy scored a median level of competence of 4 (mean = 4.2) immediately after 
residency, which is significantly lower (p < 0.001) compared with abdominal hysterectomy 
(median = 5, mean = 4.4). The laparoscopic approach scored the lowest level of competence 
(median = 2, mean = 2.5, p < 0.001). On a Likert scale, the respondents are significantly less 
interested in performing a vaginal hysterectomy compared with performing an abdominal 
approach (mean = 3.7 vs. 4.2, p < 0.001). 
Interest of respondents
Overall, 82% and 88% of the respondents are interested (Likert scale 4 and 5) in performing 
level 1 and level 2 laparoscopic procedures (basic and intermediate), respectively. For level 
3 and 4 procedures, 58% and 39%, respectively, are interested in performing these advanced 
procedures.  
Overall, 65% of the participants is satisfied (Likert scale 4 and 5) with their current laparoscopic 
skills, and all participants agreed that they were adequately trained to perform basic 
procedures during residency. However, for laparoscopic procedures levels 2, 3 and 4 this is 
91%, 26% and 6.4 %, respectively. 
Possible solutions 
All respondents were asked to consider a solution to optimize laparoscopic training during 
residency. Table 4 shows the mentioned solutions. The 3 most mentioned solutions were 
more mandatory simulation training (66%), early differentiation during residency (19%), and 
a more structured laparoscopic curriculum (16%).
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Discussion
The main findings of this study show that basic and intermediate laparoscopic surgical 
procedures are sufficiently taught and adequately implemented in the Dutch gynecologic 
residency program. However, the training and implementation of advanced procedures into 
the current residency program is not fully embedded. Furthermore, at the end of residency 
program, a significant higher competence level was found for those who keep on perform 
laparoscopic procedures compared with those who do not. A considerable number of 
gynecologists do not perform any level 3 or 4 laparoscopic procedures currently. Moreover, 
the respondents who keep on performing these procedures after residency are not able 
to do them without direct supervision, and their learning curve for advanced procedures 
continues to rise after finishing residency.
The scores for all basic and intermediate procedures represented the highest level of 
competence immediately after residency. This was already observed in 2003 [3], although 
the level of competence in the current study is even slightly higher. We therefore conclude 
that the implementation has been optimized during the past decade. The low competence 
level for advanced laparoscopic procedures is also observed in the United States and Spain 
[4, 5, 10, 11]. Einarsson et al. suggested the need to improve training for these advanced 
procedures. We consider that this is not feasible currently, and we plead for selection of 
certain residents to train them in these advanced laparoscopic procedures during residency, 
as most gynecologists will not even perform advanced laparoscopic procedures during their 
further career (Table 3). In addition, training programs are under pressure as work-hour 
Table 4 Possible solutions mentioned by the respondents to optimize laparoscopic training during 
residency
Mentioned solution
Percentage of 
respondents
%
More mandatory simulation training, including competition elements and a compulsory 
exam
66
Early differentiation during residency 19
A more structured laparoscopic curriculum with guidelines and protocols 16
More and sooner full responsibility for residents during surgical procedures 13
Surgical educators need more education and laparoscopic skills training in order to 
train their residents sufficiently
8
More scheduled operation time during residency 7
The requested possible solutions were not a mandatory item in the questionnaire and were answered as free 
text. Only the solutions that were mentioned by >5% of the respondents were included.
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restrictions have affected the resident’s case experience and a growing emphasis is placed 
on subspecialties [12-14]. At the same time, more complex surgical possibilities in MIS have 
emerged, and there is an increasing demand to measure quality and skills of residents and 
gynecologists [15]. In this context, we state that only to a selected group of residents who wish 
to specialize in the field of gynaecologic surgery should perform and be exposed to advanced 
procedures, and preliminary selection during residency could be an appropriate solution. To 
underline this idea, we found that 19% of the inquired gynecologists spontaneously gave the 
same solution and assume that early differentiation could be a realistic option to “optimize 
the implementation of MIS into residency”. Consequently, this will increase the laparoscopic 
exposure to this selected group in daily practice [16, 17].
The question remains, however, how and when do we select these residents? First, we 
observed that 42% and 61% of the respondents are not interested in performing level 3 and 
level 4 procedures, respectively. Probably, based on their interests, we can already exclude 
a reasonable high number of residents. However, a remark has to be made. Because we 
surveyed postgraduates and not the residents themselves, this statement might be relative 
and, for example, their loss of interest could have occurred because of lack of training. 
Secondly, a significantly lower level of competence was observed immediately after residency 
for gynecologists who do not perform these procedures currently, compared with the 
gynecologists who do perform these procedures nowadays (Table 3). Therefore, on theoretical 
grounds, an early selection can be made during residency, as this variation of competence can 
be observed during surgical training by using Objective Structured Assessment of Technical 
Skills (OSATS). However, the use of OSATS alone will not be completely sufficient as there are 
some concerns about the objectivity of this tool [18, 19]. Furthermore, it should be emphasized 
that minimal knowledge of advanced laparoscopic procedures is still required for all residents.
Another possible solution for better laparoscopic training during residency is more mandatory 
simulation training as mentioned by two-third of respondents. This solution is already 
implemented, and all Dutch residents need to attend and succeed a mandatory basic 
surgical course, including laparoscopic training and examination. Furthermore, in 2013, 
90% of the Dutch residents had free access to a skills laboratory in their clinic; whereas in 
2003, this was only 35% [3, 20].
The strength of our study is the high response rate of our survey of 73%, which is higher 
than comparable published studies [6, 11]. Moreover, there is an equal distribution between 
the respondents in years after residency and subspecialties. Both suggest that our results 
demonstrate an accurate representation of the Dutch residency program. A potential 
weakness is that we asked competence levels in retrospect. As competence levels are self-
rated and therefore subjective, this could make these data less reliable. 
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We observed that the learning curve of gynecologists who currently perform level 3 and 
4 laparoscopic procedures continues to rise after residency and that they are not able to 
perform these procedures without supervision (Table 3). Therefore, additional training after 
residency, for example, a fellowship, is highly recommended for this group of gynecologist. 
Since the implementation of the new guidelines for the Dutch gynecologic residency program 
in 2013, the residents are already challenged to choose a subspecialty after 4 years to practice 
this subspecialty during the last 2 years of the total residency training program of 6 years [21]. 
With these new guidelines, residents will be trained more extensively in their field of interest 
and subsequently finish residency at a higher competence level in this field. 
A remarkable observation in our study is the lower competence level and the lower interest 
in performing the vaginal hysterectomy compared with abdominal approach. Miskry et al. 
observed similar results in the UK [22]. Because the vaginal approach remains the surgical 
method of choice for hysterectomy, this is a matter of concern [23]. In addition, recent 
research showed an undesirable decrease of the vaginal approach in the Netherlands 
(from 36% in 2007 to 25% in 2012) [24]. Therefore, the vaginal approach should be trained 
extensively during residency, and we have to ensure that this approach of hysterectomy will 
not disappear from the gynecological surgical palette [25].
Conclusion
Residents are sufficiently trained to perform basic and intermediate laparoscopic procedures 
(level 1 and 2) after residency training. For advanced procedures (level 3 and 4), residents are 
not sufficiently equipped to perform these procedures without direct supervision. Therefore, 
it is obvious that the learning curve for advanced procedures continues to rise after finishing 
residency. Additional training or a fellowship after residency to perform these procedures 
independently is recommended. Moreover, these advanced laparoscopic procedures should 
especially be taught to a selected group of residents, because most gynecologists will never 
perform these procedures after residency. This will also reduce the problem of the limited 
caseload of advanced procedures in residency program. An important area for future research 
will be the further development of selection tools and determination of how to identify 
residents who should or should not pursue advanced laparoscopic training. 
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Abstract
The assessment of surgical quality is complex, and an adequate case-mix correction is missing 
in currently applied quality indicators. The purpose of this study is to give an overview of 
all studies mentioning statistically significant associations between patient characteristics 
and surgical outcomes for laparoscopic hysterectomy (LH). Additionally, we identified a 
set of potential case-mix characteristics for LH. This systematic review was conducted 
according to the Meta-Analysis of Observational Studies in Epidemiology guidelines. We 
searched PubMed and EMBASE from January 1, 2000 to August 1, 2015. All articles describing 
statistically significant associations between patient characteristics and adverse outcomes 
of LH for benign indications were included. Primary outcomes were blood loss, operative 
time, conversion and complications. The methodological quality of the included studies 
was assessed using the Newcastle-Ottawa Quality Assessment Scale. The included articles 
were summed per predictor and surgical outcome. Three sets of case-mix characteristics 
were determined, stratified by different levels of evidence. Eighty-five of 1549 identified 
studies were considered eligible. Uterine weight and Body mass index (BMI) were the most 
mentioned predictors (described, respectively, 83 and 45 times) in high quality studies. For 
longer operative time and higher blood loss, uterine weight ≥ 250 to 300g and ≥ 500g and BMI 
≥30 kg/m² dominated as predictors. Previous operations, adhesions, and higher age were 
also considered as predictors for longer operative time. For complications and conversions, 
the patient characteristics varied widely, and uterine weight, BMI, previous operations, 
adhesions and age predominated. Studies of high methodological quality indicated uterine 
weight and BMI as relevant case-mix characteristics for all surgical outcomes. For future 
development of quality indicators of LH and to compare surgical outcomes adequately, a 
case-mix correction is suggested for at least uterine weight and BMI. A potential case-mix 
correction for adhesions and previous operations can be considered. For both surgeons and 
patients it is valuable to be aware of potential factors predicting adverse outcomes and to 
anticipate on this. Finally, to benchmark clinical outcomes at an international level, it is of 
the utmost importance to introduce uniform outcome definitions.
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Introduction
Laparoscopic hysterectomy (LH) is the most performed advanced gynecologic laparoscopic 
procedure, and its implementation has increased worldwide [1]. Currently, there is a growing 
concern regarding patient safety during complex endoscopic surgical procedures, including LH 
[2]. This has led to increased efforts to measure and assess the quality of surgical procedures 
[3]. Quality indicators are widely accepted performance measures used to monitor, evaluate 
and improve the quality of care [4]. Three different types of indicators are outcome, process, 
and structural quality indicators [5]. Outcome indicators refer to direct clinical outcomes and 
are the most used indicators to assess quality of surgical care. Process indicators measure 
the complete care system (e.g., multidisciplinary meetings). Structural indicators reflect the 
setting in which the care is provided (e.g., case volume). The assessment of surgical quality is 
very complex, and one of the main problems of the introduced quality indicators is the lack of 
case-mix correction. Case-mix variables are defined as characteristics that influence surgical 
outcomes and could potentially explain the differences in outcome among hospitals and/or 
surgeons. Therefore, for a reliable interpretation of surgical outcomes, a correction for case-mix 
is of highest importance [6]. To develop an accurate quality indicator for LH, more insight is 
needed into the patient characteristics that influence surgical outcomes. Yet, no international 
consensus has been reached on this issue. A great variety of published studies mentioned 1 or 
more predicting patient characteristics for LH, but no accurate overview of these characteristics 
is available. This is a challenging topic because different outcome definitions are used in 
literature and also other factors than patient characteristics (e.g., surgeon volume, type of 
procedures etc.) could potentially influence surgical outcomes. However, a clear summary of 
patient characteristics associated with surgical outcomes is first needed in order to continue 
the discussion about the essence of case-mix adjustment for reliable quality assessment. 
The objective of this study is to identify patient characteristics that significantly influence 
the surgical outcome of LH. Additionally, we aim to compose a minimal set of potential 
case-mix variables for LH. This set should preferably be used in the development of (new) 
quality assessment tools and is the first step required to develop a valid and accurate quality 
indicator for LH.  
Materials and methods
Data sources
This systematic review was performed according to the Meta-Analysis of Observational 
Studies in Epidemiology guidelines [7]. A search of the literature in PubMed and EMBASE was 
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performed from January 1, 2000 to August 1, 2015 to identify articles describing a statistically 
significant association between patient characteristics and surgical outcomes of LH.
A clinical librarian was consulted to define the search strategy, together with the primary 
researcher (S.R.C.D.). The exact search string is shown in Supplemental Appendix 1. All 
duplicate articles were removed. All references of selected articles were reviewed to identify 
other relevant articles. If additional eligible articles were identified, a new search string 
was composed by the research librarian to include these extra references as well. This was 
repeated until no new cross-references were found. At this point the search was considered 
as definitive (see Supplemental Appendix 1). We limited the results to human studies and 
studies written in English. 
Study selection
The literature selection was performed independently by 2 authors (S.R.C.D. and E.M.S.). In 
case of uncertainty, a third author (F.W.J.) was contacted. After a first selection on titles and 
abstracts, the full text of the remaining articles were reviewed using the following exclusion 
criteria: LHs for oncologic indications, studies reporting no association between predictors 
and clinical outcomes, nonclinical studies (e.g., review, case report), and conference 
abstracts. If unexpected oncologic cases were included in the study population, only those 
studies with less than 5% oncologic cases were included. 
Equal data from multiple publications based on the same cohort were only used once in 
the final analysis. 
Predictors were defined as patient characteristics that were statistical significantly associated 
with adverse surgical outcomes. Our study focused only on patient characteristics as 
predictors, because these variables cannot be influenced in any way during the (pre)surgical 
process and are therefore suitable as case-mix characteristics. For this reason the type of 
LH, the use of different technical instruments (e.g., monopolar, bipolar, ultrasound, use 
of mobilizer etc.), preoperative medical treatment, surgeon’s volume, and the number of 
surgeons performing the procedure were not included in our study.
Surgical outcomes included intraoperative blood loss, operative time, conversion to 
laparotomy, and complications. The definition of the surgical outcomes as mentioned by 
the authors in the included paper was applied. Hospital stay was not considered as a surgical 
outcome, because hospital discharge mainly depends on the (local) guidelines. 
The included articles were summed per predictor and surgical outcome (Table 1). The 
surgical outcomes were depicted in 4 separated tables, including all selected articles with 
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the detailed predictor, the (detailed) outcome, the study population, the study design and 
the methodological quality (Table 2, 3, 4, 5).  
This systematic review did not involve human subjects and was exempt from institutional 
board review.
Quality assessment
The methodological quality of the included studies was assessed according to the Newcastle-
Ottawa Quality Assessment Scale (NO-QAS) [8]. This assessment scale assigns a specific 
study up to a maximum of 9 points, to include points for selection of the study groups, 
comparability of the groups and the ascertainment of outcome or exposure of the study. For 
example, a study was higher rated when correction for confounders or regression analysis 
was performed. The rating was done independently by the 2 review authors (S.R.C.D. and 
E.M.S.). Furthermore, the different study designs were reported: randomised controlled trial, 
prospective cohort study, retrospective cohort study, and case-control study.
Selection of case-mix variables
Per surgical outcome, 3 sets of case-mix characteristics were composed according to 
defined criteria of levels of evidence (Table 6; low, medium, and high). These criteria were 
based on the number of high quality studies (NO-QAS 9) and considerable quality studies 
(NO-QAS 8 or 7) as modified from Courrech Staal et al. [9]. Case-mix selection set 1 (low): 
all characteristics mentioned in ≥1 study with NO-QAS of 9 or ≥2 studies with NO-QAS 8 or 
7; set 2 (medium): characteristics identified in ≥1 study with NO-QAS of 9 and ≥1 study with 
NO-QAS 8 or 7, set 3 (high): characteristics mentioned in ≥2 studies with NO-QAS of 9 or ≥4 
studies with NO-QAS 8 or 7 (Table 6).
Results
Overview of studies  
An overview of the literature selection is shown in Figure 1. The literature search yielded 
1549 unique articles. After selection, 85 articles met the inclusion criteria and reported a 
significant association between specific patient characteristics and surgical outcomes. Of 
these 85 articles, 4 were randomized controlled trials, 29 prospective cohort studies, 47 
retrospective cohort studies and 5 case-control studies (Table 2, 3, 4 and 5). 
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Figure 1 Flowchart of reviewed and selected studies.
Table 1 Number of found articles that showed a statistical significant association between the 
patient characteristics and surgical outcome
                                         OUTCOME
PATIENT 
CHARACTERISTIC
(Predictor) 
Longer 
operative 
time
More 
blood 
loss
Increased 
complication 
rate
Increased 
conversion 
rate
Total
Uterine weight 47 21 7 8 83
BMI 21 11 8 5 45
Previous operations 3 na 7 6 16
Adhesions 3 3 4 2 12
Endometriosis 1 na 2 na 3
Age 3 1 4 1 9
Uterine descent na na 1 na 1
Menopause 1 na na na 1
Parity 1 1 2 na 4
Fibroid na na na 1 1
Comorbidity (previous stroke/TIA, 
DM, creatinine or platelet count, ASA 
score, hypertension)
1 na 6 na 7
Smoking na na 2 na 2
Ethnicity na na 1 na 1
Total 81 37 44 23 185
DM = diabetes mellitus, na = not applicable.
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The number of included articles per patient characteristic and surgical outcome is depicted 
in Table 1. Figure 2 demonstrates a graphical representation of the number of articles where 
a significant association between the patient characteristic (predictor) and surgical outcome 
was identified.
Uterine weight and body mass index (BMI) are by far the most mentioned patient 
characteristics influencing all surgical outcomes and described, respectively 83 and 45 times 
in the selected articles (Table 1 and Figure 2). Subsequently, previous operations, adhesions, 
and age were mentioned 16, 12, and 9 times, respectively, as predictor (Table 1).  
Several other patient characteristics were only mentioned once or a few times in the selected 
articles: parity, endometriosis, uterine descent, menopause, presence of fibroids, ethnicity, 
previous stroke, smoking, diabetes mellitus, American Society of Anesthesiologists (ASA) 
score, hypertension, creatinine serum, and platelet count (Table 1). 
The selected articles and predictors are shown in detail per surgical outcome (blood loss, 
operative time, conversion and complications) in Table 2, 3, 4 and 5. 
Predictors for longer operative time
Respectively, 47 and 21 studies reported a significant association between prolonged 
operative time and high uterine weight and high BMI.
The most mentioned detailed associations for prolonged operative time were uterine weight 
≥ 250 to 300 grams and ≥ 500 grams and BMI ≥ 30 kg/m². Previous operations and adhesions 
Figure 2 Number of selected articles that showed a statistical significant association between the 
patient characteristic and outcome (including only the characteristics which are mentioned more 
than twice).
Chapter 5
64
were also considered as relevant predictors, both mentioned in 3 studies (Table 2). Three 
studies found older age to be associated with prolonged operative time. 
Predictors for increased blood loss
For the outcome increased blood loss, 21 articles observed a significant association with 
larger uterus and 11 articles with higher BMI (Table 1), whereas uterine weight ≥ 500 g and 
BMI ≥ 30 kg/m² were mentioned the most (Table 3). In addition, 3 different studies found 
that the presence of adhesions also had an impact on blood loss.
Predictors for increased complication rate
For complications, patient characteristics varied widely, but uterine weight, BMI, previous 
operations and adhesions predominated (Table 4). Also, the predictor age was mentioned in 4 
different studies. A considerable difference was found among described ages, and no consistent 
cutoff value could be found. Endometriosis was mentioned as a significant predictor in 2 studies. 
Furthermore, comorbidity (e.g., diabetes mellitus, previous stroke, ASA score), smoking, ethnicity, 
and uterine descent were mentioned in 1 or 2 studies rated as high quality (NO-QAS 8-9). 
Predictors for increased conversion rate
For conversion (Table 5), the least studies showing a significant association with patient 
characteristics were found (a total of 23 studies, Table 1). Uterine weight, BMI and previous 
operations were the most mentioned significant predictors. Adhesion, age, and presence 
of fibroids were also found in 1 or 2 studies.
Selection of case-mix characteristics 
Three different sets of case-mix variables per surgical outcome are depicted in Table 6. 
The number of case-mix variables depends on the preferred level of evidence criteria. Looking 
at the lowest level of evidence criteria (set 1), a great variety of case-mix characteristics can 
be selected: uterine weight, BMI, adhesions, previous operations, age, endometriosis, uterine 
descent, smoking, transient ischemic attack/stroke, diabetes mellitus, and ASA score. When 
selecting the highest composed level of evidence criteria (set 3), less case-mix characteristics 
were observed: uterine weight, BMI, previous operations, and adhesions. 
In all defined levels of evidence (low, medium, and high; Table 6), uterine weight and BMI 
remained selected as relevant case-mix characteristics for all surgical outcomes.
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Discussion
In this review we aimed to identify predictors for surgical outcomes of LH. These predictors 
can be used as case-mix correctors for quality assessment and serve to correctly compare the 
outcomes of clinicians. We observed that most studies of high quality described a statistically 
significant association between higher BMI, high uterine weight, and less favorable surgical 
outcomes. Also, adhesions and previous operations seemed to be important predictors for 
the outcome of LH. These 2 characteristics are closely linked to each other, because previous 
operations are obviously associated with pelvic adhesions [10]. The strong association 
between larger uterine weight and all surgical outcomes for LH can inherently be explained 
by a larger blood supply in large uteri, the need of morcellation, and inadequate visibility 
Table 6 Selection of case-mix variables per surgical outcome; stratified per level of evidence criteria
Sets of case-mix characteristics
Set 1 (Low)
Level of evidence criteria:
≥1 study with NO-QAS 9
or
≥2 studies with NO-QAS 
8 or 7
Set 2 (Medium)
Level of evidence criteria:
≥1 study with NO-QAS 9
and
≥1 study with NO-QAS 
8 or 7
Set 3 (High)
Level of evidence criteria:
≥2 study with NO-QAS 9 
or
≥4 studies with NO-QAS 
8 or 7
Operative time Uterine weight
BMI
Adhesions
Previous operations
Age
Uterine weight
BMI
-
Previous operations
Age
Uterine weight
BMI
-
-
-
Bloodloss Uterine weight
BMI
Uterine weight
BMI
Uterine weight
BMI
Complication Uterine weight
BMI
Previous operations
Adhesions
Age
Endometriosis
Uterus descent
Smoking
TIA/Stroke
Diabetes Mellitus
ASA score
Uterine weight
BMI
Previous operations
Adhesions
Age
-
-
Smoking
-
Diabetes Mellitus
-
Uterine weight
BMI
Previous operations
Adhesions
-
-
-
-
-
-
-
Conversion Uterine weight
BMI
Previous operations
Adhesions
Age
Uterine weight
BMI
-
Adhesions
-
Uterine weight
BMI
Previous operations
-
-
NO-QAS = Newcastle-Ottawa Quality Assessment Scale.
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during surgery, which can also lead to prolonged surgery and more complications [11]. 
Higher BMI was found to be a predictor for longer operative time, more blood loss, and 
higher risk for complications and conversion. The laparoscopic entry and actual procedure 
can be more difficult in obese women. However, as has been shown in different studies, 
LH in obese women and for large uteri is still a safe and feasible approach and should be 
considered before the abdominal approach [11, 12].
Based on our search, a case-mix correction for at least uterine weight and BMI is strongly 
recommended when assessing surgical quality of LH. It remains debatable which level of 
evidence criteria a patient characteristic should meet before being selected as valid case-mix 
characteristic. However, even when we consider the highest level of evidence (Table 6), BMI 
and uterine weight remain relevant predictors for all surgical outcomes. 
Previous operations and adhesions can also be considered as potential case-mix factors. 
However, the difference in severity of adhesions makes it more complex to use for a quality 
assessment tool and quality indicator. Age is also mentioned as predictor in a number 
of high quality studies for the outcomes complications, operative time, and conversion. 
However, both younger and older ages are observed as predictors, and no specific cut-off 
point is observed, which makes a case-mix correction difficult. Furthermore, comorbidity 
characteristics (e.g., diabetes mellitus, ASA score, transient ischemic attach/stroke), smoking, 
and uterine descent should be further explored, as only 1 or 2 studies did mentioned these 
factors, however these are studies of high quality. 
Pelvic endometriosis is often mentioned as a level of difficulty of LH and therefore expected to 
be highly associated with worse surgical outcomes. However, unexpectedly, the appearance 
of endometriosis did not seem to be an important predictor in the literature, because only 3 
articles showed a significant association with longer operative time and more complications. 
A possible explanation is the difficulty in consistently determining the stage of endometriosis 
and therefore was not included as a registered patient characteristic in the studies. In addition, 
LH alone is generally not the primary treatment for (deep infiltrating) endometriosis (e.g., in 
case of bowel or bladder involvement), and therefore a large proportion of endometriosis 
cases were probably excluded in the study population of the eligible articles. Furthermore, 
it is well known that the appearance of endometriosis is closely correlated with pelvic 
adhesions, which is more often found to be a predictor. 
Strengths and limitations
The major weakness of our study is the fact that our conclusions are only based on the 
number and quality of identified articles and that a more in-depth analysis of the data was 
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not possible. Our intended design was to pool the results with meta-analysis to determine 
strong evidence. Most included studies are studies had a different main objective from our 
search query, and therefore only very limited data for analysis were available (e.g., no means, 
no standard deviations) and an enormous heterogeneity in outcomes was observed. For this 
reason it was also not possible to identify all studies that did not find a significant difference 
between patient characteristics and outcome, because most articles only described the 
statistically significant data in the results section. However, because we were able to select 
more than 80 articles, our data do give a clear overview of the importance of certain patient 
characteristics in the outcome of LH. In addition, it is clear that a case-mix correction for 
some patient characteristics is indispensable to compare surgical outcomes correctly. We 
are also aware that reporting bias may play a role in the interpretation of our results. Our 
selected list of patient characteristics includes only those characteristics that have been 
reported in literature, and possibly also other characteristics not mentioned in literature, are 
associated with certain surgical outcomes. In addition, other well-known factors or diseases 
are inherently associated with our found characteristics (e.g., hypothyroidism with BMI). 
A subject for future debate is how to apply case-mix adjustment for quality assessment tools. 
Several issues need to be taken into account as cut-off values of certain characteristics and 
how to weight these case-mix variables. 
Another important issue regards the problem in the definitions of clinical outcome in 
literature. For example, the definition of a complication varies per study. This inconsistency 
makes it more difficult to properly compare clinical outcomes and thus surgical quality, and 
therefore we mentioned all used definitions for complications in our results (Table 5). In our 
opinion it is of the utmost importance to achieve an international consensus on uniform 
outcome definitions and to implement them worldwide. An attempt was made in a recently 
published study that gives a multidisciplinary consensus on the definition of conversion [13].
Measuring quality of healthcare interventions is a complex and difficult issue. To obtain 
and develop a validated and accurate quality assessment tool for LH, our study is the first 
necessary step, and case-mix adjustment is indispensable [6]. At the current time, quality 
assessment is a much-discussed issue and ranking lists of “best hospital” and “top surgeons”
are available to everyone. These data are widely interpreted by the media and patients as 
reliable quality measurements of performance data of hospitals and surgeons. However, 
the differences in patient population between hospitals and surgeons are usually ignored. 
Therefore, these quality-ranking lists provide the clinician, the insurance company, and 
the patient with a certain false sense of security. This is especially important for teaching 
and referral hospitals, because more challenging and more complex patients are treated 
in these clinics.
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Our study gives an overview of all patient characteristics that influence the surgical outcome 
of LH. This is an important issue, not only for quality assessment but also for patient 
counselling and surgical scheduling. Based on these results surgeons will be able to better 
predict operative time, blood loss and risk for complications or conversion and anticipate 
on those issues. Furthermore, evidence-based knowledge of case-mix characteristics can 
be important considering medicolegal issues.  
In conclusion, BMI, uterine weight, adhesions and/or previous surgery are the main predictors 
for surgical outcomes of LH. For future development of outcome quality indicators of LH 
and to correctly compare surgical outcomes, a case-mix correction is suggested for at least 
uterine weight and BMI. For both surgeons and patients it is of great value to be aware of 
potential factors predicting worse clinical outcomes and to anticipate on them. Finally, 
to benchmark clinical outcomes, it is of highest importance that similar (international) 
definitions are developed.
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Supplemental Appendix 1
Complete search strategy
Pubmed
((“laparoscopic hysterectomies”[tw] OR “laparoscopic hysterectomy”[tw] OR “laparoscopically 
assisted hysterectomies”[tw] OR “laparoscopically assisted hysterectomy”[tw] OR 
“laparoscopically assisted vaginal hysterectomies”[tw] OR “laparoscopically assisted vaginal 
hysterectomy”[tw] OR “laparoscopically assisted vaginal radical hysterectomy”[tw] OR 
“laparoscopical hysterectomy”[tw] OR ((“Laparoscopy”[mesh] OR “laparoscopy”[tw] OR 
“laparoscopic”[tw] OR laparoscop*[tw]) AND (“Hysterectomy”[mesh] OR “hysterectomy”[tw] 
OR “hysterectomic”[tw] OR hysterectom*[tw])) OR “robotic hysterectomies”[tw] OR “robotic 
hysterectomy”[tw] OR “robotic assisted hysterectomies”[tw] OR “robotic assisted 
hysterectomy”[tw] OR “robot assisted hysterectomies”[tw] OR “robot assisted 
hysterectomy”[tw] OR “robotically assisted hysterectomy”[tw]) AND (“predictor”[tw] OR 
“predictors”[tw] OR predict*[tw] OR “Forecasting”[Mesh] OR “Time factors”[mesh] OR 
“learning curve”[tw] OR “Learning Curve”[mesh] OR ((“Blood Loss, Surgical”[majr] OR “blood 
loss”[ti] OR “blood losses”[ti] OR “mean estimated blood loss”[tw] OR “Intraoperative 
Complications”[majr] OR “Postoperative Complications”[majr:noexp] OR “Pain, 
Postoperative”[majr] OR “Postoperative Hemorrhage”[majr] OR “Shock, Surgical”[majr] OR 
“Surgical Wound Dehiscence”[majr] OR “complication”[ti] OR “complication severity”[tw] 
OR “complications”[ti] OR “conversion”[ti] OR “conversion rate”[tw] OR “conversion rates”[tw] 
OR “Conversion to Open Surgery”[majr] OR “hospital discharge”[ti] OR “Patient 
Discharge”[majr] OR “Patient Discharge”[ti] OR “hospital stay”[ti] OR “Length of Stay”[majr] 
OR “Length of Stay”[ti] OR “Operative Time”[majr] OR “operative time”[ti] OR “Surgical 
Time”[ti] OR “Surgery Time”[ti] OR “Surgical volume”[ti] OR “high volume”[ti] OR “low 
volume”[ti] OR “hospital volume”[ti] OR “Hospitals, Low-Volume”[majr] OR “Hospitals, High-
Volume”[majr] OR “Reoperation”[majr] OR “reoperation”[ti] OR “re-operation”[ti] OR “Surgical 
Revision”[ti] OR “revision surgery”[ti] OR “Repeat Surgery”[ti] OR “surgical site infection”[ti] 
OR “surgical site infections”[ti] OR “Surgical Wound Infection”[majr] OR “Surgical Wound 
Infection”[ti] OR “Surgical Wound Infections”[ti] OR “uterine weight”[tw] OR “uterus 
weight”[tw] OR “uterine size”[tw] OR “uterus size”[tw] OR “Organ Size”[mesh] OR “large 
uterus”[tw] OR “large uteri”[tw] OR “small uterus”[tw] OR “small uteri”[tw] OR “large 
uterus”[tw] OR ((“large”[ti] OR “small”[ti] OR “size”[ti] OR “weight”[ti]) AND (“uterus”[ti] OR 
“uteri”[ti])) OR “Uterus/anatomy and histology”[Majr:NoExp] OR “Risk Factors”[Majr] OR “Risk 
Factors”[ti] OR “Risk Factor”[ti] OR “BMI”[ti] OR “Body mass index”[ti] OR “Body Mass 
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Index”[Majr] OR ((“Uterus”[ti] OR “uterine”[ti]) AND descen*[ti]) OR “Age”[ti] OR “age 
factors”[majr] OR “Previous”[ti] OR adhesion*[ti] OR “Tissue Adhesions”[majr] OR “Parity”[ti] 
OR “Parity”[majr] OR “abdominal surgery”[ti] OR “abdomen surgery”[ti] OR “Abdomen/
surgery”[Majr] OR “endometriosis”[ti] OR “Endometriosis”[majr] OR “smoker”[ti] OR 
“smoking”[ti] OR “Smoking”[majr]) AND (“Outcome Assessment (Health Care)”[Mesh] OR 
“outcome”[tw] OR “outcomes”[tw] OR “Risk”[mesh] OR “risk factor”[tw] OR “risk factors”[tw] 
OR “safe”[tw] OR “unsafe”[tw] OR “safety”[tw] OR “Medical Errors”[mesh] OR “injury”[tw] OR 
“injuries”[tw]))) AND (“2000/01/01”[PDAT] : “3000/12/31”[PDAT]) NOT (“Animals”[mesh] NOT 
“Humans”[mesh]) AND english[la]) OR ((“laparoscopic hysterectomies”[ti] OR “laparoscopic 
hysterectomy”[ti] OR “laparoscopically assisted hysterectomies”[ti] OR “laparoscopically 
assisted hysterectomy”[ti] OR “laparoscopically assisted vaginal hysterectomies”[ti] OR 
“laparoscopically assisted vaginal hysterectomy”[ti] OR “laparoscopically assisted vaginal 
radical hysterectomy”[ti] OR “laparoscopical hysterectomy”[ti] OR ((“Laparoscopy”[majr] OR 
“laparoscopy”[ti] OR “laparoscopic”[ti] OR laparoscop*[ti]) AND (“Hysterectomy”[majr] OR 
“hysterectomy”[ti] OR “hysterectomic”[ti] OR hysterectom*[ti])) OR “robotic hysterectomies”[ti] 
OR “robotic hysterectomy”[ti] OR “robotic assisted hysterectomies”[ti] OR “robotic assisted 
hysterectomy”[ti] OR “robot assisted hysterectomies”[ti] OR “robot assisted hysterectomy”[ti] 
OR “robotically assisted hysterectomy”[ti]) AND (“predictor”[tw] OR “predictors”[tw] OR 
predict*[tw] OR “Forecasting”[Mesh] OR “Time factors”[mesh] OR “learning curve”[tw] OR 
“Learning Curve”[mesh] OR ((“Blood Loss, Surgical”[majr] OR “blood loss”[ti] OR “blood 
losses”[ti] OR “mean estimated blood loss”[tw] OR “Intraoperative Complications”[majr] OR 
“Postoperative Complications”[majr:noexp] OR “Pain, Postoperative”[majr] OR “Postoperative 
Hemorrhage”[majr] OR “Shock, Surgical”[majr] OR “Surgical Wound Dehiscence”[majr] OR 
“complication”[tiab] OR “complication severity”[tw] OR “complications”[tiab] OR 
“conversion”[ti] OR “conversion rate”[tw] OR “conversion rates”[tw] OR “Conversion to Open 
Surgery”[majr] OR “hospital discharge”[ti] OR “Patient Discharge”[majr] OR “Patient 
Discharge”[ti] OR “hospital stay”[ti] OR “Length of Stay”[majr] OR “Length of Stay”[ti] OR 
“Operative Time”[majr] OR “operative time”[ti] OR “Surgical Time”[ti] OR “Surgery Time”[ti] 
OR “Surgical volume”[ti] OR “high volume”[ti] OR “low volume”[ti] OR “hospital volume”[ti] 
OR “Hospitals, Low-Volume”[majr] OR “Hospitals, High-Volume”[majr] OR “Reoperation”[majr] 
OR “reoperation”[ti] OR “re-operation”[ti] OR “Surgical Revision”[ti] OR “revision surgery”[ti] 
OR “Repeat Surgery”[ti] OR “surgical site infection”[ti] OR “surgical site infections”[ti] OR 
“Surgical Wound Infection”[majr] OR “Surgical Wound Infection”[ti] OR “Surgical Wound 
Infections”[ti] OR “uterine weight”[tw] OR “uterus weight”[tw] OR “uterine size”[tw] OR “uterus 
size”[tw] OR “Organ Size”[mesh] OR “large uterus”[tw] OR “large uteri”[tw] OR “small 
uterus”[tw] OR “small uteri”[tw] OR “large uterus”[tw] OR ((“large”[ti] OR “small”[ti] OR “size”[ti] 
OR “weight”[ti]) AND “uterus”[ti]) OR “Uterus/anatomy and histology”[Majr:NoExp] OR “Risk 
Factors”[Majr] OR “Risk Factors”[ti] OR “Risk Factor”[ti] OR “BMI”[ti] OR “Body mass index”[ti] 
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OR “Body Mass Index”[Majr] OR ((“Uterus”[ti] OR “uterine”[ti]) AND descen*[ti]) OR “Age”[ti] 
OR “age factors”[majr] OR “Previous”[ti] OR adhesion*[ti] OR “Tissue Adhesions”[majr] OR 
“Parity”[ti] OR “Parity”[majr] OR “abdominal surgery”[ti] OR “abdomen surgery”[ti] OR 
“Abdomen/surgery”[Majr] OR “endometriosis”[ti] OR “Endometriosis”[majr] OR “smoker”[ti] 
OR “smoking”[ti] OR “Smoking”[majr]) AND (“Outcome Assessment (Health Care)”[Mesh] OR 
“outcome”[tw] OR “outcomes”[tw] OR “Risk”[mesh] OR “risk factor”[tw] OR “risk factors”[tw] 
OR “safe”[tw] OR “unsafe”[tw] OR “safety”[tw] OR “Medical Errors”[mesh] OR “injury”[tw] OR 
“injuries”[tw]))) AND (“2000/01/01”[PDAT] : “3000/12/31”[PDAT]) NOT (“Animals”[mesh] NOT 
“Humans”[mesh]) AND english[la]) OR ((((laparoscopic*[ti] OR robotic*[ti]) AND 
hysterectom*[ti]) OR “laparoscopic hysterectomies”[ti] OR “laparoscopic hysterectomy”[ti] 
OR “laparoscopically assisted hysterectomies”[ti] OR “laparoscopically assisted 
hysterectomy”[ti] OR “laparoscopically assisted vaginal hysterectomies”[ti] OR 
“laparoscopically assisted vaginal hysterectomy”[ti] OR “laparoscopically assisted vaginal 
radical hysterectomy”[ti] OR “laparoscopical hysterectomy”[ti] OR ((“Laparoscopy”[majr] OR 
“laparoscopy”[ti] OR “laparoscopic”[ti] OR laparoscop*[ti]) AND (“Hysterectomy”[majr] OR 
“hysterectomy”[ti] OR “hysterectomic”[ti] OR hysterectom*[ti])) OR “robotic hysterectomies”[ti] 
OR “robotic hysterectomy”[ti] OR “robotic assisted hysterectomies”[ti] OR “robotic assisted 
hysterectomy”[ti] OR “robot assisted hysterectomies”[ti] OR “robot assisted hysterectomy”[ti] 
OR “robotically assisted hysterectomy”[ti]) AND (“predictor”[tw] OR “predictors”[tw] OR 
predict*[tw] OR “Forecasting”[Mesh] OR “Time factors”[mesh] OR “learning curve”[tw] OR 
“Learning Curve”[mesh] OR “Blood Loss, Surgical”[majr] OR “blood loss”[ti] OR “blood 
losses”[ti] OR “mean estimated blood loss”[tw] OR “Intraoperative Complications”[majr] OR 
“Postoperative Complications”[majr:noexp] OR “Pain, Postoperative”[majr] OR “Postoperative 
Hemorrhage”[majr] OR “Shock, Surgical”[majr] OR “Surgical Wound Dehiscence”[majr] OR 
“complication”[tiab] OR “complication severity”[tw] OR “complications”[tiab] OR 
“conversion”[ti] OR “conversion rate”[tw] OR “conversion rates”[tw] OR “Conversion to Open 
Surgery”[majr] OR “hospital discharge”[ti] OR “Patient Discharge”[majr] OR “Patient 
Discharge”[ti] OR “hospital stay”[ti] OR “Length of Stay”[majr] OR “Length of Stay”[ti] OR 
“Operative Time”[majr] OR “operative time”[ti] OR “Surgical Time”[ti] OR “Surgery Time”[ti] 
OR “Surgical volume”[ti] OR “high volume”[ti] OR “low volume”[ti] OR “hospital volume”[ti] 
OR “Hospitals, Low-Volume”[majr] OR “Hospitals, High-Volume”[majr] OR “Reoperation”[majr] 
OR “reoperation”[ti] OR “re-operation”[ti] OR “Surgical Revision”[ti] OR “revision surgery”[ti] 
OR “Repeat Surgery”[ti] OR “surgical site infection”[ti] OR “surgical site infections”[ti] OR 
“Surgical Wound Infection”[majr] OR “Surgical Wound Infection”[ti] OR “Surgical Wound 
Infections”[ti] OR “uterine weight”[tw] OR “uterus weight”[tw] OR “uterine size”[tw] OR “uterus 
size”[tw] OR “Organ Size”[mesh] OR “large uterus”[tw] OR “large uteri”[tw] OR “small 
uterus”[tw] OR “small uteri”[tw] OR “large uterus”[tw] OR ((“large”[ti] OR “small”[ti] OR “size”[ti] 
OR “weight”[ti]) AND (“uterus”[ti] OR “uteri”[ti])) OR “Uterus/anatomy and histology”[Majr:NoExp] 
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OR “Risk Factors”[Majr] OR “Risk Factors”[ti] OR “Risk Factor”[ti] OR “BMI”[ti] OR “Body mass 
index”[ti] OR “Body Mass Index”[Majr] OR ((“Uterus”[ti] OR “uterine”[ti]) AND descen*[ti]) OR 
“Age”[ti] OR “age factors”[majr] OR “Previous”[ti] OR adhesion*[ti] OR “Tissue Adhesions”[majr] 
OR “Parity”[ti] OR “Parity”[majr] OR “abdominal surgery”[ti] OR “abdomen surgery”[ti] OR 
“Abdomen/surgery”[Majr] OR “endometriosis”[ti] OR “Endometriosis”[majr] OR “smoker”[ti] 
OR “smoking”[ti] OR “Smoking”[majr]) AND “Randomized Controlled Trial”[Publication Type] 
AND (“2000/01/01”[PDAT] : “3000/12/31”[PDAT]) NOT (“Animals”[mesh] NOT “Humans”[mesh]) 
AND english[la])
Embase (OVID version)
((“laparoscopic hysterectomies”.mp OR “laparoscopic hysterectomy”.mp OR “laparoscopically 
assisted hysterectomies”.mp OR “laparoscopically assisted hysterectomy”.mp OR 
“laparoscopically assisted vaginal hysterectomies”.mp OR “laparoscopically assisted vaginal 
hysterectomy”.mp OR “laparoscopically assisted vaginal radical hysterectomy”.mp OR 
“laparoscopical hysterectomy”.mp OR ((exp laparoscopic surgery/ OR “laparoscopy”.mp OR 
“laparoscopic”.mp OR laparoscop*.mp) AND (exp Hysterectomy/ OR “hysterectomy”.mp OR 
“hysterectomic”.mp OR hysterectom*.mp)) OR “robotic hysterectomies”.mp OR “robotic 
hysterectomy”.mp OR “robotic assisted hysterectomies”.mp OR “robotic assisted 
hysterectomy”.mp OR “robot assisted hysterectomies”.mp OR “robot assisted hysterectomy”.
mp OR “robotically assisted hysterectomy”.mp) AND (“predictor”.mp OR “predictors”.mp OR 
predict*.mp OR forecasting/ OR prediction/ OR learning curve.mp OR learning curve/ OR 
((*operative blood loss/ OR “blood loss”.ti OR “blood losses”.ti OR “mean estimated blood 
loss”.mp OR *complication/ or *peroperative complication/ or *postoperative complication/ 
or *preoperative complication/ or *wound complication/ OR “complication”.ti OR 
“complication severity”.mp OR “complications”.ti OR “conversion”.ti OR “conversion rate”.mp 
OR “conversion rates”.mp OR *”conversion to open surgery”/ OR “hospital discharge”.ti OR 
*hospital discharge/ OR “Patient Discharge”.ti OR “hospital stay”.ti OR *”Length of Stay”/ OR 
“Length of Stay”.ti OR *operation duration/ OR “operative time”.ti OR “Surgical Time”.ti OR 
“Surgery Time”.ti OR “Surgical volume”.ti OR “high volume”.ti OR “low volume”.ti OR “hospital 
volume”.ti OR * Low Volume hospital/ OR *High Volume Hospital/ OR *Reoperation/ OR 
“reoperation”.ti OR “re-operation”.ti OR “Surgical Revision”.ti OR “revision surgery”.ti OR 
“Repeat Surgery”.ti OR “surgical site infection”.ti OR “surgical site infections”.ti OR *Surgical 
Infection/ OR “Surgical Wound Infection”.ti OR “Surgical Wound Infections”.ti OR uterus 
weight/ OR “uterine weight”.mp OR “uterus weight”.mp OR “uterine size”.mp OR “uterus size”.
mp OR “large uterus”.mp OR “large uteri”.mp OR “small uterus”.mp OR “small uteri”.mp OR 
“large uterus”.mp OR *Organ Weight/ OR ((“large”.ti OR “small”.ti OR “size”.ti OR “weight”.ti) 
AND (“uterus”.ti OR “uteri”.ti)) OR *risk factor/ OR risk factor.ti OR risk factors.ti OR “BMI”.ti OR 
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“Body mass index”.ti OR *”Body Mass”/ OR ((“Uterus”.ti OR “uterine”.ti) AND descen*.ti) OR 
“Age”.ti OR exp *”Age”/ OR “Previous”.ti OR exp * “patient history of surgery”/ OR adhesion*.
ti OR *”Tissue Adhesion”/ OR “Parity”.ti OR *”Parity”/ OR “abdominal surgery”.ti OR “abdomen 
surgery”.ti OR *”Abdominal surgery”/ OR “endometriosis”.ti OR exp *”Endometriosis”/ OR 
“smoker”.ti OR “smoking”.ti OR exp *”Smoking”/) AND (adverse outcome/ OR exp Outcome 
Assessment/ OR “outcome”.mp OR “outcomes”.mp OR *”Risk Factor”/ OR “risk factor”.ti,ab 
OR “risk factors”.ti,ab OR “safe”.ti OR “unsafe”.ti OR “safety”.ti OR “injury”.ti OR “injuries”.ti))) 
AND 20*.yr AND exp Humans/ AND english.la) OR ((((laparoscop* OR robotic*) AND 
hysterectom*).ti OR “laparoscopic hysterectomies”.ti OR “laparoscopic hysterectomy”.ti OR 
“laparoscopically assisted hysterectomies”.ti OR “laparoscopically assisted hysterectomy”.
ti OR “laparoscopically assisted vaginal hysterectomies”.ti OR “laparoscopically assisted 
vaginal hysterectomy”.ti OR “laparoscopically assisted vaginal radical hysterectomy”.ti OR 
“laparoscopical hysterectomy”.ti OR ((exp *laparoscopic surgery/ OR “laparoscopy”.ti OR 
“laparoscopic”.ti OR laparoscop*.ti) AND (exp *Hysterectomy/ OR “hysterectomy”.ti OR 
“hysterectomic”.ti OR hysterectom*.ti))) AND (“predictor”.mp OR “predictors”.mp OR predict*.
mp OR forecasting/ or prediction/ OR learning curve.mp OR learning curve/ OR ((*operative 
blood loss/ OR “blood loss”.ti OR “blood losses”.ti OR “mean estimated blood loss”.mp OR 
*complication/ or *peroperative complication/ or *postoperative complication/ or 
*preoperative complication/ or *wound complication/ OR “complication”.ti,ab OR 
“complication severity”.mp OR “complications”.ti,ab OR “conversion”.ti OR “conversion rate”.
mp OR “conversion rates”.mp OR *”conversion to open surgery”/ OR “hospital discharge”.ti 
OR *hospital discharge/ OR “Patient Discharge”.ti OR “hospital stay”.ti OR *”Length of Stay”/ 
OR “Length of Stay”.ti OR *operation duration/ OR “operative time”.ti OR “Surgical Time”.ti 
OR “Surgery Time”.ti OR “Surgical volume”.ti OR “high volume”.ti OR “low volume”.ti OR 
“hospital volume”.ti OR * Low Volume hospital/ OR *High Volume Hospital/ OR *Reoperation/ 
OR “reoperation”.ti OR “re-operation”.ti OR “Surgical Revision”.ti OR “revision surgery”.ti OR 
“Repeat Surgery”.ti OR “surgical site infection”.ti OR “surgical site infections”.ti OR *Surgical 
Infection/ OR “Surgical Wound Infection”.ti OR “Surgical Wound Infections”.ti OR uterus 
weight/ OR “uterine weight”.mp OR “uterus weight”.mp OR “uterine size”.mp OR “uterus size”.
mp OR “large uterus”.mp OR “large uteri”.mp OR “small uterus”.mp OR “small uteri”.mp OR 
“large uterus”.mp OR *Organ Weight/ OR ((“large”.ti OR “small”.ti OR “size”.ti OR “weight”.ti) 
AND (“uterus”.ti OR “uteri”.ti)) OR *risk factor/ OR risk factor.ti OR risk factors.ti OR “BMI”.ti OR 
“Body mass index”.ti OR *”Body Mass”/ OR ((“Uterus”.ti OR “uterine”.ti) AND descen*.ti) OR 
“Age”.ti OR exp *”Age”/ OR “Previous”.ti OR exp * “patient history of surgery”/ OR adhesion*.
ti OR *”Tissue Adhesion/” OR “Parity”.ti OR *”Parity”/ OR “abdominal surgery”.ti OR “abdomen 
surgery”.ti OR *”Abdominal surgery”/ OR “endometriosis”.ti OR exp *”Endometriosis”/ OR 
“smoker”.ti OR “smoking”.ti OR exp *”Smoking”/) AND (adverse outcome/ OR exp Outcome 
Assessment/ OR “outcome”.mp OR “outcomes”.mp OR *”Risk factor”/ OR “risk factor”.ti,ab 
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OR “risk factors”.ti,ab OR “safe”.ti OR “unsafe”.ti OR “safety”.ti OR “injury”.ti OR “injuries”.ti))) 
AND 20*.yr AND exp Humans/ AND english.la) OR ((((laparoscop* OR robotic*) AND 
hysterectom*).ti OR “laparoscopic hysterectomies”.ti OR “laparoscopic hysterectomy”.ti OR 
“laparoscopically assisted hysterectomies”.ti OR “laparoscopically assisted hysterectomy”.
ti OR “laparoscopically assisted vaginal hysterectomies”.ti OR “laparoscopically assisted 
vaginal hysterectomy”.ti OR “laparoscopically assisted vaginal radical hysterectomy”.ti OR 
“laparoscopical hysterectomy”.ti OR ((exp *laparoscopic surgery/ OR “laparoscopy”.ti OR 
“laparoscopic”.ti OR laparoscop*.ti) AND (exp *Hysterectomy/ OR “hysterectomy”.ti OR 
“hysterectomic”.ti OR hysterectom*.ti))) AND (“predictor”.mp OR “predictors”.mp OR predict*.
mp OR forecasting/ or prediction/ OR learning curve.mp OR learning curve/ OR *operative 
blood loss/ OR “blood loss”.ti OR “blood losses”.ti OR “mean estimated blood loss”.mp OR 
*complication/ or *peroperative complication/ or *postoperative complication/ or 
*preoperative complication/ or *wound complication/ OR “complication”.ti OR “complication 
severity”.mp OR “complications”.ti OR “conversion”.ti OR “conversion rate”.mp OR “conversion 
rates”.mp OR *”conversion to open surgery”/ OR “hospital discharge”.ti OR *hospital 
discharge/ OR “Patient Discharge”.ti OR “hospital stay”.ti OR *”Length of Stay”/ OR “Length 
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Abstract
Background: The current healthcare system has an urgent need for tools to measure 
quality. A wide range of quality indicators have been developed in an attempt to differentiate 
between high-quality and low-quality healthcare processes. However, one of the main issues 
of currently used indicators is the lack of case-mix correction and improvement possibilities. 
Case-mix is defined as specific (patient) characteristics that are known to potentially affect 
(surgical) outcome. If these characteristics are not taken into consideration, comparisons 
of outcome among healthcare providers may not be valid. 
Objective: The objective of the study was to develop and test a quality assessment tool for 
laparoscopic hysterectomy, which can serve as a new outcome quality indicator.
Study design: This is a prospective, international, multicenter implementation study. A 
web-based application (https://www.qusum.org) was developed with 3 main goals: (1) 
to measure the surgeon’s performance using 3 primary outcomes (blood loss, operative 
time, and complications); (2) to provide immediate individual feedback using cumulative 
observed-minus-expected graphs; and (3) to detect consistently suboptimal performance 
after correcting for case-mix characteristics. All gynecologists who perform laparoscopic 
hysterectomies were requested to register their procedures in the application. A patient 
safety risk factor checklist was used by the surgeon for reflection. Thereafter a prospective 
implementation study was performed, and the application was tested using a survey that 
included the System Usability Scale.
Results: A total of 2066 laparoscopic hysterectomies were registered by 81 gynecologists. 
Mean operative time was 100±39 minutes, blood loss 127±163 mL, and the complication 
rate 6.1%. The overall survey response rate was 75%, and the mean System Usability Scale 
was 76.5±13.6, which indicates that the application was good to excellent. The majority of 
surgeons reported that the application made them more aware of their performance, the 
outcomes, and patient safety, and they noted that the application provided motivation for 
improving future performance.
Conclusions: We report the development and test of a real-time, dynamic, quality 
assessment tool for measuring individual surgical outcome for laparoscopic hysterectomy. 
Importantly, this tool provides opportunities for improving surgical performance. Our study 
provides a foundation for helping clinicians develop evidence-based quality indicators for 
other surgical procedures. 
95
A quAlity Assessment tool for lApAroscopic hysterectomy
6
Introduction
To ensure that patients receive the highest level of care, the healthcare system needs reliable 
tools for assessing quality; indeed, measuring outcome values is an essential principle [1, 2]. A 
wide range of quality indicators have been developed in an attempt to differentiate between 
high-quality and low-quality health care processes. Nearly 2 decades ago, Donabedian 
defined 3 categories of quality indicators: structure indicators, process indicators, and 
outcome indicators [3]. Structure indicators reflect the setting in which the care is provided 
(e.g., case volume, access to specific technologies, etc.). Process indicators reflect the total 
care system (e.g., multidisciplinary team management). Finally, outcome indicators reflect 
direct clinical outcomes and are most commonly used by healthcare professionals to assess 
the quality of surgical care [3]. Ideally, an optimum indicator of quality should measure, 
compare, monitor, and -most importantly- improve the quality of delivered care. Thus, 
suboptimal performance relative to an established standard can be recognized and, ideally, 
corrected. Therefore, a quality indicator must be included in an improvement strategy. In this 
context, because benchmarking and providing the physician with instant feedback can have 
positive effects on the quality of surgical care, they are recognized as important areas for 
improvement [4-6]. However, developing and selecting quality indicators are complex tasks 
[7]. The majority of quality indicators have limitations because they usually are not evidence-
based are not easily available, and/or are not suitable for quality improvement [8-11].  
The principal shortcoming of most currently used outcome indicators is their low applicability 
due to a lack of case-mix adjustment. In the context of health care, case-mix is defined as 
specific (patient) characteristics that are known to potentially affect (surgical) outcome. 
If these characteristics are not taken into consideration, comparisons of outcome among 
healthcare providers may not be valid, and patients, clinicians, insurance companies, and 
government organizations may develop a false sense of security and/or insecurity. 
Assessing quality is an indispensable step in ensuring patient safety, particularly with respect 
to the field of surgery, in which evaluating surgical performance is essential for maintaining 
high quality. Because emerging surgical technologies are frequently introduced, particularly 
with respect to minimally invasive surgery, this field is highly prone to factors that compromise 
patient safety [12]. However, no tested quality assessment tool is currently available to 
measure individual surgical performance and provide the surgeon with direct feedback 
while adjusting for case-mix characteristics. 
To address this need, we developed and tested an evidence-based quality assessment tool 
that can serve as an indicator of outcome quality for surgical procedures. For this study, 
we focused on laparoscopic hysterectomy (LH) because it is an advanced and technically 
complex procedure that is performed relatively frequently [13].  
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Materials and methods
We developed a real-time, web-based quality measurement tool called QUSUM (QUality 
indicator of SUrgical performance in Minimally invasive surgery). The primary function of this 
tool is to measure the surgeon’s performance, provide immediate individual feedback and 
to detect consistently suboptimal performance after correcting for case-mix characteristics. 
To assess the general usability of this tool, it was tested by a prospective multicenter study 
using the System Usability Scale (SUS) score as reported by Bangor et al. [14] The QUSUM 
tool was developed in four phases.
Phase 1: Determination of the benchmark and case-mix characteristics 
Operative time, intraoperative blood loss, and complications were selected as primary 
outcomes. Operative time was defined as the number of minutes between the first incision 
and insertion of the final stitch and blood loss measured in milliliters directly after the 
procedure. Complications included infection (local, organ, and/or systemic); injury (vascular, 
bowel, bladder, and/or ureter); wound dehiscence; hemorrhage (defined as >1000 mL or post-
operative bleeding); thromboembolism formation; organ dysfunction (e.g., urinary retention 
or incontinence, ileus, liver or kidney dysfunction, etc.); systemic events (e.g., medication 
error, adverse drug reaction. etc.); technical complications (e.g., failed procedure, corpus 
alienum, etc.); reactive conversion (as defined by Blikkendaal et al. [15]); and other (i.e., not 
specified). Complications were classified in four levels based on severity: level A, recovery 
without re(operation); level B, reoperation indicated; level C, permanent injury and/or loss 
of function; level D, death [16]. 
The benchmark data and case-mix characteristics specific to laparoscopic hysterectomy 
were calculated based on a multicenter prospective cohort study that included 1534 
laparoscopic hysterectomy procedures [17]. Using these data, regression models were fitted 
to the primary outcomes as follows: blood loss (numerical), operative time (numerical), and 
complication (categorical). Because blood loss and operative time had severely right-skewed 
distributions, a gamma regression model with the logarithmic link function was used. The 
independent variables (case-mix) included the logarithm of uterine weight and BMI for the 
outcome blood loss, and the logarithm uterine weight for the outcome operative time. For 
complications, a multinomial regression model with the cumulative logistic link function 
was used; the logarithm of uterine weight and the number of previous abdominal surgeries 
were used as independent variables. 
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Phase 2: Development of the type of individual feedback: O-E cumulative graphs
The regression models were used to compute the expected value (E) of each outcome after 
correcting for the case-mix variables. The difference between the observed outcome (O) and 
(E) was calculated (O‒E), and the cumulative sum of O-E was plotted as a time series. A graph 
depicting the performance of the three outcomes over time is shown in Figure 1. An out-of-
control signal was generated when cumulative blood loss exceeded 2000 mL after correcting 
for the benchmark and case-mix values, and this was defined as consistently suboptimal 
performance. For operative time this applies for 180 minutes, and for complication score when 
this value exceeded 2, these cutoff values were calculated based on an out-of-control signal 
rate of 10-20% of the benchmark data [17]. The complication score was weighted according 
to the severity: level A was rated as 1 point, whereas levels B, C, and D were each rated as 
2 points. The application instantly calculated updated graphs (including out-of-control 
signals) when the surgeon entered new data. For example, when a reoperation was needed 
and this was retrospectively entered in the application, the application instantly updated 
the graphs (including out-of-control signals). In the event of an out-of-control signal, the 
surgeon was asked to reflect upon the underperformance by completing a validated patient 
safety risk factor checklist; each surgeon also had the option to complete this checklist after 
each procedure (Table 1) [18].
Phase 3: Development and testing of the application
The following key requirements were used in the development of the QUSUM application: 
web-based, immediate feedback, platform independent, user friendly, and privacy secured. 
The QUSUM application (https://www.QUSUM.org) was developed in collaboration with 
experts from the Faculty of Social and Behavioral Sciences at Leiden University. The 
application complied with NEN 7510 standards (Dutch certification regarding informatics and 
security in the healthcare field) and was approved by the privacy officer at Leiden University 
Medical Center. Because the requested patient data were anonymous, this study was exempt 
for approval by our Institutional Review Board (C14.002). 
Phase 4: Multicenter implementation 
A prospective multicenter study was conducted using the QUSUM application. Gynecologists 
who performed laparoscopic hysterectomy procedures were requested to register their 
consecutive laparoscopic hysterectomies performed from April 2014 through November 
2015 at our website (https://www.QUSUM.org). A personal email invitation was send to 
all Dutch gynecologists performing laparoscopic hysterectomies, and gynecologists were 
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Table 1 The validated patient safety risk factor checklist used in the QUSUM application to evaluate 
of surgical performance
Domain 
(detailed description) Detailed risk factors per domain
Surgeon
(functioning of the 
surgeon)
Lack of experience (of surgeon or resident)
Lack of technical skills (of surgeon or resident)
Lack of leadership
Surgical team
(functioning of the scrub 
or circulating nurse)
No qualified staffing (e.g. student/pupil because of shortage of staff or 
unqualified staffing)
Lack of experience of the scrub nurse (concerning this procedure)
Lack of knowledge of the procedure of scrub nurse
Lack of experience of circulating nurse
Technology 
(availability and 
functioning of equipment 
and instruments)
Instrument(s) not present or available
Instrument(s) do(es) not work properly
It is not known how to handle instruments (either surgeon or scrub nurse)
Equipment is not present 
Equipment doesn’t work properly
Limited vision (e.g. because of condensation and/or smoke)
It is not known how to handle equipment (either surgeon or scrub nurse)
Social interaction
(teamwork and 
communication)
Poor communication between OR team members (e.g. 
misunderstandings)
Failure of professional communication (either verbal or non-verbal)
Poor collaboration between OR team members
Environment
(potentially cause 
distraction or disruptions 
of the surgical process)
Distractions (e.g. telephone calls, case irrelevant conversations, door 
movements)
Disruption of the surgical process (surgical process has to be interrupted 
because of distractions)
Too many people in the OR
Patient
(patient-related risk 
factors)
Severe adhesions
Unexpected comorbidity, please specify (e.g. unknown bleeding disorder 
(e.g. v Willebrand disease, hemophilia))
Fallibility 
(factors that influence the 
fallibility of the surgeon)
Moment of day surgery takes place (e.g. during evening or night shifts)
Perceived high workload
Fatigue of the surgeon
Safety 
(Compliance or safety 
protocols)
Poor compliance of briefing procedure
Poor compliance of debriefing procedure
Poor compliance of (surpass) checklist (if applicable)
Anesthesiology Anesthesiology-related problems
Other Free text option, please specify
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recruited through conferences and meetings. The following patient characteristics were 
registered: age; BMI (kg/m²); number of previous abdominal procedures; date the current 
hysterectomy was performed; type of hysterectomy (total laparoscopic hysterectomy, 
supracervical laparoscopic hysterectomy, laparoscopic assisted vaginal hysterectomy, or 
robotic-assisted hysterectomy); uterine weight (in grams); and the 3 primary outcomes (blood 
loss, operative time, and complications). Follow-up for complications lasted up to 6 weeks 
postoperatively, and gynecologists were automatically reminded to fill in the complication 
form using an automatic pop-up function.
Participants could register immediately postoperatively or at any given moment after surgery. 
Directly after entering the data, a risk-adjusted O-E cumulative graph was generated for each 
primary outcome (Figure 1). This graph provided the surgeon with immediate individual 
feedback. A flow chart depicting the entire QUSUM application and data registration is 
showed in Figure 2 (also see Video, Supplemental Digital Content 1, which demonstrates 
and explains the QUSUM application).
Determine usability of the application
At the end of the prospective registration period, all users received a validated survey that 
was developed by the Faculty of Social and Behavioral Sciences at Leiden University and 
included the System Usability Scale and questions regarding the surgeon’s awareness, 
motivation, and ease of use of the application (Table 2). 
Statistical analysis
The mean and standard deviation of the System Usability Scale scores were calculated 
using SPSS version 22 (IBM Corp., Armonk, NY). A System Usability Scale score >70 (of 100) 
was considered to be good to excellent [14]. A 5 point and 7 point Likert scale was used to 
measure the awareness and motivation of the users and the ease of use of the application. 
For these scales, the median and interquartile ranges were calculated. Patient characteristics 
and surgical outcome variables between benchmark data and newly registered data were 
compared using the independent Student t-test or the chi-square test. Differences were 
statistically significant at p<0.05.
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Results
Procedure data
A total of 2066 LH procedures were entered by 81 gynecologists. Mean (±SD) uncorrected 
operative time was 100±39 minutes, blood loss was 127±163mL, and the overall complication 
rate was 6.1%. The majority of procedures performed were total laparoscopic hysterectomies 
(91.4% of all procedures registered, Table 3). 
Procedure data for the benchmark and QUSUM cohort are summarized in Table 3. Comparing 
these data revealed significant improvement over the last five years with respect to operative 
time (from 116±42 to 100±39 minutes; p<0.001) and blood loss (from 185±247 to 127±163 
ml; p<0.001); in contrast, the number of complications did not change significantly (7.7% 
vs. 6.1%; p=0.068). 
Table 2 Awareness, motivation and ease of use; results of final survey to all users
Questions
User awareness 
(Strongly) 
Disagree %
Neutral 
%
(Strongly) 
Agree %
Median, 
(IQR)*
Because of the QUSUM application I am 
generally more aware of: 
  My performance during an LH procedure 20.9 35.8 43.3 3.0 (1)
  My surgical outcomes during an LH 
procedure
17.8 28.4 53.8 3.5 (1)
  The patient safety risk factors during an LH 
procedure
14.9 37.3 47.8 3.0 (1)
Questions
User motivation
(Strongly) 
demotivating 
%
Neutral 
%
(Strongly) 
motivating 
%
Median, 
(IQR)†
How would you describe the effect of seeing 
the QUSUM graphs on your subsequent LH 
performance?
10.4 41.8 47.7 4.0, (2)
How would you describe the effect of seeing 
the QUSUM graphs on registering your 
subsequent LHs in the QUSUM application?
9.0 43.3 47.7 4.0 (2)
Question 
Easiness application
(Very) 
difficult %
Neutral 
%
(Very) 
easy %
Median, 
(IQR)*
Registering LHs in the QUSUM application is 1.5 4.4 94.1 5.0 (1)
* Likert scale 1 to 5.
† Likert scale 1 to 7.
IQR = interquartile range.
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QUSUM application data
Sixty-one of the 81 participating gynecologists (75.3%) completed the survey at the end of 
the study period. There were no differences in outcomes between the gynecologists who 
completed the survey and who did not completed the survey. The mean System Usability 
Scale score was 76.5±13.6 (range, 47.5-100), which represents a good to excellent score 
[14]. The majority of respondents indicated that using the QUSUM application made them 
more aware of their performance, the surgical outcomes, and patient safety. Moreover, the 
surgeons reported that using the application motivated them to focus on their performance 
in the future. Ninety-four percent of the users reported that they found it either easy or very 
easy to register their procedures in the QUSUM application (Table 2).
Table 3 Procedure data of used benchmark and new registered QUSUM study data of all entered 
laparoscopic hysterectomies
Benchmark data 
2009/2010
N=1534
QUSUM data 
2014/2015
N=2066 P value
95% CI of the 
difference
Operative time (min), mean ±SD 116±42 100±39 0.001 -13.3, -18.7
Blood loss (mL), mean±SD 185±247 127±163 0.001 -43.9, -72.5
Uterus weight (g), mean±SD 227±199 217±204 NS* 5.9, -21.7
Age (y), mean±SD 47.8±10.2 48.6±11.4 0.038 1.5, -0.4
BMI (kg/m²), mean±SD 27.2±5.3 28.3±6.1 0.001 1.5, -0.7
Complications 118 (7.7%) 127 (6.1%) NS* NA†
Previous procedures 0.001 NA†
  none 918 (60.9%) 1128 (56.1%)
  one 397 (26.3%) 520 (25.9%)
  two 143 (9.5%) 223 (11.1%)
  > two 50 (3.3%) 136 (6.9%)
Reactive conversion to laparotomy 32 (2.1%) 9 (0.4%) 0.001 NA†
Procedure type 0.001 NA†
  TLH 957 (62.4%) 1888 (91.4%)
  SLH 391 (25.5%) 89 (4.3%)
  LAVH 185 (12.1%) 68 (3.3%)
  Robotic 0 (0%) 21 (1.0%)
* NS = not significant.
† NA = not applicable.
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Comment
Here we report the development and test of a real-time, dynamic, quality assessment 
tool used to reflect upon individual surgical performance. To date, many tools have been 
developed for monitoring surgical outcome. However, we consider our QUSUM application 
to be a unique tool because the application is easy to use, provides immediate feedback to 
the surgeon, and includes case-mix correction. In addition, the opportunity for reflection 
is incorporated into this tool through the use of a risk factor checklist (Table 2). Thus, 
we believe that our application provides an accurate indicator of quality with respect to 
laparoscopic hysterectomy. Importantly, the QUSUM application is a dynamic tool because 
it can be adjusted to an established benchmark, can incorporate case-mix correction, and 
can accommodate out-of-control values when required. With respect to quality assessment, 
this is an essential factor, given that benchmark criteria can change over time, particularly 
with relatively new surgical procedures that are still evolving and become optimized over 
time. This notion is illustrated in our data because the benchmark for the surgical outcomes 
changed significant during the last five years (Table 3) (which partly can be due to increased 
experience [19]). To ensure that a quality indicator is up to date, periodic reevaluations are 
essential.
This is the first study to test a quality assessment tool using the System Usability Scale, a 
highly robust and validated survey scale that allows users to assess an application’s usability 
[14]. The high mean System Usability Scale score for our QUSUM application is rather 
exceptional, given that this was the first use of this application, this suggesting that the 
application has good to excellent usability and that the features selected were appropriate 
for our group of participants. We believe that the key to creating a successful registration tool 
lies in achieving high usability. Clinicians are increasingly required by government agencies 
to register a wide variety of clinical data for quality control purposes. However, whether 
the data collected truly reflects the quality of the care provided remains an open question. 
Therefore, case-mix adjustment is an essential step to successfully implement a tool that 
can accurately and transparently measure quality [20, 21]. Indeed, if individual performance 
reports are not corrected for case-mix variables, surgeons may decline to provide care for 
high-risk patients because of fear of negative ratings [22]. Therefore, case-mix correction is 
increasingly important in order to succeed with a quality indicator regarding the uptake of 
surgeons. Although a quality indicator should not have a punitive goal, without good quality 
indicators, undesirable suboptimal outcomes can go undetected for extended lengths of time. 
This study has several strengths, including a carefully chosen design and key features of the 
application, which include the use of immediate feedback. This latter feature is particularly 
important because it facilitates the engagement of users, improves registration behavior, 
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and increases the user’s intrinsic motivation for personal improvement [6]. The majority of 
users reported that the application provided motivation with respect to their performance 
and registration behavior (Table 2), which is an important finding, given the increasing 
administrative burden that most clinicians face. Moreover, 94% of users reported that 
registering a procedure in the application was easy or very easy, a crucial factor for keeping 
users engaged. An additional strength of our approach is that we used validated benchmark 
values and case-mix characteristics that were based on a previous prospective cohort study.17 
Using accurate values is considered to be a basic criterion when developing an evidence-
based quality indicator. In particular, the selection of case-mix characteristics is incredibly 
important, which should be evidence based [20]. Lastly, we tested our application in a large, 
multicenter, prospective study. 
On the other hand, the reliability of the data that were entered into the application was 
dependent on the integrity of the participating surgeons. However, this potential limitation 
would apply to all forms of quality assessment tools, and previous studies have shown that 
the overall accuracy of data entered by clinicians is high [5, 17].
It is also important to note that data measured using a quality indicator are generally a 
close approximation of reality but may not necessarily reflect the true situation precisely. 
Therefore, penalizing surgeons and/or hospitals based only on the raw data obtained using 
a quality indicator may not necessarily be appropriate. When a specific indicator provides a 
less favorable outcome, this should be considered a first sign to reflect on the below-average 
outcome. We have taken the first step towards addressing this issue by using an out-of-control 
signal and by evaluating key features in our application (Table 2). In addition, the majority of 
participants reported that using the QUSUM application increased their awareness regarding 
their performance, surgical outcome, and patient risk factors during the procedure (Table 2). 
This awareness automatically leads to self-evaluation and control of individual outcomes, 
thereby inherently improving surgical outcome.  
This study may serve as a foundation for developing quality indicators for use in other 
surgical procedures. An important prerequisite when developing a new quality indicator is 
to define and select clinically relevant outcomes that can be measured instantly and that 
reflect performance quality. With respect to oncological procedures, long-term outcomes (for 
example, five-year survival and the recurrence of disease) will be less suitable for the QUSUM 
application because direct feedback cannot be provided. However, other outcomes such 
as radicality of resection and the number of resected lymph nodes are potentially suitable, 
provided that benchmark and case-mix values are determined first. Furthermore, for future 
development of quality assessment tools and internationally benchmark comparisons, we 
advocate for the use of similar accepted definitions of clinical outcomes. This will allow 
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quality comparisons on international level. Thus, the QUSUM application can be adapted 
for use in a variety of surgical procedures. Although we do not necessarily advocate using 
quality assessment for every type of surgical procedure, quality assessment is particularly 
recommended for high-risk and/or high-volume procedures [23].
In this study, we focused on surgical outcomes. However, one may question whether a 
slightly longer operative time or 50mL more blood loss is truly relevant to the patient and the 
patient’s ultimate recovery, which is obviously the ultimate goal in healthcare. Nevertheless, 
recent studies reported a direct relationship between longer operative time and increased 
risk of complications, reoperations, and higher hospital costs [24, 25]. Moreover, in addition 
to assessing surgical outcomes, patient-reported outcome measures (PROMs) should also 
be taken into consideration when evaluating quality of care. 
In conclusion, we recognize that most quality indicators have specific limitations, and the 
challenge is to develop an indicator that provides the most accurate overview of the current 
quality of care. As summarized by Porter; ”the absence of comprehensive and rigorous 
outcome and cost measurement is arguably the biggest weakness standing in the way of 
health care improvement” [26].
In developing the QUSUM application, we attempted to overcome the limitations of currently 
used quality indicators. However, in this context, a quality indicator has little value if the 
performance being measured cannot be improved (e.g., by providing feedback or the 
opportunity for reflection). Therefore, we recommend that surgeons and other health care 
providers take the lead in developing suitable evidence-based quality indicators using our 
study as a starting point. 
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Abstract
Purpose: To compare hospital versus individual surgeon’s perioperative outcomes for 
laparoscopic hysterectomy (LH), and to assess the relationship between surgeon experience 
and perioperative outcomes. 
Methods: A retrospective analysis of all prospective collected LHs performed from 2003 to 
2010 at one medical center was performed. Perioperative outcomes (operative time, blood 
loss, complication rate) were assessed on both a hospital level and surgeon level using 
Cumulative Observed minus Expected performance graphs.
Results: A total of 1618 LHs were performed, 16% total laparoscopic hysterectomies and 84% 
laparoscopic supracervical hysterectomies. Overall outcomes included mean (SD±) blood 
loss 108.9±69.2 mL, mean operative time 95.4±39.7 minutes and a complication occurred 
in 76 (4.7%) of cases. Suboptimal perioperative outcomes of an individual surgeon were 
not always detected on a hospital level. However, collective suboptimal outcomes were 
faster detected on a hospital level compared to individual surgeon’s level. Evidence of a 
learning curve is seen; for the first 100 procedures, a decrease in operative time is observed 
as individual surgeon experience increases. Similarly, the risk of conversion decreases up 
to the first 50 procedures.
Conclusion: An individual outlier (i.e., surgeon with consistently suboptimal performance) 
will not always be detected when monitoring outcome measures only on a hospital 
level. However, monitoring outcome measures on a hospital level will detect suboptimal 
performance earlier compared to monitoring only on an individual surgeon’s level. To 
detect performance outliers timely, insight into an individual surgeon’s outcome and skills 
is recommended. Furthermore, an experienced surgeon is no guarantee for acceptable 
surgical outcomes. 
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Introduction
In an effort to improve patient safety in gynecologic surgery, there has been an increasing 
focus on measures of perioperative outcomes. As the field of minimally invasive surgery 
involves new and evolving technology, these procedures may be particularly vulnerable to 
adverse incidents [1]. Individual surgeon outcomes as well as hospital-wide complication 
rates have been reported; possible uses for this information vary from quality improvement 
projects, credentialing, ranking list and reimbursement profiles [2]. One of the main 
problems of this widely released data is the lack of an accurate case-mix correction (patient 
characteristics that could influence outcomes). As referral hospitals perform more complex 
procedures and treat more challenging patients, this can potentially result in less optimal 
surgical outcomes [3]. This case-mix correction may be appropriate when analyzing data 
on a surgeon level as well, and has been recommended for parameters including uterine 
weight and BMI regarding laparoscopic hysterectomy (LH) [3]. In addition, many of the quality 
assessment registries focus only solely on hospital outcome measures, merging all individual 
surgeon outcomes. This can result in lack of detection of lesser-skilled surgeons who may 
exhibit suboptimal performance. Furthermore, the experience of a surgeon is increasingly 
being used as a component in assessment of surgical quality [4-8], and it is important to 
determine the value of an individual surgical skills factor [9]. 
The aim of this study is to compare hospital outcome measures versus individual surgeon 
outcomes for LH. Further, we aim to assess the relationship between surgeon experience 
and perioperative outcomes once corrected for case-mix characteristics.  
Materials and methods
In this retrospective study, all consecutive cases of laparoscopic hysterectomy (laparoscopic 
supracervical hysterectomy (LSH) and total laparoscopic hysterectomy (TLH)) performed 
for benign uterine disease between January 2003 to December 2010 at the Department of 
Obstetrics and Gynecology of the University of Tübingen, Germany were collected. Exclusion 
criteria included indication of malignancy, deep infiltrating endometriosis or urogenital 
prolapse in order to limit confounding factors which may be attributed to more complex 
operations. 
The primary outcome measures included: operative time (minutes from first incision to skin 
closure), estimated blood loss (milliliters) and complications. The blood loss was calculated 
using the following formula: ((Hemoglobin concentration preoperative (g/l))-(Hemoglobin 
1st day postoperative (g/l))) / ((Hemoglobin preopoperative (g/l))-(Hemoglobin 1st day 
postoperative (g/l))) /2)*1000 [10]. Complications included infection (local, organ and/or 
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systemic), injury (vascular, bowel, bladder and/or ureter), wound dehiscence, hemorrhage 
(defined as >1000mL or post-operative bleeding), thromboembolism formation, organ 
dysfunction (e.g., urinary retention or incontinence, ileus, liver or kidney dysfunction), 
systemic events (e.g., medication error, adverse drug reaction, etc.), technical complications 
(e.g., failed procedure, corpus alienum, etc.), and other (i.e., not specified) [11]. For this study, 
complications were classified by two levels of severity: level 1 (recovery without (re)operation) 
and level 2 (reoperation indicated, permanent injury and/or function loss or death). Additional 
data, which was abstracted from the medical record, included: conversion to laparotomy, 
BMI (kg/m²), uterus weight (gram), number of previous abdominal surgery and age.
The Ethics Committee of the Medical Faculty of the University of Tübingen approved this study.
Data analysis
Statistical analyses were performed using R statistical software, version 20 for Windows 
and SPSS version 22 (IBM Corp., Armonk, NY). In addition to descriptive statistics, we fitted 
regression models for the primary outcomes measures. For the numerical outcomes of blood 
loss and operative time, a gamma regression model with the logarithmic link function was 
used. For the categorical outcome of perioperative complications (defined as none, level 1 
or level 2) a multinomial regression model with cumulative logistic link function was used. 
Adjustment factors were adapted from previous research [9]; all outcomes were adjusted for 
uterine weight. In addition, blood loss was adjusted for BMI and complication was adjusted 
for the number of previous abdominal surgeries. We computed a numerical complication 
score by rating a level 1 complication at 1 point and a level 2 at 2 points. 
Upon fitting the regression models, we obtained expected outcomes (given the relevant 
patient characteristics) for each surgery. From these, we constructed individual performance 
graphs (cumulative Observed minus Expected (O-E)) for every surgeon per surgical outcome 
(operative time, blood loss and complication score). These individual O-E graphs provided an 
intuitive representation of the performance in risk-adjusted outcomes over time. Furthermore, 
we combined the results of all surgeons into a single O-E graph to show the performance at 
the hospital level. It should be noted, that since we determined the expected performance 
on the same data, the perceived performance will be exactly according to the benchmark. 
However, the combined graph shows the progression over time.
Furthermore, we studied the learning effect by regressing the three outcomes on each 
surgeon’s experience (i.e. number of previous LH performed) in addition to the above-
mentioned patient characteristics. We modelled the effect of experience by using penalised 
regression splines as implemented in the R package mgcv [12].
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Results
A total of 1618 LHs were performed by 12 gynecologists over the study period. Overall mean 
(±SD, range) blood loss was 108.9 (±69, 709)mL, mean operative time 95.4 (±39.7, 390) minutes 
and there was a 4.7% complication rate. The surgical experience of the 12 gynecologists 
ranged between 18 and 202 procedures at the end of the study period. Table 1 outlines the 
perioperative characteristics of the LH cases by individual surgeon.
Figures 1, 2, 3 show the cumulative Observed minus Expected Graphs for the individual 
surgical outcome of blood loss, operative time and complication score on both the hospital 
level (Figure 1a, 2a, 3a) and the individual surgeon’s level (Figure 1b, 2b, 3b). 
Figure 1 Observed-minus-Expected (O-E) graphs for outcome blood loss.
Explanation of the graphs: when the line drops, the surgeon/hospital performed better than expected. When 
the line rises, the surgeon/hospital performed less optimal than expected.
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Hospital-level outcome measures (Figure 1a, 2a and 3a)
For blood loss (Figure 1a), the outcome measures were diverse and the graph line alternately 
moved downward and upward. The downward part of the graph line indicated a cumulative 
better outcome than expected; the upward part of the graph line indicated a cumulative 
less optimal outcome than expected. 
For operative time (Figure 2a), less optimal outcomes were observed for the first two years, 
indicating a learning curve. After two years a cumulative operative time of 4900 minutes 
more than expected was observed. Thereafter, the graph line continued to move downward, 
indicated that cumulative better outcomes for this hospital was observed than expected. 
Figure 2 Observed-minus-Expected (O-E) graphs for outcome operative time.
Explanation of the graphs: when the line drops, the surgeon/hospital performed better than expected. When 
the line rises, the surgeon/hospital performed less optimal than expected.
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For complications (i.e., level 1 and level 2 complications) (Figure 3a), in the first year there 
was an upward trend in the graph, which indicated less optimal outcomes, with cumulative 
3.9 complications more than expected. Thereafter, the graph line moved downward and the 
complication outcome measure for the hospital continued below zero, indicated that the 
complication score for the hospital was better than expected. 
Comparing individual versus hospital outcome measures, a more rapid detection of 
suboptimal outcomes was detected for all three outcomes on hospital level (Fig, 1, 2 and 3). 
Individual outcome measures (Figure 1b, 2b, 3b)
For blood loss (Figure 1b), a considerable difference between all individual outcome 
measures was observed. Surgeon 8 can be considered an outlier, since the graph of this 
Figure 3 Observed-minus-Expected (O-E) graphs for outcome complication score.
Explanation of the graphs: when the line drops, the surgeon/hospital performed better than expected. When 
the line rises, the surgeon/hospital performed less optimal than expected.
Chapter 7
120
surgeon continued to move upward (ended with cumulative 915 mL more blood loss than 
expected). The same applied for surgeon 4 (ended with cumulative 873mL more blood 
loss than expected). The best individual outcome measure for blood loss was observed for 
surgeon 5 (cumulative 1537mL blood loss less than expected).  
With regards to operative time (Figure 2b), an upward trend in the graphs of almost all 
individual surgeons was observed for the first two years, indicated less optimal performance. 
Thereafter, most of the surgeons performed better than expected, indicated by a descending 
graph line. However, surgeon 8 was observed as an outlier, as the graph of this surgeon 
continued to move upward (ended with cumulative 2267 minutes more operative time 
than expected). Surgeon 1 and surgeon 5 can be considered as better skilled surgeon of this 
hospital, and these outcomes compensated the suboptimal outcome of surgeon 8 (resulting 
in good outcome measures on a hospital-level; i.e., descending graph, Figure 2a). 
Figure 4 Log odds of Blood loss and surgeons experience.
The grey shaded area represents the Standard Deviation (SD).
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Figure 5 Log odds of Operative time and surgeons experience.
The grey shaded area represents the Standard Deviation (SD).
For complication score (Figure 3b), three inferior outliers were observed (surgeon 4, surgeon 
6 and surgeon 7) with a score of respectively, 2.5, 3.9 and 3.92 more complications than 
expected. The graph line of these surgeons continued to move upward.
Surgeon’s experience
Figures 4, 5, 6, and 7 showed the log odds graphs of surgeon’s experience per surgical 
outcome, corrected for case-mix characteristics. For blood loss, an association was observed 
between increasing surgical experience and decreased blood loss, however this should be 
interpreted with caution given the large standard deviation observed (Figure 4). 
For operative time, up to 100 procedures a clear decrease was observed as experience 
increased (Figure 5). A higher complication rate was found when experience increased; 
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however this was not statistically significant (Figure 6). Up to 50 procedures a clear decrease 
was observed for conversion rate, with a plateau thereafter (Figure 7).
Discussion
Surgeons and hospitals may be expected to provide evidence of the quality of care which 
they deliver by documenting outcome measures [13]. To date, most of the publically reported 
quality indicators are based on hospital-level outcome measures, such as complication 
and reoperation rates. As demonstrated in our results, monitoring outcome measures 
exclusively on the hospital level will not always detect individual surgeon with extreme 
outcomes. We have demonstrated that suboptimal outcomes of a lesser-skilled surgeon will 
Figure 6 Log odds of Complication score and surgeons experience.
The grey shaded area represents the Standard Deviation (SD).
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be compensated by the superior skills of other surgeons in the same hospital, resulting in a 
normal or good quality outcome measure for the hospital (Figure 2 and Figure 3, e.g. surgeon 
8 is compensated by surgeon 1 and surgeon 5). Therefore, in order to evaluate quality of 
care accurately, outcome measures should also be assessed on individual surgeon’s level. 
As we observed, good hospital outcome measures do not necessarily reflect good surgeon 
outcome measures and vice versa. However, when all surgeons of one hospital perform less 
optimal, this will be detected quicker on a hospital level (Figure 2). This can be considered 
as strength of monitoring outcome measures on a hospital level instead of individual.  
Surgical experience is often discussed as a proxy for quality assessment measurement [4-8]. 
Our data also showed a clear association between increased surgical experience and both a 
Figure 7 Log odds of Conversion rate and surgeons experience.
The grey shaded area represents the Standard Deviation (SD).
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decreased operative time (after 100 procedures) and conversion rate (after 50 procedures). 
Compared to previous literature which has suggested a learning curve of 30 cases for LH, this 
demonstrates a slower rate of improvement [5, 14]. One possible explanation for the longer 
learning curve found in this study is that a more experienced surgeon may take on more 
complex procedures, which can consequently cause more complications and less optimal 
outcomes [4]. The outcomes in this study were corrected for case-mix characteristics such 
as uterine weight, BMI and previous abdominal surgery, although there may be unknown 
variables for which no correction was applied such as severe endometriosis, age and other 
comorbidities [3]. Hence, our data suggest that experience alone is not sufficient to assure 
the quality of surgical care; individual skills may provide more information about the actual 
quality of individual surgical performance. 
Strengths of this study include the correction for case-mix characteristics in all performed 
analyses, which makes the comparison of surgical outcomes more precise. Additionally, we 
were able to longitudinally follow all 12 surgeons and record all their consecutive procedures 
from the beginning of their (laparoscopic) career. A potential limitation of our study was the 
necessity to calculate blood loss using the value of Hemoglobin drop, as opposed to surgeons 
estimated blood loss or a different objective marker. Furthermore, it is difficult to confirm 
external validity of the complication rates as our chosen definition of complications differs 
from the more frequently reported Clavien Dindo scale. Other limitations inherent to the study 
of quality and performance include the issues of rare outcomes and small case numbers. 
For example, if the incidence of a particular adverse outcome is relatively low, one can not 
presume that the absence of a complication in a small series of patients implies optimal 
care [15]. This phenomenon occurred in our results; two surgeons had a complication rate of 
0% (surgeon 10 and 12), which was based on only a few procedures (18 and 21 procedures, 
respectively). Additionally, if we look closer to the surgeon with the highest mean operative 
time (surgeon 10), this was based on 18 procedures and the high mean was only due to one 
single procedure with an operative time of 284 minutes. Therefore, small sample sizes should 
always be taken into account when measuring surgical quality [15]. Small sample sizes is 
in general a problem in (advanced) gynecologic surgery [16]. Therefore, surgical outcomes 
with a low incidence should be measured on both hospital level and individual level in an 
effort to detect consistently suboptimal performance timely. 
An important subject for future research is the definition of a performance outlier. Different 
methods are defined to determine an outlier [17]. In our study we choose to define the 
outliers as the best and worst performers, compared to their own benchmark. However, this 
does not necessarily mean these surgeons are also superior or inferior skilled compared to 
the national or worldwide benchmark. Therefore, before drawing any conclusion of quality 
assessment outcomes, benchmark and outlier definition should be defined first, and we urge 
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that international definitions should be adopted. In addition, it is also important to define 
clinically relevant quality outcomes since, for example, blood loss of 50-100mL more or less 
is not always clinically relevant for the patient, and the same applies for operative time. 
However, recent studies have shown significant associations between increased operative 
time and complication rates or reoperations [18].
Although performance ratings may be useful, there is potential for falsely low or high ratings 
both on the surgeon and hospital level. For this reason, reliable case-mix adjustment is 
of major importance to benchmark surgical outcomes correctly. Our study showed that 
measurement of quality on a hospital level would detect suboptimal performances quicker 
and in a more consistent fashion. However, it is still possible to misidentify an individual 
surgeon who is either a high or low performer. Further insight into the individual surgeon’s 
outcome measures and skills is required to detect suboptimal performances timely. 
Furthermore, experience alone is not a sufficient measurement assessment to assure surgical 
quality and a very experienced surgeon is unfortunately no guarantee for acceptable surgical 
outcomes.
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Abstract
Background: Since the introduction of minimally invasive surgery (MIS), concerns for 
patient safety are more often brought to the attention. Knowledge about and awareness 
of patient safety risk factors are crucial in order to improve and enhance the surgical team, 
the environment, and finally surgical performance. The aim of this study was to identify 
and quantify patient safety risk factors in laparoscopic hysterectomy and to determine their 
influence on surgical outcomes. 
Methods: A prospective multicenter study was conducted from April 2014 to January 2016, 
participating gynecologists registered their performed laparoscopic hysterectomies (LHs). If 
deemed necessary, gynecologists could fill out a checklist with validated patient safety risk 
factors. Association between procedures with and without an occurred risk factor(s) and 
the surgical outcomes (blood loss, operative time, and complications) were assessed, using 
multivariate logistic regression and generalized estimation equations.
Results: Eighty-five gynecologists participated in the study, registering total 2237 LHs. For 
627(28%) procedures, the checklist was entered (in total 920 items). The most reported risk 
factors were related to the surgeon (19.6%), the surgical team (14.4%), technology (16.6%) 
and the patient (26.8%). The procedures where a risk factor was registered had significantly 
less favorable outcomes, higher complication rate (10.5 vs. 4.8% (p=0.002), longer operative 
time (114 vs. 95 minutes (p<0.001)), and more blood loss (110 vs. 168 mL (p=0.047)), which 
was mainly due to the technological and patient-related risk factors.
Conclusion: Technological incidents are the most important and clinically relevant risk 
factors affecting surgical outcomes of LH. Future improvements of MIS need to focus on 
this. As awareness of safety risk factors in MIS is important, embedding of a safety risk factor 
checklist in registration systems will help surgeons to evaluate and improve their individual 
performance. This will inherently improve the surgical outcomes and thus patient safety. 
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Introduction
Since the introduction of minimally invasive surgery (MIS) in daily surgical practice, patient 
safety issues have increasingly received attention. Implementation of new technologies 
in surgery is a challenge for practicing surgeons, especially when it comes to complex 
procedures such as MIS. In general, MIS requires a more demanding work environment 
compared to conventional surgery, and in order to facilitate the surgeon in this, a fast 
development of new medical devices is observed [1]. In contrast to the introduction of 
newly developed drugs, new devices are mostly introduced into the operating room without 
proper evidence regarding their benefit and safety. This can potentially lead to patient safety 
issues in daily clinical practice, as also seen after the wide introduction of the laparoscopic 
power morcellator; years after this introduction, the U.S. Food and Drug Administration (FDA) 
issued a statement discouraging the use of power morcellation in the majority of women 
undergoing hysterectomy or myomectomy for uterine fibroids due to the potential risk of 
upstaging of uterine sarcoma [2]. 
Besides improper introduction of new technologies, limited experience and skills of the 
surgeon are considered to be important risk factors in MIS [3]. In addition, also communication 
and environmental failures occur commonly during surgical procedures and are recognized 
as risk factors regarding patient safety [1, 4]. Knowledge about and awareness of these patient 
safety risk factors are crucial to improve and enhance the surgical team, the environment, 
and finally surgical performance. However, it is not known whether and how these validated 
risk factors directly affect surgical outcome. In order to improve the surgical process, insight 
into the occurrence of events as potential risk factors and their consequences is required. 
Laparoscopic hysterectomy (LH) is the most performed advanced laparoscopic procedure 
in gynecological surgery [5]; therefore this procedure is ideal for further analyses. The aim 
of this multicenter prospective study was to identify and quantify patient safety risk factors 
in LH and to assess their influence on surgical outcomes.   
Materials and methods
During this prospective multicenter study, all gynecologists performing advanced MIS 
(regarding the ESGE classification [6]) were asked to register their consecutive LHs from April 
2014 to January 2016 in a secured web-based application.
During initial registration, gynecologists were asked to enter the number of LHs performed 
yearly (their annual surgical volume), the total amount of LH performed during their career 
(their experience) and the number of years they were performing LHs. After initial registration, 
the application was available 24/7 for the registration of all consecutive performed LHs. 
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After entering the procedure data, the gynecologist could optionally enter a checklist 
with validated patient safety risk factors and observations, which could have potentially 
influenced the outcome of the procedure (Table 1). The risk factor checklist was developed 
based upon previous research [3]. A brief description of every domain and risk factor was 
easily available by the use of information pop-ups. A free text option was available to write 
additional comments.
The following patient characteristics were registered: age, BMI (kg/m²), uterine weight, 
number of previous abdominal surgeries defined as laparotomy (including cesarean section) 
or therapeutic laparoscopy, and the presence and stage of endometrioses (stage 1 minimal, 
stage 2 mild, stage 3 moderate and stage 4 severe, as defined by the American Society for 
Reproductive Medicine [7]). Additionally, the surgical outcomes collected included the 
type of hysterectomy (total laparoscopic hysterectomy (TLH), supracervical laparoscopic 
hysterectomy (SLH), laparoscopic-assisted vaginal hysterectomy (LAVH), and robotic 
hysterectomy), intra-operative blood loss (millilitres, collected in containers and directly 
measured after surgery), operative time, and complications. Operative time was defined 
as the number of minutes between first incision and the final stitch. Complications were 
registered according to the classification of the Dutch Society of Obstetrics and Gynecology 
[8], including infection (local, organ and systemic), injury (vascular, bowel, bladder and ureter), 
wound dehiscence, hemorrhage (>1000mL, postoperative bleeding), thromboembolism, 
dysfunction (urinary retention, incontinence, ileus, liver, kidney), systemic (medication error, 
adverse drug reaction), technical (failed procedure, corpus alienum), reactive conversions (as 
defined by Blikkendaal et al. [9]), and other (not specified). The postsurgical follow-up period 
lasted for 6 weeks after discharge. After the 6 weeks, gynecologists received an automatic 
reminder from the application to register any possible postoperative complication. All surgical 
outcome data were mandatory items to register in the web-based application.
Since only limited anonymous patient data were requested, our Institutional Review Board 
at Leiden University Medical Center exempted this study (C14.002) from approval.
Data analysis
For the statistical analysis, SPSS version 20.0 (SPSS Inc, Chicago, IL) was used. The number of 
entered risk factor was summed per domain and per detailed risk factor (Table 1). Mean values 
were calculated and shown with their standard deviation (SD). Patient characteristics and 
surgical outcomes were compared between two groups: LHs with entered risk factor(s) and 
LHs without entered risk factor(s) (Table 2). Multivariate logistic regression was used for risk 
adjustment in assessing associations between procedures with and without an entered risk 
factor checklist and surgical outcomes. Variables used in this model included BMI, previous 
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abdominal operations, the presence of endometriosis, type of LH, uterine weight, operative 
time, blood loss and complications (Table 2). A sub-analysis was performed comparing 
entered risk factor per domain and surgical outcomes (Table 3). The influence of surgeon’s 
volume, experience, and years of experience on the entering of a risk factor checklist were 
calculated using binary logistic regression analysis.  
To account for the clustering of data from multiple entered procedures and risk factor 
checklists by a single surgeon, generalized estimation equations were used for all analyses. 
Ninety-five percent confidence intervals were calculated of all odd ratios. Statistical 
significance was defined as a p-value <0.05. 
Results
During the study period, a total of 85 gynecologists participated and entered their performed 
LHs. Mean (SD) LH experience (total amount of performed LH during their career) of the surgeons 
was 177 (173), with a range of 800 procedures. A total number of 2237 LH procedures were 
entered and for 627 (28%) procedures, the risk factor checklist was filled in. Because more 
than one risk factor could be entered per procedure, a total of 920 patient safety risk factors 
were registered. All entered risk factor are depicted in Table 1, subdivided by domain. The most 
frequently reported risk factor domains were surgeon (19.6% and in 7.3% of all procedures), 
surgical team (14.4% and in 5.4% of all procedures), technology (16.6 % and in 6.2% of all 
procedures), and patient-related risk factors (26.8% and in 10% of all procedures) (Table 1). 
Regarding the domain ‘surgeon’, lack of experience (of surgeon or resident) was mainly reported, 
i.e., 141 times (15.3% of all entered items). Furthermore, lack of experience/knowledge of the 
scrub/circulating nurse was also considered one of the main potential risk factors, reported 
in total 141 times (15.3% of all entered items). Registered technology-related events included 
mainly the improper functioning of instrument(s) and/or equipment, and were reported in 
total 94 times (10.2% of all entered items). Patient-related factors such as unexpected severe 
adhesions were mentioned 182 times (19.8% of all entered items). Social interaction including 
teamwork and professional communication was entered 9 times (1% of all entered items). 
Other patient safety risk factors with low count of events were environment (2.2%), fallibility of 
the surgeon (0.5%), and lack of compliance to the safety protocols (1.2%). Anesthesiological-
related issues were reported in 30 of the procedures (3.2% of all entered items). 
In 116 procedures the free text option was filled out. The main issues reported were patient-
related issues (e.g., morbid obesity, adhesions, previous operations, endometriosis, large 
uterus, fibroids, etc.), together with logistical and setup problems (e.g., “had to wait for 
assistance”, “testing new equipment in new theater”, “procedure was part of a training 
course”).
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Table 1 Used patient safety risk factor checklist with number and percentage of entered items per 
domain
Domain 
(detailed description)
Number of entered 
domains (%; and % 
of total procedures 
N=2237) Detailed risk factors per domain
Number 
of entered 
detailed 
options
Surgeon
(functioning of the 
surgeon)
164 (19.6; 7.3) Lack of experience (of surgeon or 
resident)
141
Lack of technical skills (of surgeon or 
resident)
27
Lack of leadership 2
Surgical team
(functioning of the 
scrub or circulating 
nurse)
120 (14.4; 5.4) No qualified staffing (e.g., student/
pupil because of shortage of staff or 
unqualified staffing)
25
Lack of experience of the scrub nurse 
(concerning this procedure)
78
Lack of knowledge of the procedure 
of scrub nurse
26
Lack of experience of circulating nurse 37
Technology 
(availability and 
functioning of 
equipment and 
instruments)
139 (16.6; 6.2) Instrument(s) not present or 
available
18
Instrument(s) do(es)n’t work 
properly
75
It is not known how to handle 
instruments (either surgeon or scrub 
nurse)
5
Equipment is not present 4
Equipment does not work properly 19
Limited vision (e.g. because of 
condensation and/or smoke)
31
It is not known how to handle 
equipment (either surgeon or scrub 
nurse)
5
Social interaction
(teamwork and 
communication)
9 (1.1; 0.4) Poor communication between 
OR team members (e.g., 
misunderstandings)
5
Failure of professional communication 
(either verbal or nonverbal)
1
Poor collaboration between OR team 
members
3
Table 1 continues on next page
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Table 2 shows patient characteristics and surgical outcomes of entered procedures and the 
differences between procedures with (n=627) and without (n=1610) an entered risk factor 
checklist. There were no significant differences in patient characteristics between the two 
groups with the exception of previous abdominal surgery (p<0.001), with a higher rate in the 
LH group where a risk factor checklist was entered. For all reported surgical outcomes, a 
significant difference was observed in favor of the procedures where no risk factors occurred: 
complications 10.5 versus 4.8% (p=0.002), blood loss 110.1 versus 167.6 mL (p=0.047), and 
operative time 114.3 versus 95.3 minutes (p<0.001).
Table 1 Continued
Domain 
(detailed description)
Number of entered 
domains (%; and % 
of total procedures 
N=2237) Detailed risk factors per domain
Number 
of entered 
detailed 
options
Environment
(potentially cause 
distraction or 
disruptions of the 
surgical process)
21 (2.5; 0.9) Distractions (e.g., telephone calls, 
case irrelevant conversations, door 
movements)
10
Disruption of the surgical process 
(surgical process has to be 
interrupted because of distractions)
7
Too many people in the OR 4
Patient
(patient-related risk 
factors)
224 (26.8; 10) Severe adhesions 182
Unexpected co-morbidity, please 
specify (e.g., unknown bleeding 
disorder (e.g., v Willebrand disease, 
hemophilia))
57
Fallibility 
(factors that influence 
the fallibility of the 
surgeon)
11 (1.3; 0.5) Moment of day surgery takes place 
(e.g., during evening or night shifts)
1
Perceived high workload 3
Fatigue of the surgeon 7
Safety 
(compliance or safety 
protocols)
1 (0.1; 0.04) Poor compliance of briefing 
procedure
0
Poor compliance of debriefing 
procedure
1
Poor compliance of (surpass) 
checklist (if applicable)
0
Anesthesiology 30 (3.6; 1.3) Anesthesiology-related problems 30
Other 116 (13.9; 5.1) Free text option, please specify 116
Total 835 920
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Table 3 Difference in surgical outcomes of LHs with and without an entered risk factor checklist 
stratified per safety domain
Safety Domain
Entered checklist?
Blood loss 
ml ± SD p-value 
Operative 
time min ± SD p-value
Compli-
cations p-value
Surgeon 
Yes (n=164) 135.0 ± 156.5 0.879 109.8 ± 26.7 0.408 8.5% 0.445
No (n=2073) 125.5 ± 164.6 99.8 ± 39.7 6.3%
Surgical team 
Yes (n=120) 148.8 ± 203.3 <0.001 107.4 ± 37.8 <0.001 6.7% 0.032
No (n=2117) 124.9 ± 161.5 100.2 ± 39.0 6.4%
Technology 
Yes (n=139) 202.6 ± 286.3 <0.001 126.9 ± 53.1 <0.001 12.2% <0.001
No (n=2098) 121.1 ± 151.3 98.9 ± 37.2 6.1%
Social interaction 
Yes (n=9) 141.7 ± 106.1 0.428 129.6 ± 30.8 <0.001 11.1% 0.242
No (n=2228) 126.1 ± 164.2 100.5 ± 39.0 6.4%
Environment 
Yes (n=21) 200.5 ± 206.6 0.005 126.7 ± 48.1 <0.001 9.5% 0.554
No (n=2216) 125.5 ± 163.5 100.3 ± 38.8 6.4%
Patient 
Yes (n=224) 213.5 ± 244.9 <0.001 120.6 ± 48.7 <0.001 14.3% <0.001
No (n=2013) 116.5 ± 149.4 98.4 ± 37.1 5.6%
Fallibility 
Yes (n=11) 101.8 ± 72.2 0.531 113.5 ± 38.5 0.034 9.1% 0.358
No (n=2226) 126.3 ± 164.4 100.5 ± 39.0 6.4%
Safety 
Yes (n=1) na na na
No (n=2236) na na na
Anesthesiology 
Yes (n=30) 154.7 ± 149.4 0.293 114.5 ± 39.0 0.001 10.0% 0.357
No (n=2207) 125.8 ± 164.2 100.4 ± 39.0 6.4%
Na = not applicable.
Table 3 shows the difference in surgical outcomes stratified per entered risk factor domain. 
When technological-related risk factors were registered, all surgical outcomes were 
significantly less favorable (p<0.001 for blood loss, operative time, and complications). 
This also was found for the procedures with risk factors related to the surgical team (e.g., 
no qualified staffing, lack of experience/knowledge of the scrub/circulating nurse) and 
to patient-related issues (especially adhesions). It appeared that for procedures where 
surgeon-related risk factors occurred (e.g., lack of experience and/or lack of technical skills), 
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no significant difference was observed in surgical outcomes compared to procedures where 
no risk factor occurred. 
The experience of the surgeon was not correlated to the number of registered risk factor 
checklist of the surgeon, p=0.425 (95% CI = 0.998-1.001). A similar result was seen for surgeon’s 
volume and years of experience, respectively p=0.936, (95% CI = 0.987-1.014) and p=0.085 
(95% CI = 0.999-1.015).
Discussion
In this prospective cohort study, 85 gynecologists entered their LHs, and when deemed 
necessary, they could additionally fill in a risk factor checklist. In 28% of LHs, surgeons entered 
at least one patient safety risk factor. We observed less favorable surgical outcomes in the 
group LHs where a risk factor checklist was registered (Table 2). Patient-related risk factors 
and technological-related problems were listed as most important risk factor during LH, 
affecting negatively all surgical outcomes (Table 3). The lack of proper functioning equipment 
and instruments in the surgical field is well known to be associated with an increased risk 
of incidents [10]. In our study, 6.2% of all registered procedures encountered technological 
problems. This percentage is considerably lower compared to previously studies, as Wubben 
et al. [11] found equipment-related incidents in 16% of observed surgeries and Verdaasdonk 
et al. [12] observed technical incidents in 87% of recorded laparoscopic cholecystectomies. 
However, these percentages are not comparable with our study, as they focused on 
technological incidents counted by direct observations or video observations. In our study, 
the registered events were entered by the surgeon him/herself, which makes these events 
clinically more relevant, and the event had to be serious enough for the surgeon to remember 
and register it afterward, especially since it might influence their surgical outcomes. Therefore, 
our number could be an underestimation of the actual percentage of occurred risk factors. 
We observed that the occurrence of patient-related risk factors, such as adhesions, are of 
significant influence on all surgical outcomes (Table 3). We consider patient-related risk factors 
of a different nature compared to the other registered risk factors; for example, as doctors 
cannot influence comorbidity of a patient (e.g., extent of adhesions, obesity etc.) [13]; however 
we do have a responsibility for technological issues or surgical team-related problems, and 
these are therefore important targets for future improvements regarding patient safety. 
It is notable that surgeons criticized their selves (i.e., “functioning of the surgeon”) in 20% 
of the registered risk factors. Surprisingly though, our data showed that the occurrence of 
these surgeon-related risk factors did not affect any surgical outcomes (Table 3). Yet, the 
occurrence of risk factors relating to the surgical team (i.e., lack of experience/knowledge 
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of scrub/circulating nurse) did significantly affect surgical outcomes. Although, it can be 
questionable whether a difference of 20-30mL blood loss truly is clinically relevant (Table 3), 
it could indicate that the surgical team in its entirety is more important to surgical outcomes 
than previously thought [3]. Therefore, it seems obvious to assume that a dedicated and 
experienced surgical team will lead to increased efficiency, better communication, and 
inherently enhance patient safety. Still, we need to emphasize that the primary responsibility 
for a procedure and its outcomes lies in the hands of the (primary) surgeon and not the other 
members of the surgical team. 
It has been shown that when a laparoscopic procedure is performed under distracting 
conditions, performance could be directly affected [14]. Our results showed that the effect 
of environmental events seems to be a minor subject since this domain was only entered 21 
times, corresponding with less than 1% of all procedures (Table 1). However, the occurrence 
of environmental risk factors adversely affected the outcomes blood loss and operative 
time (Table 3). This suggests, that when an environmental event is clinically relevant and 
significant enough to be noticed, it could negatively influence outcomes. This observation 
emphasizes the clinical impact of the environment as also shown in previous studies [1, 4].
Since the development of the time-out protocol by the World Health Organization (WHO) 
[15], multiple publications demonstrated that the use of this protocol improves patient 
outcomes, teamwork, and communication [16]. In our study, the domain of safety (e.g. 
poor compliance of safety protocols) is only mentioned once. Therefore we can conclude 
that the implementation of this briefing is well established and (inter) nationally accepted. 
A potential limitation of our study is that it is conceivable that surgeons will enter more risk 
factor items when they performed a procedure with unfortunate outcomes, in order to justify 
their suboptimal performances. This could potentially lead to reporting bias. To correct for 
these limitation, we used generalized estimation equation to account for the clustering of 
data by a single surgeon. 
Technological problems are the most relevant and important patient safety risk factors, 
and future improvements need to focus on this to enhance quality and safety of MIS. It is 
not acceptable that nowadays technological problems are still such a major patient safety 
issue in these modern times, and a concise training and/or briefing for the entire surgical 
team should be mandatory when new devices are introduced. Evidence showed that most 
technological issues can be solved with decent preparation and more attention to technology 
during briefing [1, 10]. Our risk factor checklist can be seen as an individual guidance tool, 
for instance when the performance of a surgeon is consistently suboptimal. The use of the 
current checklist allows individual reflection and will potentially help to improve individual 
performance [16], this will inherently increase awareness and insight in risk factors in MIS.
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Abstract
Objective: To determine the effect of additional gamification elements in a web-based 
registry system in terms of engagement and involvement to register outcome data, and to 
determine if gamification elements have any effect on clinical outcomes. 
Methods: Randomized controlled trial for gynecologists to register their performed 
laparoscopic hysterectomies (LH) in an online application. Gynecologists were randomized 
for two types of registries. Both groups received access to the online application; after 
registering a procedure, direct individual feedback on surgical outcomes was provided 
by showing three proficiency graphs. In the intervention group, additionally gamification 
elements were shown. These gamification elements consisted of points and achievements 
that could be earned, and insight in monthly collective scores. All gamification elements 
were based on positive enforcement.
Results: A total of 71 gynecologists were randomized and entered a total of 1833 LH 
procedures. No significant difference was found between the groups in terms of engagement 
and involvement on a 5-point Likert scale, respectively 2.34±0.87 versus 2.56±1.05 and 
3.63±0.57 versus 3.33±1.03 for the intervention versus the control group (p>0.05). The 
intervention group showed longer operative time than the control group (108±42 vs. 101±34 
minutes, p=0.04), no other differences were found in terms of surgical outcomes.
Conclusions: The addition of gamification elements in a registry system did not enhance 
the engagement and involvement of clinicians to register their clinical data. Based on our 
results, we advise that registry systems for clinical data should be as simple as possible with 
the focus on the main goal of the registry. 
Trial registration: The study was registered in www.trialregister.nl (NTR 5040).
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Introduction
The administrative responsibilities of clinicians are currently much to complain about and 
the struggle to balance this “paperwork” burden with the clinical care is cumbersome. 
Clinicians are increasingly imposed to register a wide range of data that is intended to use 
for quality assessment. It is shown that on average a doctor spends around 17% of working 
hours on his/her administrative responsibilities only, and this percentage is even increasing 
(Woolhandler & Himmelstein, 2014). 
However, the use of registered clinical data for auditing is recognized as an important tool 
for quality improvement (van Leersum et al., 2013; Maruthappu, Trehan, Barnett-Vanes, 
McCulloch, & Carty, 2015; Ivers et al., 2012). Therefore, since the improvement of patient 
safety and quality of care are both high on the international political agenda, the registration 
of clinical data is indispensable in the current duties of a clinician(Dreyer & Garner, 2009). 
Besides, this data collection is also needed to support the possibility to conduct clinical 
research studies. As incomplete or incorrect data is not usable for the assessment of quality 
or for conducting clinical research, it is essential to engage and motivate clinicians to register. 
In this context, gamification elements may offer opportunities to motivate and engage 
doctors to participate in medical registries. Gamification can be explained as the use 
of game elements and techniques in existing applications or in nongame contexts, to 
motivate and engage users with a system (Morris, Croker, Zimmerman, Gill, & Romig, 2013). 
Gamification focuses on making necessary and annoying tasks more enjoyable through a 
positive approach (Dithmer et al., 2015). During the last few years gamification is used within 
a broad variety of domains, such as finance, health, education, news and entertainment, 
for example by the earning of badges, points and achievements when completing specific 
tasks (Deterding S, Dixon D, Khaled R, & Nacke L, 2011). In a similar vein, serious gaming is 
increasingly used to train doctors technical and non-technical skills relevant to the surgical 
field (Graafland, Schraagen, & Schijven, 2012). To note, gamification and serious gaming are 
two different concepts, but show many similarities. Serious gaming refers to games for non-
entertainment purposes whereas gamification refers to the use of elements from games in 
non-game contexts (Deterding S et al., 2011). 
Despite the increased popularity of gamification, to the best of our knowledge, this strategy 
had not been used yet in the context of medical research to motivate an engage physicians 
participating in medical studies, and even more interesting, on the impact on clinical 
outcomes. However, recent studies showed that the use of gamification impacted residents’ 
engagement in simulation training, and motivated heart patients as a part of a rehabilitation 
program (Kerfoot & Kissane, 2014; Dithmer et al., 2015). Furthermore, it is noted that the 
impact of gamification in health-related contexts has achieved significant results (Pereira, 
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Duarte, Rebelo, & Noriega, 2014). Therefore, the introduction of gamification elements could 
potentially be helpful to motivate clinicians to register their data completely and correctly. 
In this light, it is well known that providing audit and feedback to the clinician leads to 
improvements in professional practice. Audit and feedback is defined as a summary of clinical 
performance over a specified period of time preferably leading to clinical actions (Ivers et al., 
2012). However, there is lack of knowledge about what kind of feedback is most effective to 
increase insight in personal performance and to increase engagement to register medical 
data (Ivers et al., 2012; Maruthappu et al., 2015). The high workload of surgeons is a main 
reason for non-participation in medical registries and aspects such as lack of support and 
feedback, but also lack of rewards and recognition are cited as reasons to not participate in 
medical registries (Albers & Sedler, 2004; Rahman et al., 2011). Hypothetically, the addition 
of gamification elements in the provision of feedback could enhance the effect of feedback 
because of the positive enforcement of gamification. 
The aim of this study is to determine the effect of additional gamification elements in a 
web-based registry system for laparoscopic hysterectomy (LH) in terms of engagement and 
involvement of gynecologists to register their outcome data and to determine if gamification 
elements have any effect on clinical outcomes.   
Methods
Design and participants
The CONsolidated Standards Of Reporting Trials (CONSORT) statement was followed to 
describe the design of the study (Schulz, Altman, & Moher, 2010). All Dutch gynecologists 
who perform laparoscopic hysterectomy (LH) were eligible for participation and were asked 
to register all their consecutive LHs between April 2014 and November 2015 at a newly 
introduced web-based application, https://www.QUSUM.org (QUality indicator of SUrgical 
performance in Minimally invasive surgery).
Gynaecologists were recruited by a personal email invitation. A study notification in the 
NTOG (Dutch Journal of obstetrics and gynaecology) and an email newsletter through the 
WGE (Working Group Gynecologic Endoscopy) were published to increase the number of 
participants. 
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Interventions
Control group
Participants assigned to the control group received access to the web-based application. 
Directly after entering a LH procedure, feedback on surgical outcomes was provided by 
showing three cumulative Observed minus Expected proficiency graphs for three surgical 
outcomes (blood loss, operative time and complications) (Figure 1). These graphs provided 
the surgeon with immediate individual feedback.
Intervention group
The intervention group also received access to the web-based application. Besides the 
individual, immediate feedback graphs as well gamification elements were shown (Figure 
2 and Figure 3A, 3B, 3C, 3D, 3E).
The gamification elements were developed by experts from the Institute of Psychology, Leiden 
University, and were selected to induce competition, motivation and collaboration based on 
positive enforcement. They consisted of three key components; 1. points that could be earned 
when there was registered procedure had less blood loss and/or less operative time than 
what could be expected based on the case mix, and points for the contribution of knowledge 
to the study (i.e., by providing additional information concerning the procedure, Figure 
3A, 3B and 3C), 2. participants could earn individual achievement badges for their general 
contribution by registering procedures (Figure 3D) and, 3. insight in a monthly collective 
score which represented the aggregate scores of all registered procedures per month of all 
participants in the intervention group. Each month the scores of the QUSUM collective were 
compared with existing national benchmark data (Figure 3C and 3E). In addition to these 
key components, an activity tracker showing the latest contributions of all participants was 
visible at the homepage (Figure 3A). Also, after entering a procedure, a message popped-up 
showing how many points the participant had earned (Figure 3B). 
The application complied with NEN 7510 standards (Dutch certification regarding informatics 
and security in the healthcare field) and was approved by the privacy officer at Leiden University 
Medical Center. Since no identifiable patient data was requested, this study was exempted 
from approval by our Institutional Review Board at Leiden University Medical Center. 
Outcome measure
The primary outcomes of this study were engagement and involvement of participants 
to register their procedures, which were assessed by the use of a web-based survey. This 
survey was developed by the Institute of Psychology at Leiden University and was send to all 
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participants at the end of the study period (November 2015). A Likert scale of 1 to 5 was used 
(never to always, never to a great deal, not at all to very, not at all to always). It is shown that 
different types of motivation can be most objectively answered using Likert-scales (Ryan & 
Connell, 1989). Furthermore, involvement and engagement were assessed by the behavior 
of users as logged by the application (e.g., number of login sessions, number of active views 
of features of the application). Furthermore, during initial registration, the users were asked 
to rate their motivation to participate in this study on a Likert scale 1 to 5 (e.g., very low to 
very high), to enter the number of LHs performed yearly (their annual surgical volume), to 
enter the total amount of LH performed during their career (their experience) and to enter 
the number of years they were performing LHs (Table 1).
As secondary outcome was selected; the effect of the gamification elements on the 
surgical performance, which was defined as operative time, intraoperative blood loss, 
and complications. Operative time was described as the number of minutes between the 
Figure 2 Homepage QUSUM application (https://www.QUSUM.org) as seen by users randomized in 
the intervention group.
All gamification elements are explained in Figure 3. Participants randomized in the control group had no ac-
cess to these gamification elements: QUSUM collective scores, monthly comparisons of QUSUM Collective 
Scores, Achievements, Recent QUSUM Collective Activities (Activity tracker).
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Figure 3 Gamification elements used in QUSUM application.
A. Activity tracker, showing the latest contributions to the QUSUM study by the participants in the 
intervention group. Here, participants are able to see that other participants (from the intervention group) 
are contributing to the total score.
B. After register a new procedure, a message pops-up that shows how many points the participant had 
earned by registering this very procedure.
C. The user is part of the QUSUM collective (represents the scores of all registered procedures of all 
participants). When the user performs better than expected, a contribution is made to the collective scores.
Figure 3 Gamification elements used in QUSUM application.
D. Overview of personal achievements.
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first incision and insertion of the final stitch, blood loss was measured in millilitres, and 
complications were registered as determined by the Dutch Society of Obstetricians and 
Gynecologists (Twijnstra, Zeeman, & Jansen, 2010).  
Figure 3 Gamification elements used in QUSUM application.
E. Monthly comparison of QUSUM Collective Score; when the QUSUM collective (i.e., all participants in the 
intervention group) performs better than the national benchmark this is indicated by a green scale, when 
the collective performs worse this is indicated by a red scale.
Table 1 Baseline characteristics of participants
All participants 
N=71, Mean (SD)
Gamification 
group N=37, 
Mean (SD)
Control 
group N=34, 
Mean (SD) P value
Total number of entered procedures 27.5 (23.1) 27.4 (18.2) 27.6 (27.5) 0.98
Initial study motivation of users a 3.9 (0.7) 4.0 (0.83) 3.9 (0.92) 0.22
Years of experience b 6.0 (4.3) 5.3 (3.6) 6.8 (4.9) 0.15
Surgeon’s annual volume c 28.7 (10.7) 27.2 (11.2) 30.4 (10.1) 0.21
Surgeon’s experience d 150.9 (137.3) 129.7 (108.4) 173.9 (161.6) 0.18
a Likert scale 1 to 5 (very low to very high).
b The number of years performing laparoscopic hysterectomies.
c The number of laparoscopic hysterectomies performed yearly.
d The total amount of laparoscopic hysterectomies performed during their career.
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Sample size
A prospective sample size calculation was not applicable for this study, since the intent 
was to include as many gynecologists as possible. We consider a retrospective sample size 
calculation as arbitrary. 
Randomization
During initial registration participants were randomly assigned to either the control or the 
intervention group using computer-generated randomization. Block center randomization 
was applied, meaning that gynecologists from the same center were allocated in the same 
group, in order to avoid notification of the other study condition when discussing results 
with direct colleagues. Participants were included for analysis when at least one procedure 
was entered in the application.
Figure 4 Flowdiagram of participants.
153
Gamification to enGaGe clinicians in reGisterinG data
9
Statistical methods
For the statistical analysis, SPSS version 22 (IBM Corp., Armonk, NY) was used. Mean values 
of surgical outcomes were calculated with their standard deviation (SD). Differences were 
statistically significant at p<0.05.
To account for clustering of data from multiple entered procedures by a single surgeon, 
generalized estimation equations were used for the analyses of differences of surgical 
outcome between the two groups. Logistic regression was used to analyse the difference 
between the groups with respect to their activity on the application. Dependent variables 
used in this model included total number of entered procedures and study motivation of 
users. The questionnaire regarding engagement and involvement consisted of multiple 
subscales, measured on a 5-point Likert scale. For each subscale the Kaiser-Meyer-Olkin 
(KMO) measure was used to assess the general factor structure. Then, for each subscale 
that met the KMO criterion of > 0.5, a factor analysis was performed to assess which items 
to include in the subscale. Items with factor load < .30 were removed. Finally, the reliability 
of each subscale was calculated using Cronbach’s Alpha. We adopted the threshold value of 
.70 or above to consider the subscale as reliable. In order to assess the influence of condition 
on the various subscales, a MANOVA was conducted. 
Results
From April 2014 to November 2015, a total of 71 Dutch gynecologists enrolled in the study and 
entered one or more LH procedures. Of the participants, 37 gynecologists were randomized 
in the gamification group and 34 participants in the control group. A total of 53 participants 
(75%) completed the survey, of which 28 of the gamification group and 25 of the control 
group (Figure 4).
A total of 1833 LHs were registered. The mean ±SD number of entered procedures of 
participants was 27.5±23.1 (Table 1). Surgical volume and experience of both groups is 
shown in Table 1. 
Engagement 
The observed mean (±SD) for the engagement subscale was 2.44±0.96 for all participants 
combined (Table 2). No significant difference was found between the two groups; 2.34±0.87 
for the intervention group versus 2.56±1.05 for the control group (p=0.41).
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Involvement 
For the involvement subscale a score of 3.49±0.83 was observed for all participants combined 
(Table 2). No significant difference was found between the two groups, respectively 3.63±0.57 
versus 3.33±1.03 for the intervention and the control group (p=0.19). The majority of both groups 
considered the contribution to the QUSUM study as (very) important (Likert scale of 3.96±1.0). 
Activity on application
No significant difference for any activity on the application was observed between the 
two groups (Table 3). A mean of 22.2±18.8 login sessions was observed for all participants 
combined.
Table 2 Engagement and Involvement outcomes
Survey question per domain
All 
participants, 
Mean (SD)
Gamification 
group, Mean 
(SD)
Control 
group, 
Mean (SD) p-value
Domain engagement 2.44 (0.96) 2.34 (0.87) 2.56 (1.05) 0.41
How often, while performing a LH, do you 
think about the outcomes shown in the 
QUSUM graphs? a
1.91 (1.2) 1.58 (0.96) 2.19 (1.3)
How often, while registering a LH into the 
QUSUM application, do you think about the 
QUSUM graphs? a
3.25 (1.5) 3.06 (1.4) 3.41 (1.5)
Outside of performing and registering LHs, 
how often do you think about the QUSUM 
graphs? a
2.07 (1.1) 1.68 (0.9) 2.41 (1.1)
In general, during your participation in 
the QUSUM study, how much have you 
talked about the QUSUM study with your 
colleagues? b
3.09 (1.1) 3.10 (1.0) 3.08 (1.2)
Domain involvement 3.49 (0.8) 3.63 (0.57) 3.33 (1.03) 0.19
Do you think that the QUSUM study will 
improve the surgical outcomes for LH in 
general? c
3.26 (1.0) 3.26 (0.9) 3.27 (1.7)
Do you think it is important to contribute to 
the QUSUM study? 
3.96 (1.0) 4.16 (0.8) 3.78 (1.1)
Do you strive to score above average on the 
surgical outcomes as shown in the QUSUM 
graphs (operative time, blood loss, and 
complications)? d
3.54 (1.2) 3.65 (0.9) 3.46 (1.5)
a Likert scale 1 to 5 (never to always, b never to a great deal, c not at all  to very, d not at all to always.
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Surgical outcomes
A significant difference was observed for mean (±SD) operative time. The intervention group 
showed longer operative time (108±42 minutes) than the control group (101±34 minutes) 
(p=0.039). For blood loss and complications no significant difference was observed between 
the two groups, 122±164 vs. 144±173 mL and 4.8 vs. 8.7%, for respectively the intervention 
and control group (Table 4).
Table 3 Activity on application
All 
participants 
N=71, Mean 
(SD)
Gamification 
group N=37, 
Mean (SD)
Control 
group 
N=34, 
Mean (SD) p-value
95% 
confidence 
interval of the 
difference
Number of login sessions 22.2 (18.8) 22.9 (18.2) 21.5 (19.8) 0.53 -7.6 – 10.4
Number of active views 
of individual feedback 
graphs
3.1 (4.0) 2.5 (2.4) 3.8 (5.3) 0.59 -3-3 – 0.64
Number of active views of 
list of entered procedures
22.6 (30.1) 19.4 (20.0) 26.1 (38.2) 0.96 -21.5 – 8.0
Table 4 Surgical outcomes of entered procedures per randomized group
All procedures
N=1833
Gamification 
group, N=922
Control group, 
N=911 p-value 
Operative time min, mean (SD) 104.4 (38.5) 107.8 (42.1) 101.0 (34.0) 0.04
Blood loss mL, mean (SD) 132.8 (172.9) 122.1 (164.0) 143.6 (172.8) 0.27
Complication rate 6.7% 4.8% 8.7% 0.29
BMI, mean (SD) 28.5 (11.6) 28.4 (12.8) 28.5 (10.1) 0.82
Uterine weight gram, mean (SD) 214.9 (205.5) 220 (201.8) 209 (208) 0.46
Ease of use of application
A significant difference was observed regarding the clearness of the possibilities of the 
QUSUM application. Participants in the intervention group, who used the application with 
gamification elements showed lower scores (3.65±1.2) than the control group (4.24±0.7) 
(p=0.019) (Table 5). Overall, registering procedures in the applications is considered for the 
majority of users as (very) easy (4.46±0.7). The individual, direct feedback graphs for surgical 
outcomes (Figure 1), which are provided in both groups, are considered clear (overall score 
of 3.56±1.2) and useful (overall score 3.79±1.1).
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Conclusions
The addition of gamification elements in a registry system did not enhance the engagement 
and involvement of clinicians to register their clinical data. In addition, our results showed that 
the features of the application were significantly less clear for the users in the gamification 
group, which can be explained by the fact that this version of the application consisted 
of many more elements that need to be understood. This may suggest that easiness and 
simplicity of an application is more important to engage users. Furthermore, if we look 
at surgical outcomes, we observed a significant difference in operative time in favor of 
the group without gamification elements. Therefore, our results demonstrated that the 
addition of gamification elements did not show any advantages and may even imply that 
the gamification elements could distract users from the primary goal of the application, 
which is the provision of direct feedback to the surgeon.  
In general, the application introduced in this study was rated as very useful and (very) easy to 
use by the majority of participants (Table 4). Therefore, we recommend that registries should 
be simple and exclusively collect data that is truly relevant and usable. In addition, we assume 
that gamification elements will also be distracting in more comprehensive registry systems. 
Another important result is that the majority of users believe it is important to contribute to a 
study and consider that the registration of procedures in the application has positive impact 
on their clinical performances (Table 2). This suggests that the participating clinicians are 
already aware about the necessity of registering clinical data, and therefore, the focus should 
Table 5 Ease of use of application
Survey questions
All 
participants,
Mean (SD)
Gamification 
group,
Mean (SD)
Control 
group, 
mean (SD) p-value
Have the possibilities of the QUSUM 
application (registering, reviewing own 
procedures, etc.) been clear to you? a
3.97 (1.0) 3.65 (1.2) 4.24 (0.7) 0.02
Registering LHs in the QUSUM application 
is (very difficult to very easy) b 
4.46 (0.7) 4.48 (0.7) 4.43 (0.6) 0.75
Has it been clear to you how to interpret 
the QUSUM graphs of surgical outcomes 
(operative time, blood loss, and 
complications)? a
3.56 (1.2) 3.39 (1.3) 3.70 (1.2) 0.30
Do you consider the QUSUM graphs of 
surgical outcomes (operative time, blood 
loss, and complications) as provided by the 
QUSUM application useful? c
3.79 (1.1) 3.62 (1.2) 3.95 (1.0) 0.22
a Likert scale 1 to 5 (not at all to completely, b very difficult to very easy, c not at all to very much. 
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be placed on making this easier and less comprehensive for them.  Furthermore, to reduce 
the extensive administrative workload of clinicians, a future development of new registries 
should be the possibility to implement these in existing data systems. 
A strength of our study is the fact that this is, in our knowledge, the first study that determined 
the effect of gamification elements in a randomized control design study. Considering 
the current extensive administrative workload for clinicians this is an interesting topic 
(Woolhandler & Himmelstein, 2014) and attempts to make registries more fun and more 
easy for clinicians are increasingly relevant. Although we conducted our study with the 
use of a registry application for laparoscopic hysterectomy, we consider our results to be 
generalizable to registries of other kinds of procedures and specialties.  
The benefits of additional gamification elements are previously demonstrated in other 
domains of healthcare (e.g., simulation training for residents and patient engagement to 
rehabilitation) (Kerfoot & Kissane, 2014; Dithmer et al., 2015). However, unexpectedly, our 
study did not show any benefits from the applied gamification elements in the domain of 
doctor’s engagement and involvement to register clinical data. In comparison to other fields, 
the use of gamification elements in medical (research) registries has several limitations 
regarding the choice of elements. As privacy issues limits the boundaries of possibilities in 
gamification, we also must be careful with the use of elements, which are considered to be 
fun respecting patient related outcomes. Furthermore, in many cases the financial resources 
are limited to properly design a registry system and their gamification elements.  
A possible limitation of our study could be the fact that the used gamification elements were 
not intuitive enough for users to understand, which could result in the opposite effect of their 
initial goal. A potential solution for this problem is to instruct all users first about the exact 
meaning of the gamification elements. However, this will shift the accent to games instead 
of registration. And in daily practice this is probably a mission impossible, since we will all 
recognize the fact that reading of a detailed guideline and/or instruction is cumbersome and 
annoying for clinicians. Therefore, we consider that gamification elements can only have a 
chance of success, when the meaning is completely intuitive and no detailed explanation 
required. Another potential weakness is the relatively low number of participants, however 
since the participants entered more than 1800 procedures they were sufficiently exposed 
to the gamification elements.  
Much research has demonstrated the positive impact of feedback on clinical outcomes 
and professional practice (Ivers et al., 2012; Maruthappu et al., 2015; Foy et al., 2005; 
Trehan, Barnett-Vanes, Carty, McCulloch, & Maruthappu, 2015). Therefore, another possible 
explanation of our results might be the following: the individual, immediate feedback 
graphs on surgical outcomes, which were shown in both groups (Figure 1), may already have 
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provided enough positive enforcement to involve users. As a consequence, no difference 
between the groups was observed.  
With this study we investigated the question, how to make a registry system more attractive 
for clinicians to register data. To conclude, our study showed that the addition of gamification 
elements in a registry did not affect engagement and involvement of clinicians. Based on our 
results, we advise that registry systems for clinical data should be as simple as possible with 
the focus on the main goal of the registry. This is especially true considering the increased 
pressure to register a large amount of (clinical) data currently; irrelevant features, which can 
distract users from the primary task, should therefore be minimized.
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Quality assessments of surgical care and patient safety issues have become increasingly 
important in health care. To ensure that patients receive the highest level of care, the 
healthcare system needs reliable tools for assessing quality. In this thesis, we developed a 
new quality assessment tool for laparoscopic hysterectomy (LH) and explored new methods 
to correctly measure, compare and improve the quality of surgical care. Furthermore, the 
implementation of advanced laparoscopic procedures in gynaecology in the Netherlands 
and in residency is described.
Quality assessment of surgical care is especially important when new technologies are being 
introduced or complex surgical techniques such as minimally invasive surgery (MIS) are 
being performed. Currently, a worldwide on-going shift towards surgical indications in the 
minimally invasive approach is observed. First, we determined how advanced laparoscopy 
was implemented in gynaecology in The Netherlands (Chapter 2), and observed a significant 
increase in the total number of laparoscopically performed procedures (three times as high as 
5 years ago). The tremendous increase was mainly due to the major increase of the number 
of LHs performed. This was especially caused by a shift in indications, which we discussed in 
Chapter 3; a large uterus, oncology and high BMI are nowadays also appropriate indications 
for LH. However, since not every clinic or gynaecologist has the resources or skills to provide 
LH for these more challenging cases, the possibility for referral is of highest importance to 
offer the patient the most minimally invasive approach of hysterectomy.  
We observed that surgeons encounter new dilemmas because of the wide introduction of MIS 
and the rapid introduction of new technologies (Chapter 3). New devices could potentially 
be introduced into the operating room without proper evidence of their benefit and safety 
[1], which could lead to patient safety issues in daily clinical practice. This was also observed 
after the wide introduction of the laparoscopic power morcellator. Years after its introduction, 
the U.S. Food and Drug Administration (FDA) issued a statement discouraging the use of 
power morcellation in the majority of women undergoing hysterectomy or myomectomy 
for uterine fibroids due to the potential risk of upstaging of an occult uterine sarcoma [2]. 
Maintaining knowledge of these matters and knowledge of new introduced instruments is 
essential to assure the quality of care. 
Case volume and experience as quality assessment measurement?
Nowadays, case volume and surgical experience is often discussed as a proxy for quality 
assessment measurement [3-9]. In Chapter 2, we showed that introducing an annually case 
volume of 20 advanced procedures will have considerable consequences for daily practice. 
Almost 40% of the practicing gynaecologists and 12% of the hospitals in the Netherlands 
would not meet this requirement. To supply all gynaecologists who perform advanced 
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laparoscopic procedures with at least 20 advanced laparoscopic procedures, the total 
number of laparoscopic procedures needs to rise annually with 15% (740 procedures).  We 
consider that centralization of certain high-complex laparoscopic procedures is inevitable 
to accomplish a required case volume and to maintain individual surgical skills to perform 
these. However, case volume as quality assessment measurement should be introduced 
with caution. No firm evidence is available regarding the optimal case volume in the field 
of (advanced) laparoscopic gynaecology [10]. Furthermore, volume seems to be an indirect 
indicator for other important aspects of health care providers, such as process and/or 
structural aspects, potentially explaining the positive volume-outcome association [11]. In 
addition, arbitrarily chosen volume criteria seem to be weak and ignore the fact that high 
volumes do not rule out suboptimal care, and lower volumes do not exclude high-quality 
surgery [12]. The same applies for surgical experience, as described in Chapter 7; here we 
observed a decrease in operative time and conversion rate until 100 and 50 LH procedures 
respectively. However we also found that a very experienced surgeon is not necessarily a 
guarantee for the best surgical outcome, and experience alone is not sufficient to assure 
the quality of surgical care. Therefore, case volume and/or experience is not a sufficient 
measurement assessment to assure surgical quality, and we consider that other factors such 
as individual surgical skills will provide more relevant information on the actual quality of 
surgical performance.
Trends in type of hysterectomy
In Chapter 2 we described trends in the distribution of hysterectomies.  A significant and 
preferable decrease in abdominal hysterectomy (AH) is observed, and is responsible for 
58% of the increase in LH.  However, an undesirable decrease in the number of vaginal 
hysterectomies (VHs) was also observed, which is a matter of concern, given that VH is 
still considered the approach of first choice for hysterectomy [13, 14]. The observations 
from Chapter 2 are rather paradoxical; on the one hand, a preferred increase of advanced 
laparoscopic procedures is observed, however, on the other hand, this increase is mainly 
caused by the expansion of LH, which is partially at the expense of the VH. Therefore, we 
need to scrutinize if this shift in hysterectomy (i.e., VH to LH) is actually unwanted. Since the 
advantages of the laparoscopic approach become more apparent, the gold standard for 
hysterectomy is currently a matter of debate; patient related outcomes such as pain and 
hospital stay seem to be in favour of the laparoscopic approach. However, operative time 
and costs are still in clear advantage of VH [13, 15-18]. We do not exclude that in the future 
LH may be comparable to VH in terms of clinical outcomes and costs, however for now VH 
should be brought back in focus, and we need to ensure that this approach of hysterectomy 
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does not disappear from the gynaecologic surgical palette. This is especially important during 
residency; in Chapter 4 we observed that residents are less interested in performing VH 
compared to AH. Furthermore, residents’ experience in VH seems relatively low, and studies 
have shown that the majority of residents perform less than 20 VHs during residency [19-21]. 
As a result, graduating residents expressed a lack of confidence in performing VH, and these 
concerns are widely recognized in the literature 22. 
This matter brought us to the question, how proficient are residents actually to perform the 
different approaches of hysterectomy and to perform (advanced) laparoscopic procedures? 
In Chapter 4 we explored this question. We concluded that residents are perfectly trained 
for basic and intermediate laparoscopic surgical procedures (Chapter 4, Table 3), but not 
sufficiently trained to perform advanced laparoscopic procedures without supervision. This 
includes the lack of proficiency to perform LH after residency, and additional training (in 
the form of a fellowship) is required after residency to perform these procedures without 
supervision. In addition, we observed that 42% to 61% of the gynaecologists were not even 
interested in performing advanced procedures, and 63% to 96% of gynaecologists no longer 
perform any advanced laparoscopic procedures after graduating (Chapter 4). 
Training programs are under pressure as work-hour restrictions have affected the resident’s 
case experience and a growing emphasis is placed on subspecialties [23-25]. Therefore, we 
advocate that training of advanced laparoscopic procedures should only be reserved to a 
selected group of residents, and preliminary selection during residency is recommended 
(to note, minimal knowledge of advanced laparoscopic procedures is still required for all 
residents). This selection of residents can be conducted by means of interests of residents 
to perform advanced procedures as well as their variation in competence level (Chapter 
4). However, the use of Objective Structures Assessment of Technical Skills (OSATS) to 
measure proficiency of residents is not regarded as completely sufficient and objective [26, 
27].  Therefore, reliable quality assessment tools to measure the quality and skills of both 
residents and gynaecologists are needed. This is particularly relevant for more complex and 
frequently performed procedures such as LH. 
Requirements of a Quality assessment tool
A first essential step towards reliable quality assessment of surgical performance is insight 
into case-mix variables (i.e., patient characteristics that influence surgical outcomes). The 
differences in case-mix variables between hospitals and surgeons are often ignored in used 
quality indicators, and this provides the clinician, the insurance company, and the patient 
with a certain false sense of (in)security. For a reliable interpretation and comparison of 
surgical outcomes, a correction for case-mix is of highest importance. 
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To identify all relevant case-mix characteristics for surgical outcomes of LH, we conducted 
a systematic review as described in Chapter 5. We observed that most studies of high 
quality described a statistically significant association between higher BMI, high uterine 
weight, and less favourable surgical outcomes for LH such as blood loss, operative time, 
conversion to laparotomy and complications. Also, adhesions and previous operations 
seemed to be important predictors for the outcomes of LH. Based on our search, we found 
that a case-mix correction for at least uterine weight and BMI is strongly recommended 
when assessing and comparing surgical quality of LH. Besides, evidence-based knowledge 
of case-mix characteristics is important considering patient counselling, surgical scheduling 
and medico-legal issues. This is especially relevant for clinics such as referral hospitals that 
are treating more complex patients. 
New Quality Indicator for LH
Taken into account the aforementioned requirements to measure surgical quality, we developed 
and validated a web-based quality measurement tool for LH called QUSUM (QUality indicator of 
SUrgical performance in Minimally invasive surgery). This was performed in collaboration with 
the department of Medical Statistics and the Institute of Psychology, as described in Chapter 
6. This online and real-time application was (inter)nationally launched in a prospective study 
(www.qusum.org), and used by gynaecologists all over the world that registered in total more 
than 2000 LHs. The primary functions of this tool were to measure surgeon’s performance, to 
provide immediate individual feedback, and to detect consistently suboptimal performance, 
all corrected for case-mix characteristics. Directly after registering a new LH procedure, three 
risk-adjusted Observed minus Expected (O-E) cumulative graphs were shown to the surgeon; 
one graph for each primary outcome (i.e., blood loss, operative time and complication score). 
The difference between the observed outcome (O) and expected outcome (E) was calculated 
(O‒E), and the cumulative sum of O-E was plotted as a time series (Chapter 6).
To test the application, we used the System Usability Scale (SUS), a highly robust and 
validated survey scale that allows users to assess the usability of an application [28]. The 
mean SUS score for our QUSUM application was 76.5, suggesting that the application has 
good to excellent usability and that the features selected were appropriate for our group 
of participants. In addition, the majority of participants reported that using the QUSUM 
application increased their awareness regarding their performance, surgical outcomes, 
and patient risk factors during the procedure. This will lead to self-evaluation and control 
of individual outcomes, thereby inherently improving surgical outcome. We consider our 
developed QUSUM application to be a unique tool as it is easy to use, provides immediate 
feedback to the surgeon, and includes a case-mix correction.
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We observed that quality assessment is a dynamic process, as our study showed that the 
benchmark for surgical outcomes changed significantly over time (Chapter 6). The QUSUM 
application is developed to be dynamic and established benchmark data can be adjusted 
when required. Furthermore, our used benchmark values and case-mix characteristics 
were based on a previous prospective multicenter cohort study [29]. These are important 
prerequisites when developing an evidence-based quality indicator. 
Another important issue regarding quality assessment is that most of the published quality 
indicators are based on hospital outcomes and not on individual surgeon’s outcome measures 
as the QUSUM application. With a retrospective analysis of 1618 LHs we demonstrated in 
Chapter 7 that monitoring outcome measures exclusively on hospital level would not 
always detect an individual outlying surgeon (i.e., surgeon with consistently suboptimal 
performance).  We observed that suboptimal outcomes of a lesser-skilled surgeon were 
masked by the superior skills of other surgeons in the same hospital, resulting in average 
quality outcome measure for the hospital. As a result, suboptimal care could potentially be 
delivered for an undue length of time, without the possibility to detect this. Therefore, we 
concluded that quality assessment should also be monitored on individual surgeon’s level. 
It is important to note that the reliability of entered data for registries and quality indicators 
is always dependent upon the integrity of the clinician. Previous studies have shown that 
this accuracy is generally high [29, 30]. In addition, in the future the application might be 
implemented into the electronic patient record and, outcome data will be transferred 
automatically, which makes incorrect registration difficult. However, we want to emphasize 
that a quality indicator should not have a punitive goal. Data measured by a quality indicator 
are generally a close approximation of reality, but may not always reflect the true situation 
precisely. Therefore, penalizing surgeons and/or hospitals based only on the raw data of 
quality indicators may not necessarily be appropriate. When a specific indicator provides 
a less favourable outcome, this should be considered as first sign to reflect on the below 
average outcome. 
With our developed QUSUM application we created the possibility for clinicians to reflect 
and evaluate their individual performances. In the same application, we also implemented 
a patient safety risk factor checklist based upon previous research [31]. This checklist 
consisted of an adapted framework of risk factors in MIS and was composed of 10 different 
domains; surgeon related, surgical team, technology, social interaction, environment, patient, 
fallibility, safety, anaesthesiology and other. If any risk factors were observed during the 
procedure, which potentially could have influenced the clinical outcomes, the participating 
gynaecologist could optionally enter this information into the checklist when registering the 
procedure. We consider that the embedding of a patient safety risk factor checklist in used and 
new registries help surgeons to evaluate, reflect and improve their individual performance. 
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In Chapter 8 we identified and quantified all entered patient safety risk factors in LH and 
determined their influence on surgical outcomes. We observed that in 28% of LHs a risk 
factor checklist was entered. The most reported risk factor domains were surgeon related 
risk factors (19.6%), surgical team risk factors (14.4%) and technology related risk factors 
(16.6%, e.g., availability and functioning of equipment and instruments). 
We observed significantly less favorable surgical outcomes in the group of LHs where 
a risk factor checklist was registered. Technological incidents are the most significant 
and important risk factors influencing surgical outcomes of LH. Implementation of new 
technologies in surgery is challenging for practicing surgeons, especially when it comes to 
complex procedures such as MIS. As technology evolves rapidly over time, we should no 
longer accept technological failures. Therefore, future changes in MIS need to focus on these 
technological incidents and errors. General knowledge of technical issues and knowledge 
on how to handle instruments and errors should be mandatory before participating in MIS 
and the introduction of new instruments brings a responsibility to the whole surgical team. 
Risk factors regarding the surgical team (e.g. lack of experience/knowledge of scrub/
circulating nurse) seem to be relevant as well with respect to surgical outcomes.  A dedicated 
and skilled surgical team will be more efficient, will better communicate with each other and 
will potentially enhance patient safety. Yet, the main responsibility for a procedure always 
lies primarily in the hands of the surgeon and not in the first place of the other members of 
the surgical team. The same applies to the participation of a resident, which is frequently 
mentioned as justification for less optimal surgical outcome. However, recent research 
showed that trainee involvement was not associated with adverse patient safety or a higher 
overall complication rate [32, 33]. In addition, the primary surgeon, in this case the teacher 
remains responsible for achieving favorable surgical outcomes
Since the improvement of patient safety and the quality of care are both high on the 
international political agenda [34], the registration of clinical data is indispensable in the current 
duties of a clinician. Consequently, it is not surprising that the engagement and motivation of 
clinicians to register their data is essentially for the success of a quality assessment registry.
In this context, we hypothesized that gamification elements may offer opportunities to 
motivate and engage doctors to participate in medical registries. Gamification can be 
explained as the use of game elements and techniques in existing applications or in nongame 
contexts, to motivate and engage users with a system [35]. Gamification focuses on making 
necessary and annoying tasks more enjoyable through a positive approach [36]. During 
the last few years gamification is used within a broad variety of domains, such as finance, 
health, education, news and entertainment, by earning badges, point and achievements 
when completing specific tasks [37]. 
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In Chapter 9 we explored, in collaboration with the Institute of Psychology, the additional 
value of gamification elements in a registry system for LH in terms of engagement and 
involvement of gynaecologists to register their outcome data. In a randomized control trial 
we observed that gamification elements did not show any advantages, and that it may even 
distract users from the primary goal of the application. Therefore, we recommend that new 
and existing registries should be simple, and exclusively collect data that are truly relevant 
and usable. This is especially true considering the increased pressure to register a large 
amount of (clinical data) currently, and irrelevant features, which can distract users from 
the primary task, should therefore be reduced.
In this context, we should ask ourselves which data is truly relevant? In this thesis we focused 
on (surgical) outcome measures. However, one may question whether a slightly longer 
operative time is truly clinically relevant to the patient and her recovery? Still, recent studies 
reported a direct relationship between a longer operative time and an increased risk of 
complications, reoperations, and higher hospital costs [38, 39]. Moreover, it is increasingly 
important to take into consideration patient’s perspectives on their health status, also 
known as the patient-reported outcomes measures (PROMs). In the near future, we expect 
that PROMs and Value Based Health Care as defined by Porter et al. will become and adopt 
an important position when assessing quality of care [40]. 
To conclude, quality assessment in surgical care is very important, though very difficult. With 
this thesis we attempted to overcome the limitations of currently used quality indicators 
and developed a dynamic, unique quality assessment tool to reflect upon individual surgical 
performance with case-mix correction. 
Future perspectives
To enhance patient safety, monitoring quality of health care is indispensable. In this thesis 
we described different possibilities and requirements in the domain of quality assessment 
for surgical procedures. We consider this as a foundation for the development of new 
quality indicators for other surgical procedures, and recommend that surgeons and other 
healthcare providers take the lead in developing suitable evidence-based quality indicators 
using this thesis as a starting point. Our developed QUSUM application can therefore easily 
be adapted to other procedures. An important prerequisite is first to define and select 
clinically relevant outcomes, that can be measured instantly and that reflect performance 
quality for that specific procedure. Thereafter, it is necessary to determine benchmark 
data and case-mix characteristics for the selected procedure, preferable by performing 
a prospective study. A correct case-mix adjustment is of major importance to correctly 
benchmark surgical outcomes, especially because the concern of surgeons for incorrect 
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negative performance ratings is a great problem in the field of quality assessment and 
transparency.
Looking at quality improvement of surgical care, Geoffrey Rose has stated the famous 
prevention paradox [41]: for high-risk procedures much individual gain can be achieved, while 
on the other hand, when in a large number of procedures (high-volume) a relatively small 
improvement can be achieved, this will eventually result great benefits of quality of surgical 
care.  In this light, we do not necessarily argue for the development of quality assessment tools 
for every type of surgical procedure but we believe this should be particularly recommended 
for certain high-risk and/or high-volume procedures. 
A quality indicator has little value if the performance being measured cannot be improved 
(e.g., by providing feedback, detection of suboptimal performance or the opportunity for 
reflection). Therefore, the possibility to improve is key issue to enhance the quality of care, and 
future research should focus on it. For example, as this thesis showed, there is considerable 
room for improvement in the area of technological problems in MIS and attempts to enhance 
the currently used instruments and equipment should be encouraged.  
Furthermore, to correctly benchmark surgical outcomes, we recommend that at an 
international level the same definitions of clinical outcomes are adopted and used. This 
will allow quality comparisons at an international level.  
Another important aspect for future research is the definition of an outlier (i.e., clinician with 
consistently suboptimal performances) [42]. Definitions of suboptimal performances may 
be different between national and international societies.  These differences will depend 
on (inter)national benchmark values but also on cultural diversity. Awareness of these 
differences is important. 
A next step for the QUSUM project and a key issue for new registries is the possibility to 
implement these in an existing data system (e.g. electronic patient records). Currently, the 
merge of multiple registry systems is highly cumbersome and a struggle in the present 
registration climate. Logically, duplicate and inconvenient registries are extremely annoying 
for clinicians and increase their administrative workload. 
Clinicians themselves should take the lead in the development of quality registries and how to 
(publicly) release their data. We should be aware of the fact that media and/or governmental 
agencies could interpret certain quality measures incorrectly, and given the current (social) 
media possibilities these inaccuracies can be directly widely spread. Therefore, an active 
participation of the clinician is extremely important for the development of quality registries 
and for a correct interpretation of measured outcome data. 
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Transparency and measurement of quality of health care have received considerable attention 
in recent years. Quality indicators have been developed in an attempt to differentiate between 
high and low quality of healthcare processes. Assessing quality is an indispensable step to 
ensure patient safety, particularly in the field of minimally invasive surgery (MIS). In 2007 the 
report of the Dutch Health Care Inspectorate was published, in which concern was expressed 
regarding patient safety during MIS. This report stated that specific quality measures are 
needed to develop a formal quality system for laparoscopic procedures to enhance patient 
safety. However, most of the currently applied quality indicators are not corrected for case-
mix characteristics; these are patient characteristics that affect (surgical) outcome (e.g., high 
BMI, enlarged uterus). Quality assessment without correction for case-mix characteristics 
will result in an invalid comparison of outcomes among healthcare providers
In this thesis, we developed a new quality assessment tool for laparoscopic hysterectomy 
(LH) and explored new methods to correctly measure, compare and improve the quality of 
surgical care.
First, we observed in Chapter 2 a significant increase in the total number of advanced 
laparoscopically performed procedures in the Netherlands. The tremendous increase was 
mainly due to the major increase of the number of LHs performed. This was especially caused 
by a shift in indications, which we discussed in Chapter 3; a large uterus, low risk oncology 
and high BMI are nowadays also appropriate indications for LH.
Nowadays, case volume and surgical experience is often discussed as a proxy for quality 
assessment measurement. In Chapter 2, we showed that introducing an annually case 
volume of 20 advanced laparoscopic procedures would have considerable consequences 
for daily practice. Almost 40% of the practicing gynaecologists and 12% of the hospitals in 
the Netherlands would not meet this requirement. We consider that centralization of certain 
high-complex laparoscopic procedures is inevitable to accomplish a required case volume 
and to maintain individual surgical skills to perform these. However, case volume as quality 
assessment measurement should be introduced with caution. High volumes do not rule out 
suboptimal care, and lower volumes do not exclude high-quality surgery.
In Chapter 2 we also described trends in the distribution of hysterectomies. A significant 
and preferable decrease in abdominal hysterectomy (AH) is observed in favour of the LH. 
However, an undesirable decrease in the number of vaginal hysterectomies (VHs) was also 
observed, which is a matter of concern, given that VH is still considered the approach of first 
choice for hysterectomy. In Chapter 4 we observed that residents are even less interested 
in performing VH compared to AH. Furthermore, we found that residents are not sufficiently 
trained to perform advanced laparoscopic procedures without supervision. This includes 
the lack of proficiency to perform LH after residency, and additional training (in the form of 
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a fellowship) is required to perform these procedures without supervision. In addition, we 
observed that 63% to 96% of gynaecologists no longer perform any advanced laparoscopic 
procedures after graduating. Therefore, we advocate that training of advanced laparoscopic 
procedures should only be reserved to a selected group of residents, and preliminary 
selection during residency is recommended. Reliable quality assessment tools to measure 
the quality and skills of both residents and gynaecologists are therefore needed.
A first essential step towards reliable quality assessment of surgical performance is to 
get insight in case-mix variables. For a reliable interpretation and comparison of surgical 
outcomes, a correction for case-mix is of highest importance. To identify all relevant case-mix 
characteristics for surgical outcomes of LH, we conducted a systematic review as described 
in Chapter 5. We observed that higher BMI and high uterine weight are associated with less 
favourable surgical outcomes for LH such as blood loss, operative time, conversion and 
complications. Also, adhesions and previous operations seemed to be important predictors 
for the outcomes of LH.
In Chapter 6 we describe the development and validation of a web-based real-time quality 
measurement tool for LH (www.qusum.org). This online application was (inter)nationally 
launched and more than 2000 LHs were registered by more than 80 gynaecologists. The 
primary function of this tool was to measure surgeon’s performance, to provide immediate 
individual feedback, and to detect consistently suboptimal performance, all corrected for 
case-mix characteristics. The usability of the application was good to excellent. And the 
majority of participants reported that using the QUSUM application increased their awareness 
regarding their performance, surgical outcomes, and patient risk factors during the procedure.
Another important issue regarding quality assessment is that most of the published quality 
indicators are based on hospital outcomes and not on individual surgeon’s outcome 
measures as the QUSUM application. In Chapter 7 we observed that suboptimal outcomes 
of a lesser-skilled surgeon were masked by the superior skills of other surgeons in the 
same hospital, resulting in average quality outcome measure for the hospital. As a result, 
suboptimal care could potentially be delivered for an undue length of time, without the 
possibility to detect this. Therefore, we concluded that quality assessment should also be 
monitored on individual surgeon’s level.
With our developed QUSUM application we created the possibility for clinicians to reflect 
and evaluate their individual performances by the implementation of a validated patient 
safety risk factor checklist. This list consisted of an adapted framework of risk factors in MIS, 
which could be entered by the surgeon (e.g., technical failures, communication problem). 
We observed that in 28% of LHs a risk factor checklist was entered and technology related 
risk factors were most important considering patient safety (Chapter 8). 
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Currently, the registration of clinical data is indispensable in the current duties of a clinician, 
which can be annoying and cumbersome. In this context, we hypothesized that gamification 
elements may offer opportunities to motivate and engage doctors to participate in medical 
registries. Gamification can be explained as the use of game elements in existing applications 
to motivate and engage users with a system. In a randomized control trial (Chapter 9) we 
observed that gamification elements did not show any advantages, and that it may even 
distract users from the primary goal of the application. Therefore, we recommend that new 
and existing registries should be simple, and exclusively collect data that are truly relevant 
and usable.
To conclude, quality assessment in surgical care is very important, though very difficult. With 
this thesis we attempted to overcome the limitations of currently used quality indicators 
and developed a dynamic, unique quality assessment tool to reflect upon individual surgical 
performance with case-mix correction. 
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Transparantie en het meten van de kwaliteit van (chirurgische) zorg heeft de afgelopen jaren 
toenemende aandacht gekregen. Momenteel worden hiervoor kwaliteitsindicatoren gebruikt, 
die idealiter onderscheid kunnen maken tussen suboptimale zorg en hoogwaardige zorg. Het 
beoordelen van de kwaliteit van zorg is een belangrijk aspect om de patiëntveiligheid en hoge 
kwaliteit van zorg te waarborgen. De minimaal invasieve chirurgie (MIC) is een voorbeeld van 
hoogcomplexe chirurgische zorg daar met name hoogwaardige technologie bij de operatie 
wordt geïntroduceerd en waar een (aanstaande) chirurg een leercurve voor moet doorlopen. 
Deze MIC techniek werd, gezien de technologische mogelijkheden (video-laparsocopisch ope-
reren, introductie elektrochirurgie, verbeterde instrumenten etc.) aan het eind van de vorige 
eeuw plots massaal geïntroduceerd in het chirurgische pallet. In 2007 werden de beoefenaars 
van die MIC echter opgeschrikt door een zeer kritisch rapport vanuit de Inspectie voor de 
Gezondheidszorg (IGZ) over de toepassing en introductie van deze relatief nieuwe vorm van 
chirurgie. De implementatie zou tot meer complicaties leiden en bracht de patiëntveiligheid 
in gevaar. Dit leidde tot de vraag naar eenduidige kwaliteitsindicatoren binnen de MIC. Echter, 
het correct meten van de kwaliteit van zorg is zeer complex en het grootste probleem van 
de meest gebruikte kwaliteitsindicatoren is dat er niet gecorrigeerd wordt voor case-mix; 
dit zijn patiënt karakteristieken die de klinische uitkomsten kunnen beïnvloeden (bijv. een 
hoge BMI, comorbiditeit, grote tumoren, eerdere operaties etc.). Zonder te corrigeren voor 
deze karakteristieken is een eerlijke vergelijking van de chirurgische uitkomstmaten en dus 
de kwaliteit tussen ziekenhuizen en/of behandelaars niet goed mogelijk. 
In dit proefschrift beschrijven wij de ontwikkeling en valorisatie van een nieuw uniek kwali-
teitsinstrument voor de laparoscopische uterusextirpatie (baarmoeder verwijdering middels 
kijkoperatie). Ook onderzoeken wij hoe de kwaliteit van chirurgische zorg correct gemeten, 
vergeleken en verbeterd kan worden. 
In hoofdstuk 2 hebben wij de implementatie van complexe laparoscopisch ingrepen bestu-
deerd en zien wij dat deze aantallen binnen de gynaecologie enorm gestegen zijn in de afge-
lopen jaren. Deze stijging wordt met name veroorzaakt door de forse toename van het aantal 
laparoscopische uterusextirpaties (ook laparoscopische hysterectomie (LH) genoemd). In 
hoofdstuk 3 beschrijven wij dat dit vooral komt doordat de indicaties voor het uitvoeren van 
een laparoscopische uterusextirpatie steeds verder verlegd worden. Tegenwoordig komen 
ook patiënten met een grote uterus, laag stadium- en laag risico oncologische aandoening 
en een hoge BMI in aanmerking om een uterusextirpatie laparoscopisch uit te voeren.
Een hoger volume van complexe chirurgische ingrepen wordt tegenwoordig steeds vaker 
gehanteerd als maat voor kwaliteit. Een minimaal behandelvolume van 20 ingrepen per jaar 
wordt hierbij als passend beschouwd. In hoofdstuk 2 laten we zien dat het instellen van 
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volumenormen voor complexe laparoscopische ingrepen in de gynaecologie grote conse-
quenties kan hebben voor de dagelijkse praktijkvoering: 40% van de gynaecologen en 12% 
van de ziekenhuizen voeren minder dan 20 van deze ingrepen per jaar uit. Centralisatie van 
bepaalde hoog complexe ingrepen is dan onvermijdelijk om zo aan een gesteld volume te 
komen en om de vaardigheden te behouden om deze ingrepen veilig uit te kunnen voeren. 
Doch, men moet voorzichtig zijn deze normen in te stellen. Het excluderen van laagvolume 
klinieken zal niet automatisch leiden tot het uitsluiten van ondermaatse zorg, daarnaast 
spelen factoren als chirurgische skills en ervaring ook een belangrijke rol in de uitkomsten. 
Tevens zagen wij dat er een verschuiving in benadering van de uterusextirpatie in Neder-
land in de afgelopen vijf jaar plaatsvond. De abdominale benadering (via een buiksnede) 
nam significant af ten gunste van de laparoscopische benadering, Dit is een gewenste ver-
schuiving, daar de laparoscopische benadering duidelijk voordelen heeft ten opzichte van 
de open abdominale chirurgie (sneller herstel, minder peroperatief bloedverlies, minder 
infecties, cosmetiek). Echter, ook een significante afname van de vaginale uterusextirpatie 
(via de schede) ten gunste van de laparoscopische benadering werd geobserveerd. Dit is een 
minder gewenste verschuiving, omdat de vaginale uterusextirpatie tot op heden gezien alle 
voordelen voor de patiënt (geen uitwendige littekens, kortere operatietijd, minder kosten) 
beschouwd wordt als de benadering van eerste keus. 
Oorzaken van deze verschuiving onderzochten wij verder in hoofdstuk 4, waarin we de 
bekwaamheid niveaus van jonge klaren (gynaecologen die ≤ 5 jaar geleden de opleiding tot 
gynaecoloog hebben afgerond) in het uitvoeren van (laparoscopische) ingrepen analyseer-
den. Geconcludeerd kan worden dat jonge klaren minder interesse hebben om de vaginale 
uterusextirpatie uit te voeren ten opzichte van de abdominale hysterectomie. verder blijkt 
dat jonge klaren onvoldoende getraind worden tijdens de opleiding om complexe laparo-
scopische ingrepen, zoals de LH, na het afronden van de opleiding zonder supervisie uit te 
kunnen voeren. Derhalve is extra training na de opleiding (bijv. een fellowship) noodzakelijk 
alvorens complexe laparoscopische ingrepen bekwaam uitgevoerd kunnen worden. Ook 
werd gezien dat een groot deel van de gynaecologen (63 tot 96%) deze ingrepen nooit meer 
uitvoert na het afronden van de opleiding. Zodoende pleiten wij ervoor dat alleen een gese-
lecteerde groep assistenten bepaalde complexe laparoscopische ingrepen getraind krijgt in 
de opleiding. Ook voor deze selectie is een betrouwbaar kwaliteitsinstrument zeer gewenst 
om zo de chirurgische vaardigheden correct te kunnen meten. 
Een eerste stap naar de ontwikkeling van een kwaliteitsinstrument om de chirurgische be-
kwaamheid correct te meten is inzicht in case-mix karakteristieken (patiënt karakteristieken 
die klinische uitkomsten kunnen beïnvloeden). Betrouwbare onderlinge vergelijkingen van 
de kwaliteit van chirurgische zorg is niet mogelijk zonder deze case-mix correctie.
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Met behulp van een systematische review (hoofdstuk 5) hebben wij die case-mix karak-
teristieken kunnen identificeren voor chirurgische uitkomsten van de laparoscopische 
uterusextirpatie. Zo blijkt dat een hoger BMI en een vergrote uterus gerelateerd zijn aan 
minder goede chirurgische uitkomsten (meer bloedverlies, langere operatie tijd en meer 
complicaties). Ook zijn verklevingen in de buik en eerdere buikoperaties in de voorgeschie-
denis nauw gerelateerd aan minder succesvolle uitkomsten. 
Met het in acht nemen van bovenstaande vereisten, hebben wij een uniek web-based, real-
time kwaliteitsinstrument ontwikkeld (www.QUsUM.org). Dit instrument meet individuele 
chirurgische prestaties bij de LH, met een correctie voor case-mix (hoofdstuk 6). De online 
applicatie is (inter)nationaal geïntroduceerd en meer dan 2000 LH’s zijn geregistreerd door 
ruim 80 gynaecologen. Het doel van de applicatie is drievoudig: 1. het correct meten van 
individuele chirurgische prestaties, 2. de chirurg voorzien van directe individuele feedback, en 
3. het detecteren en signaleren van (opeenvolgende) suboptimale prestaties. In hoofdstuk 6 
werd onderzocht hoe de bruikbaarheid van de applicatie is. Deze bleek aan de hand van een 
referentiemeting (de sUs score) goed tot uitstekend te zijn. Daarnaast bleek de bewustwor-
ding van de individuele prestaties, de chirurgische uitkomsten en de patiënt veiligheid toe 
te nemen bij de gebruiker. Dit zijn belangrijke punten in het kader van kwaliteitsverbetering. 
veel kwaliteit uitkomsten worden momenteel gebaseerd en openbaar gemaakt op basis van 
uitkomsten op ziekenhuis niveau. In hoofdstuk 7 laten we zien dat het van belang is om de 
kwaliteit van chirurgische zorg ook op het individuele niveau van de operateur te meten. 
Zo blijkt dat de operateurs met minder optimale uitkomsten gecompenseerd worden door 
collega operateurs met (boven) gemiddeld goede uitkomsten. Dit resulteert weer in een 
gemiddeld tot goede kwaliteit uitkomst op ziekenhuisniveau. Zonder zicht op de kwaliteit 
van de individuele operateur is het mogelijk dat er suboptimale zorg geleverd wordt voor 
een onnodig lange tijdsduur. Kwaliteit moet bij voorkeur dus ook op individueel niveau 
gemeten worden, zoals wij laten zien in de QUsUM applicatie.  
Een kwaliteitsinstrument is van weinig waarde wanneer er geen verbetering mogelijkheden 
zijn. Om deze reden ontwikkelden wij een gevalideerde patiëntveiligheid risico checklist, 
welke geïmplementeerd werd in de QUsUM applicatie. Hierdoor hadden operateurs de 
mogelijkheid om na elke ingreep aan te geven wat voor risico factoren een rol hebben 
gespeeld tijdens het uitvoeren van de operatie (bijv. technische problemen, communicatieve 
problemen ect). Deze risicofactoren hebben we geanalyseerd en gekwantificeerd in 
hoofdstuk 8. Het blijkt dat bij ruim een kwart van de ingrepen een risico factor aanwezig 
was, en dat technologische incidenten de grootste rol speelden bij de patiëntveiligheid 
tijdens een laparoscopische uterusextirpatie. 
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Door de toenemende vraag naar transparantie in de zorg, wordt van artsen verwacht dat zij 
steeds meer registraties invullen. Dit is een tijdrovend proces, wordt vaak als hinderlijk erva-
ren en kan ten koste te gaan van de patiëntenzorg, Door middel van een gerandomiseerde 
trial hebben we onderzocht of gamification elementen van toegevoegde waarde zijn om 
operateurs te motiveren en te betrekken bij het registreren van data (hoofdstuk 9). Gamifi-
cation is het gebruik maken van bepaalde spelelementen in een bestaand systeem. via een 
positieve benadering zouden deze elementen gebruikers kunnen motiveren de applicatie in 
te vullen. Het bleek dat de toevoeging van dit soort elementen geen enkel voordeel heeft en 
de gebruikers zelfs kan afleiden van het primaire doel van registratie. Derhalve concluderen 
wij dat bestaande en nieuwe registratie systemen zo simpel mogelijk moeten zijn, en alleen 
relevante data geregistreerd dienen te worden. 
Concluderend, om de patiëntveiligheid te waarborgen is het monitoren van de kwaliteit van 
zorg onmisbaar geworden. In dit proefschrift worden de knelpunten beschreven, oplossin-
gen en aanbevelingen gegeven hoe de kwaliteit van de laparoscopische hysterectomie (als 
complexe minimaal invasieve chirurgische ingreep) kan worden gemeten en de ontwikkeling 
van een nieuw uniek kwaliteitsinstrument beschreven. Met een goede kwaliteitsindicator zou 
men idealiter suboptimale zorg kunnen onderscheiden van kwalitatief hoogwaardige zorg. 
Daarnaast is het van belang dat met behulp van een kwaliteitsindicator de mogelijkheid tot 
kwaliteitsverbetering bestaat. Hierin speelt individuele feedback en reflectie van en naar de 
operateur toe een belangrijke rol. De taak voor het ontwikkelen en definiëren van accurate 
kwaliteitsindicatoren ligt bij de beroepsgroepen en het gebruik van case-mix correctie is 
hierbij van essentieel belang gebleken. 
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